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Abstract 
Introduction: valid, norm-referenced questionnaires are essential for research 
and clinical practice. After initial scale validation efforts, the validity and 
reliability of questionnaires are frequently not re-assessed. The Short Health 
Anxiety Inventory (SHAI) and the Health Anxiety Questionnaire (HAQ) were 
subject to norm-generation and a validation exercise using meta-analysis. This 
information informed a commentary on the cognitive-behavioural 
conceptualisation of heath anxiety. 
Method: a reverse citation search from the publication date of each paper to 
April 2016 was conducted using Medline, PychInfo and Web of Science. Data 
was extracted regarding mean score, standard deviation, reliability coefficients 
and correlations with other measures from all studies utilising either scale. Data 
was included from a total of 137 study arms.  
Results: population norms for both scales in various populations were generated 
via the meta-analysis of mean scores. The SHAI was found to have good 
average reliability (! =0.870, computed from 54 studies) and correlations with 
other psychometric support its construct validity. There was insufficient data to 
assess the reliability and validity of the HAQ using meta-analysis.  
Discussion: under the current analysis, the SHAI was confirmed to have good 
construct validity and reliability. Correlations between the SHAI and other 
measures provided evidence that supported the cognitive-behavioural 
conceptualisation of health anxiety. There was no evidence that the HAQ lacked 
construct validity, however this could not be confirmed with the available data.  
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1.1. Introduction 
Health anxiety will affect everyone at some point in their life.  For some, 
however this anxiety can be debilitating and will severely interfere with daily life 
(Salkovskis & Warwick, 1986; Tang et al., 2009). In contrast to non-anxious controls, 
those with more severe health anxiety or hypochondriasis will not be reassured by a 
doctor following a benign diagnosis of a bodily state that is causing worry (Lucock, 
Morley, White, & Peake, 1997). It is this group that are more likely to be seen in a 
mental health clinic and require input from a clinical psychologist (Taylor & 
Asmundson, 2004). Those with health anxiety use healthcare services significantly 
more than the rest of the population (Barsky, Ettner, Horsky, & Bates, 2001), 
presumably because they do not feel reassured by doctors that they are in fact healthy.  
The prevalence of hypochondriasis or of health anxiety is difficult to assess, this 
is in part due to changes in definition over time. Noyes (2001) points out that under 
DSM-III (American Psychiatric Association, 1986) criteria a person experiencing panic 
attacks would be excluded from receiving a diagnosis of hypochondriasis, under DSM-
IV (American Psychiatric Association, 1994) this exclusion criteria was extended to 
anyone with an anxiety disorder or depression. This increasingly stricter criteria means 
fewer individuals will meet diagnostic level so will not be counted in prevalence 
studies. More recently the diagnosis of hypochondriasis has been removed from DSM-
V (American Psychiatric Association, 2013) and replaced with somatoform disorder and 
illness anxiety disorder. Accurately establishing prevalence is further complicated by 
whether one defines hypochondriasis as a categorical diagnosis, or an extreme of a 
dimensional health anxiety construct (Ferguson, 2009). The fact that hypochondriasis or 
severe health anxiety can only be established in the absence of an existing medical 
condition also contributes to the difficult in estimating its prevalence (Noyes, 2001). In 
a narrative review Noyes (2001) reported that the point prevalence estimates of 
hpochondraisis in community populations ranged from 4-25%, although the highest end 
of this estimate was derived from an older study with methodological problems. A 
systematic review of studies reporting on the prevalence of hypochondriasis in 
community samples reported rates of 4.5-10% (Creed & Barsky, 2004). When only 
including studies using DSM or ICD-10 criteria, prevalence drops to 0.2-7% (median 
4.2%). The findings of this systematic review are more robust than other prevalence 
studies as it only included papers that assessed hypochondriasis on the basis of clinical 
cut-off or diagnostic interview.  
Norm-referenced psychometric measures can complement a clinician’s 
structured assessment of health anxiety by offering a quantitative assessment of an 
individual’s symptoms. Use of norm-referenced questionnaires also enable a clinician to 
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examine whether a client’s score differs in comparison to a normative sample, provides 
an indication of the magnitude of this disparity and whether this difference is in the 
direction and to the extent that is expected (Sperlinger, 2002). Such measures are also 
essential in quantitatively evaluating the success of treatment in clinical practice and in 
formal research (Barkham, Hardy, & Mellor-Clark, 2010). Use of a norm-referenced 
questionnaire has the advantage of allowing a clinician to determine whether an 
intervention has reduced an individual’s score below an established clinical cut-off 
(clinically significant change; Jacobson, Follette, & Revenstorf, 1984) and indicate 
whether this change is sufficient in magnitude to be attributable to the intervention 
rather than measurement error (reliable change; Jacobson & Truax, 1991).  
In order for a measure to be effective it must demonstrate good construct 
validity, that is measure what it purports to measure (Strauss & Smith, 2009) and be 
reliable, or consistently assess a construct across differing testing situations and 
populations (Cronbach, 1947). Finally, so that the effectiveness of clinical interventions 
may be effectively evaluated, a measure must also be sensitive to changes in a construct 
(Vermeersch, Lambert, & Burlingame, 2000). To assess these qualities, a scale will 
undergo a validation process. This usually involves administering a pool of potential 
scale items to a large sample, participants scores are then subjected to a factor analysis 
and redundant items are deleted. The resulting scale then undergoes an assessment of 
construct validity and reliability checks. All of these steps are essential in developing 
psychometrically sound measures (Rust & Golombok, 2009). However, I argue this 
one-off validation process is insufficient and it is possible that a measure may be 
employed in research and have only undergone validation procedures in a single 
sample. This is problematic, because a scale cannot be said to have inherent construct 
validity and reliability (Vacha-Haase & Thompson, 2011). In fact, every application of 
a scale provides an opportunity to better understand its psychometric properties and the 
construct it purports to measure (Strauss & Smith, 2009).  
This thesis utilises published data to better understand the psychometric 
properties of two measures of health anxiety: The Health Anxiety Questionnaire (HAQ; 
Lucock & Morley, 1996) and the Health Anxiety Inventory (SHAI; Salkovskis, Rimes, 
Warwick, & Clark, 2002). I aim to develop normative data and investigate variations in 
the reliability and construct validity of both scales. I will also use this information as a 
means to review the construct of health anxiety from the perspective of the cognitive-
behavioural model of health anxiety (Salkovskis & Warwick, 1986). To achieve these 
aims, I systematically searched the research literature for every published application of 
the HAQ and SHAI. I then extracted data relating to each scale from these papers and 
then performed a meta-analysis on this information. 
In this first chapter, I provide an overview of the literature pertaining to health 
anxiety, including a discussion of whether it may be best described as a categorical or 
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continuous variable. I also systematically review the evidence for the cognitive-
behavioural model of health anxiety because the HAQ and SHAI are both based on this 
conceptualisation of health anxiety. This is followed by a summary of the scale validity 
literature as applied to scale development, with a focus on construct validity. Finally, I 
discuss how the scale validity literature has been applied to measuring health anxiety, 
this includes a brief review of health anxiety measures and a rationale for investigating 
the HAQ and SHAI. Chapter two outlines the method I have used including literature 
searching, data extraction, quality inclusion criteria and means of analysis. Chapter 
three contains the results of the meta-analysis of mean scores and reliability coefficients 
of the HAQ and SHAI. Chapter four consists of a review and meta-analysis of 
correlation coefficients between the HAQ/SHAI and other measures. This chapter also 
includes an evaluation of the variation in reliability coefficients using meta-regression 
Finally, chapter five will comprise my discussion of these results and places them in the 
context of the wider literature.  
1.2. What is health anxiety?  
 As previously discussed, the affective experience of anxiety about one’s health 
is something everyone will experience. Most people can reassure themselves they are 
well or a visit to the doctor will provide sufficient reassurance that there is nothing to 
fear and their anxiety will dissipate (Salkovskis & Warwick, 2001). However, for a 
significant minority, this reassurance only provides temporary relief and very soon their 
worries return (Speckens, Spinhoven, Van Hemert, & Bolk, 2000). It is this group who 
are particularly troubled by health anxiety and are most likely to require support from a 
mental health professional (Taylor & Asmundson, 2004).  
 Before proceeding, it is important to distinguish between hypochondriasis and 
health anxiety. Confusingly, the terms have been used interchangeably in the literature, 
but also may refer to different entities (Ferguson, 2009). Hypochondriasis has been 
considered both as a discrete medical syndrome characterised by a fear of having 
contracted an illness (DSM-IV; American Psychiatric Association, 1994) and as a 
dimensional construct at the extreme end of normal health anxiety (Warwick & 
Salkovskis, 1990). In DSM-V hypochondriasis has been removed and replaced by 
somatic symptom disorder and illness anxiety disorder (American Psychiatric 
Association, 2013). Ferguson (2009), points out that understanding the latent structure 
of both health anxiety and hypochondriasis is important as this will impact on the 
selection of participants for research, the design of studies and also on the content of 
clinical interventions. If hypochondriasis is a categorical entity, this would imply a 
single causal factor or multiple factors in combination that lead to a unique grouping of 
individuals. If this scenario exists, then research will need to be designed to incorporate 
individuals who fall within this group and clinical practice would be best suited to 
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follow a diagnostic approach. However, if hypochondriasis is dimensional, then this 
implies multiple causal factors and research should focus on identifying and separating 
these variables. Additionally, study samples should be selected to include all degrees of 
hypochondriasis rather than those achieving ‘caseness’ and dimensional measures 
should be used to assess the degree of health anxiety (Ferguson, 2009).   
The latent structure of hypochondriasis and health anxiety is particularly 
relevant to this thesis because, as indicated above it will affect the way I analyse the 
data collected from the literature. If both lie on a continuum, treating health anxiety as a 
continuous variable and seeking correlations with other measures and normative scores 
in different population would be appropriate. If categorical then I will need to pay extra 
attention to the description of samples and treat hypochondriasis as a categorical 
variable. It is also important as I aim to provide a commentary on the cognitive-
behavioural construct of health anxiety as assessed by both scales. 
A taxometric analysis seeks to determine whether the latent structure of a 
construct is best described as categorical or dimensional (Ruscio and Ruscio, 2004). 
Three taxometric analyses have been conducted on samples with health anxiety. The 
first Ferguson (2009) used the Whitely Index (WI; Pilowsky, 1967) to measure health 
anxiety in 711 working-age adults who did not have a physical illness. This was to 
ensure that those who were anxious about having an actual illness rather than being 
generally anxious about their health were excluded. Ferguson achieved this by asking 
whether participants were receiving any medical treatment.  This may be problematic as 
individuals may be ill (e.g. ongoing asthma) and not be receiving medical input. The 
study may also have excluded individuals who are anxious about a medical condition 
that they are not being treated for. Ferguson (2009) reported that a dimensional latent 
structure of health anxiety was best supported by the data. Ferguson suggested this 
procedure be repeated in a medically unwell sample to determine if the latent structure 
differs in the population. However, this study has been criticised for having too small a 
sample to detect whether there are two distinct groups; one being health anxious, the 
other not. This is because health anxiety is thought to have a median point prevalence of 
4.2% (Creed & Barsky, 2004), at this incidence rate, a representative sample of 711 
would contain only 31 individuals with clinically significant health anxiety 
(Asmundson, Taylor, Carleton, Weeks, & Hadjstavropoulos, 2012).  
A second analysis was conducted by Longley and colleagues (Longley et al., 
2010). They argued that Ferguson’s (2009) analysis was limited because the sample 
were middle-old aged so were more likely to be physically unwell or have past 
experience of severe illness. They also criticised the use of six items of the Whitely 
index as being too-short a measure to accurately reflect the full range of health anxiety 
(responses on three of the original nine items were not used in the taxometric analysis, 
because their validity indicators were too low). Longley et al (2010) analysed data from 
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1083 undergraduates who completed the Illness Attitudes Scales (IAS; Kellner, 1987), 
the Multidimensional Inventory of Hypochondriacal Traits (MIHT; Longley et al., 
2005) and the Whitely Index (Pilowsky, 1967). They claim that their analysis is superior 
as it focusses on younger people and uses a range of measures, so will better capture the 
hypochondriasis construct. They replicated Ferguson’s findings, concluding that 
hypochondriasis is likely to be a dimensional construct. 
More recently, Asmundson, Taylor, Carleton, Weeks and Hadjstavropoulos (2012) 
analysed IAS scores from 1768 university students using factor mixture modelling. This 
involves performing a factor analysis on the data and determining whether any factors 
are most closely related with one sub-group compared to another. The authors 
concluded that two distinct groups could be found in their sample. The two factors that 
distinguished the groups were those assessing focus on bodily states and the extent that 
these states interfered with day-to-day life. Surprisingly, the authors report that 81.4% 
of the sample fell in an ‘anxious group’ and the remaining 18.6% in a ‘non-anxious’ 
group that reported universally low scores across all factors. This anxious group was 
larger than expected: the authors had predicted an ‘anxious’ group should be 
proportionate to the prevalence of health anxiety which would equate to 7-80 
individuals. This number is based on the point prevalence rates of 0.4-4.5% reported in 
Asmundson et al., (2012), the upper estimate of 80 corresponds to the 4.2% median 
prevalence reported by Creed and Barsky (2004). In their study, Asmundson et al., 
(2012) argue that for the large ‘anxious’ sample, health anxiety exists on a continuum 
while the smaller ‘non-anxious’ sample is a distinct group that does not experience any 
health anxiety. This final study has the advantage of a large enough sample size to 
detect a smaller health-anxious subsample, although I argue the sample is still likely to 
be insufficient to detect a separate group based on a lower prevalence rate of 0.4%.  
In summary, the evidence for the latent structure of health anxiety is mixed, with 
two studies reporting a dimensional structure and one a taxonic structure. Importantly, 
all studies were consistent with the view that for those with health anxiety, this is likely 
to be a dimensional construct. 
Another difficulty with research regarding health anxiety is that its definition has 
altered over time (Starcevic & Noyes, 2014) and it shares some characteristics with 
other disorders, notably panic disorder, obsessive compulsive disorder (OCD) and 
generalised anxiety (Starcevic, 2014). I will now discuss the recent changes in the 
definition of health anxiety. This is followed by a discussion of mental health conditions 
that are related to health anxiety and somatic concerns. 
In terms of defining hypochondriasis, DSM-IV emphasised a fear of illness due 
to a preoccupation with, and misinterpretation of bodily symptoms. Key to this 
definition is a persistence of such fears despite reassurance from medical personnel 
(American Psychiatric Association, 1994). The ICD-10 (World Health Organisation, 
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1992) criteria are similar to that of DSM-IV, however differ in that they do not require 
medical investigation to be unable to account for somatic symptoms (Pannekoek & 
Stein, 2014).  
This picture is complicated by the fact that in DSM-V hypochondriasis has been 
removed and replaced by two diagnoses; illness anxiety disorder and somatic symptom 
disorder. Illness anxiety disorder emphasises the presence of anxieties about health and 
concerns about having or catching an illness, in the absence of somatic symptoms. The 
criteria also include avoidance behaviours (e.g. avoiding health-related information) or 
behaviours related to health (e.g. monitoring one’s internal states for symptoms of 
illness). In contrast, somatic symptom disorder relates to when individuals experiences 
“…somatic symptoms that are distressing or result in significant disruption in daily life” 
and “Excessive thoughts, feelings, or behaviours related to the somatic symptoms or 
associated health concerns: (p.331 American Psychiatric Association, 2013). Crucially 
it is possible to achieve diagnostic criteria for somatic symptom disorder without 
experiencing any anxiety about one’s health. In contrast, the cognitive behavioural 
model (see next section), which influenced the development of both the HAQ and 
SHAI, conceptualises health anxiety as an extreme form of worry about one’s health. 
This means that some individuals who may meet diagnostic criteria for somatic 
symptom disorder would not be considered to have health anxiety according to the 
cognitive model. 
Another important criterion for the definition of health anxiety is lack of 
responsiveness to reassurance from medical professionals. As I will outline in the next 
section, according to the cognitive model, lack of effective reassurance is a maintaining 
factor for health anxiety. Other approaches such as the interpersonal model view lack of 
responsiveness to reassurance as a causative factor and relates this to an individual’s 
attachment style and the means that they seek help from others (Stuart, 2104). 
In this thesis, I will adopt a definition of health anxiety that is consistent with the 
cognitive behavioural model, this is because both the HAQ and SHAI aim to measure a 
health anxiety construct that is founded on this model. Accordingly, the definition of 
health anxiety that I will use is “an extreme and persistent form of worry about one’s 
health that continues despite reassurance from a medical professional”. This definition 
is consistent with the DSM-IV hypochondriasis, and DSM-V illness anxiety disorder, 
however some individual’s meeting criteria for DSM-V somatic symptom disorder 
would not experience health anxiety by this definition. 
In terms of relationship with other mental health problems, health anxiety shares 
some similarities with other mental health conditions that have a somatic component 
(Starcevic, 2014). In panic disorder an individual may focus on a bodily state and 
interpret it as evidence they have a severe illness and that they are about to die as a 
result. The immediacy of the prospect of death is a difference between panic disorder 
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and health anxiety: an individual with panic disorder will feel they are going to die from 
an illness almost immediately, whereas someone with health anxiety will believe they 
will die of an illness at some time in the future. Other differences include a focus on the 
symptoms of the panic attack itself and thoughts that occur during an attack, whereas in 
health anxiety the focus is likely to be on a broader range of bodily states and will be 
present more frequently (Deacon & Abramowitz, 2008).  
OCD is another condition with some overlap with health anxiety (Ania Greeven, 
Spinhoven, & van Balkom, 2009); the intrusive thoughts characteristic of OCD are 
similar to the thoughts about health and body experienced by those with health anxiety. 
Similarly, continually checking one’s body for signs of illness may also be thought of as 
a kind of compulsion. Similarly, the role of reassurance in (only temporarily) reducing 
uncertainty about a health problem is similar to the temporary relief felt by an 
individual with OCD when they complete a ritual behaviour (Starcevic, 2014). What 
distinguishes health anxiety is poorer insight and more strongly held beliefs that are 
related to the self, for example having an illness because they are ‘an unwell person’. 
Those with OCD have greater insight into their condition and their OCD symptoms are 
more likely to be experienced as unrelated to the self; for example continually checking 
on the safety of a loved one despite being aware that this is irrational and that the 
individual is safe (Starcevic, 2014). An empirical evaluation of the differences between 
those with hypochondriasis, OCD and healthy controls reported those with 
hypochondriasis have significantly more worries about illness than those with OCD. 
Those with hypochondriasis have less obsessive-compulsive symptoms than those with 
OCD, but have significantly more OCD symptoms than healthy controls (Anja Greeven, 
van Balkom, van Rood, van Oppen, & Spinhoven, 2006). 
 As conceptualised by the cognitive model, anxiety and worry are central 
features of health anxiety (Salkovskis & Warwick, 2001). This has some similarities to 
generalised anxiety disorder which is characterised by worry across multiple life 
domains, however health anxiety differs in terms of worries being specifically related to 
one’s health. Illness phobia is another related form of anxiety and concerns fear that one 
may catch an infectious disease; this may be characterised by avoiding situations where 
one may catch an illness, a lack of somatic symptoms and a fear of becoming unwell in 
the future. In contrast, those with health anxiety are more likely to have a somatic 
symptom and be fearful they are already unwell (Noyes, 2001b). 
 Finally, there is some relationship between health anxiety and depression, for 
example those experiencing depression may report some signs of health anxiety such as 
overly ruminating about a bodily state or symptom. Starcevic (2014) points out that 
usually when a person is depressed any health anxiety symptoms are secondary and may 
be better explained by depression. In clinical practice, Starcevic suggests collecting 
information around a person’s experience and to determine the temporal relationship 
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between the two, or determine if health anxiety is only felt when the person is 
experiencing depression. Finally, another possibility is that depression may be an 
emotional reaction to the experience of health anxiety; again this may be determined by 
careful assessment and examining the temporal relationship between the two (Starcevic, 
2014). 
In summary, the evidence for the underlying structure of hypochondriasis and 
health anxiety is mixed and the definition of hypochondriasis has altered over time, 
including its deletion from DSM-V. Because of this I will use the term hypochondriasis 
when referring to the clinical syndrome, as defined using DSM-III/IV criteria, whereas I 
will use the term health anxiety to describe the cognitive and affective experience of 
anxiety about health. 
1.3. Theories of health anxiety 
 I now outline and evaluate two contemporary theories of health anxiety. I focus 
on cognitive-behavioural formulation of health anxiety as both the HAQ and SHAI are 
based on this approach. The majority of this section comprises of a systematic review of 
the literature pertaining to the model originally conceived by Salkovskis and Warwick 
(1986). I will also briefly discuss the somatosensory amplification theory (Barsky, 
2001), which is a related but distinct account of health anxiety. 
A secondary aim of this thesis is to employ scores relating to the HAQ and SHAI 
to investigate the construct validity of this conceptualisation of health anxiety. I will 
also include a brief overview of the process of Somatosensory Amplification, a related, 
but distinct theory of health anxiety. 
1.3.1. The cognitive model of health anxiety  
   The cognitive-behavioural of health anxiety was initially proposed by Salkovskis 
and Warwick (1986) who reported successfully treating health anxiety in a single-case 
series. This was expanded in later papers and book chapters (Salkovskis & Warwick, 
1990; 2001). The cognitive model draws on Beck’s conceptualisation of anxiety being a 
result of a perception of being under threat (Beck & Emery, 2005). Central to this is the 
often catastrophic misinterpretation of novel or unusual bodily sensations as being 
indicative of a health problem. The model suggests that individuals form dysfunctional 
or inaccurate beliefs or assumptions about their health, generally through their early life 
experiences. These beliefs are then activated by a critical incident which then leads to 
negative automatic thoughts related to health and illness.  
An example may be a middle-aged man who thinks he is having a stroke 
because he notices a tingling in his left hand (misinterpretation of bodily states). He 
may hold the belief that ‘all men will die of a stroke in middle age’ because two family 
members had strokes at similar age that he is now (dysfunctional belief about health). 
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He was more aware of this because he had reached the same age and also because a 
colleague had recently had a stroke (critical incident). This led to him having the 
thought that this tingling was due to a stroke rather than part of normal sensory variation 
(cognitive misattribution). See figure 1 for overview of the cognitive model of health 
anxiety. 
 
Figure 1. The cognitive model of health anxiety (Salkovskis & Warwick, 2001). 
Dysfunctional beliefs about health are then maintained by increased attention 
being paid towards bodily states or selectively attending towards information that 
confirms the belief that they are unwell. ‘Safety seeking’ behaviours may also occur; a 
person may seek out information that they are unwell by touching the relevant area of 
their body or by focussing their attention toward unusual bodily states. Another example 
of this is frequently seeking out reassurance from medical professionals that they are in 
fact well.  
In the example of the man who was fearful of having a stroke, he may then keep 
looking out for signs he is having a stroke such as his fingers tingling again (selective 
attention). He may touch or rub his hand, which itself may lead to his fingers tingling 
more, in turn leading to an increase in anxiety. He may visit his doctor (safety seeking 
behaviour) and be reassured that he is not ill. Unfortunately, the relief felt by the man 
will only be temporary, as reassurance will only help a person realise they are not ill at 
that time. As soon as he notices another bodily state that concerns him, he will then 
become anxious again and then require additional reassurance.  As an alternative to 
providing reassurance, therapy founded on the cognitive model focusses on a person’s 
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appraisal and misinterpretation of benign bodily states (Taylor & Asmundson, 2004). A 
therapist will help a client develop an alternative theory of the meaning of unusual or 
novel bodily states (e.g. that tingling in the fingers is a result of normal variation rather 
than a sign of illness). 
1.3.2. Evidence for the cognitive model 
 I now review the research investigating each component of the cognitive model, 
beginning with a discussion of the evidence for differential health related beliefs being 
held by those with health anxiety. I performed a systematic review of the literature and I 
included articles if they evaluated a component of the cognitive behavioural model as 
described by Salkovskis and Warwick (2001).  The following search terms were entered 
into Web of Science; ‘hypochond* OR health anxiety’ the results were then combined 
with output from the term ‘cognitive’. I also searched all articles citing the two original 
papers by Salkovskis and Warwick (1986; 1990). Reference lists of included papers 
were also searched for relevant papers. Search dates ranged from 1986-2016. 
1.3.2.1. Health related beliefs 
According to the cognitive model, individuals with health anxiety are 
hypothesised to possess dysfunctional beliefs about illness and wellness. The content of 
the beliefs may be similar to those held by non-health anxious individuals, but are 
thought to be less-flexible and more extreme than the wider population. 
A study published soon after the initial cognitive model papers, investigated the 
core beliefs held by 10 people undergoing Cognitive Behavioural Therapy (CBT) for 
hypochondriasis (Wells & Hackmann, 1993).  These were accessed by the treating 
therapist who asked participants about mental images they may experience that are 
related to their health. The therapist then used the ‘downward arrow’ approach used in 
CBT (Taylor & Asmundson, 2004) to elicit core beliefs about health. Participants 
reported specific beliefs about illness (e.g. ‘worrying about my health will keep me 
safe’, ‘if I’m ill people will abandon me’) and death (e.g. ‘death means this will go on 
forever’, ‘death means I’ll be weak and punished forever’). Despite this study having a 
small sample and lacking control participants, it provides some indication of the beliefs 
held by those with health anxiety. Although this study may be criticised for asking only 
about images related to health and death: it may be that other images are important to 
the subjective experience of health anxiety, but these may not have been uncovered 
because these were not asked about. 
When presented with health-related vignettes (e.g. accidently swallowing 
contaminated water and being advised to seek medical attention), those with 
hypochondriasis are more likely to believe this will result in a negative health outcome 
(e.g. becoming unwell) than healthy controls. This effect was limited to health-related 
vignettes and was not found in non-health related vignettes (e.g. arriving home to find 
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the house had been burgled). Participants were then given a further piece of information 
designed to either provide reassurance or increase anxiety. The authors found both the 
hypochondriasis group and controls equally responsive to reassurance (Haenen, De 
Jong, Schmidt, Stevens, & Visser, 2000). This is in contrast to the finding that those 
with health anxiety are less responsive to reassurance (Lucock et al., 1997), although 
reassurance in the first study may have only been effective because the vignettes 
concerned hypothetical situations rather than being about the participant themselves. 
This effect was replicated using a questionnaire study of 158 students. Those scoring 
more highly on measures of health anxiety were more likely to predict a worse outcome 
from being unwell than those with lower health anxiety, although this effect only held 
for more serious illnesses, rather than minor concerns (Marcus, 1999). 
Another study asked 133 undergraduate students to rate out of 100 whether twenty 
different descriptions of bodily symptoms were an indication of illness. Participants 
were also asked to rate whether the symptom was likely to be a sign of severe or minor 
illness. Those scoring more highly on the Illness Attitude Scales were more likely to 
rate a symptom as being a sign of illness and as having a catastrophic outcome  (Marcus 
& Church, 2003). This relationship held even when accounting for negative affect and 
worry, so suggests these health beliefs are unique to health anxiety rather than being 
accounted for by another generic cognitive process (e.g. trait anxiety).  
 Two studies conducted with undergraduates (Fulton, Marcus, & Merkey, 2011) 
employed the Irrational Health Beliefs Scale (IHBS; Christensen, Moran, & Wiebe, 
1999) a measure containing 20 vignettes that assesses biases in an individual’s 
interpretation of health-related information. They reported that those scoring more 
highly on health anxiety measures were more likely to report irrational beliefs about 
health, in both samples this relationship was mediated by trait anxiety. The authors 
point out that on the basis of their study irrational health beliefs cannot be said to be a 
causal factor in health anxiety. It may be that the relationship could be the reverse or 
that irrational health beliefs are more likely to be held by those with a particular 
cognitive style or those who score more highly on measures of trait anxiety.   
Compared to healthy controls, individuals with hypochondriasis are more likely 
to believe a bodily symptom is indicative of a serious illness, to a lesser extent this 
effect was found in an anxiety disorder sample (Florian Weck, Neng, Richtberg, & 
Stangier, 2012a). This may be because of some conceptual overlap between health 
anxiety and generalised anxiety. Additionally, this was assessed using a series of 
vignettes so refer to a hypothetical situation, it may be that this effect would not be 
replicated if the symptom was one actually experienced by participants.  
There is also evidence that individuals with hypochondriasis have a more rigid 
and narrow view of being in good health (Weck, Neng, Richtberg, & Stangier, 2012b). 
Those with hypochondriasis are more likely to hold beliefs that good health involves 
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being without any signs of illness and are more likely to believe that an ambiguous 
symptom is a sign of disease (Barsky, Coeytaux, Sarnie, & Cleary, 1993). 
 Overall, there is convincing evidence that those with severe health anxiety or 
hypochondriasis hold irrational beliefs about their health. Additionally, this effect 
appears to be restricted to beliefs about health and illness rather than more general 
negative or dysfunctional beliefs. There is also emerging evidence that those with health 
anxiety have a narrower view about what constitutes good health. 
1.3.2.2. Critical incidents/triggering events 
Another component of the cognitive model of health anxiety is the hypothesis that 
a particular event (e.g. a colleague becoming unwell) can trigger latent dysfunctional 
beliefs or assumptions about health. Three studies reported experimental evidence 
relating to the triggering of health anxiety (Kaur, Butow, & Sharpe, 2013; Lecci & 
Cohen, 2002; Marcus, 1999).  
 In the first study, Marcus (1999) asked 2,117 undergraduates to complete a task 
that involved making sentences out of groups of words that were presented in 
nonsensical order. Health-anxiety was triggered using illness-related words, participants 
then completed the State scale of the STAI (Spielberger, Gorsuch, & Lushene, 1970). 
Marcus reported that threat related words did not increase state anxiety in those scoring 
high in health anxiety, however it did increase state anxiety in those scoring lower on 
health anxiety.  
Another study conducted with undergraduate participants (Lecci & Cohen, 2002) 
triggered health anxiety by taking a medical history and then blood pressure readings. 
Participants were informed they had a ‘dangerously high blood pressure’ and then 
completed a Stroop task, control participants were not given this information. Those in 
the experimental condition showed greater interference on a Stroop task, this effect was 
specific to negative health related words and did not occur in response to non-health 
related words. 
A third paper (Kaur et al., 2013) randomised undergraduate participants to receive 
a health anxiety induction using the same procedure as Lecci and Cohen (2002) but 
found no effect on attentional processing as assessed by a dot-probe task and an 
emotional Stroop task. 
 There is mixed evidence from studies attempting to trigger health anxiety in 
laboratory studies, with studies using the same method reporting conflicting results.  
1.3.2.3. Core cognitions 
The cognitive model of health anxiety proposes four core cognitions thought to be 
involved in the development and maintenance of health anxiety. These relate to the 
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perceived: likelihood of illness; cost and awfulness of illness; means of coping with 
illness; and inadequacy of medical services (Salkovskis & Warwick, 2001).  
The Health Cognitions Questionnaire (HCQ; Hadjistavropoulos et al., 2012) was 
designed to directly measure these core cognitions. In the scale validation paper, high 
HCQ scores were associated with increased health anxiety and a lack of response to 
medical reassurance in both a medically well community sample of 273 and another 
sample of 208 who were physically unwell. In the healthy sample, only ‘perceived 
difficulty coping with illness’ and the ‘likelihood of illness’ predicted health anxiety 
(medical services inadequacy and awfulness of illness did not). In the medical sample 
perceived ‘medical services inadequacy’, ‘likelihood of illness’ and ‘awfulness of 
illness’ predicted increased health anxiety (difficulty coping did not). This indicates 
there may be some differences in the experience of health anxiety in those who are well, 
who may think more about the challenges and likelihood of being ill, compared to those 
who are unwell whose thoughts may be more focussed on the experience of being ill. 
The HCQ-perceived inadequacy of medical services subscale predicted lack of response 
to reassurance (assessed by the Reassurance Questionnaire; Speckens et al., 2000) even 
when the SHAI-14 was included as a predictor. This is a potentially helpful aspect of 
the HCQ, as it may assist clinicians in determining those who will not be reassured by a 
medical professional. A potential difficulty of this scale is that it focusses on a 
hypothesised group of core-cognitions and was developed from a pool of items that 
aimed to directly assess these hypothesised cognitions. There has been no other 
investigation as to whether there are other cognitions that relate specifically to health 
anxiety, nor whether they are the most important; it may be that other cognitions are 
important to the health anxiety construct or may be more important in predicting 
response to reassurance. It is not possible to determine this, simply because the focus of 
the HCQ is the core cognitions described above and items concerning other cognitions 
have not been asked about. For example, it is notable that the HCQ and the SHAI do not 
feature questions about death, despite this historically being a feature of 
hypochondriasis (Kellner, 1987) and the presence of death-related mental images in the 
study conducted by Wells and Hackman (1993). This is particularly relevant as fear of 
death has been closely linked to hypochondriasis (Noyes, Stuart, Longley, Langbehn, & 
Happel, 2002).  
Indirect evidence for the importance of the core-cognitions described by 
Salkovskis and Warwick (1985) comes from the success of a cognitive reattribution 
intervention in reducing health anxiety (Kerstner et al., 2015). In this study participants 
were trained to alter their attribution of a bodily state from an illness appraisal to finding 
an alternative external explanation. A recent meta-analysis of 13 RCTs reported CBT 
for health anxiety was superior to no-treatment controls, with an average pre/post 
treatment effect size of 0.95 (Olatunji et al., 2014). CBT interventions for health anxiety 
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also include other non-cognitive components (Taylor & Asmundson, 2004), therefore it 
is not possible to determine whether cognitive or non-cognitive aspects of the 
intervention reduced health anxiety. 
In summary, there is some evidence for an association between health anxiety and 
the core cognitions included in the cognitive model of health anxiety, however these 
results warrant replication. It is also not possible to determine whether additional 
cognitions specific to health anxiety are of importance as the current research has 
focussed only on those outlined by (Warwick & Salkovskis, 1990). The role of 
cognitions in health anxiety is further supported by evidence from successful treatment 
of health anxiety with CBT. However, there was only one study that specifically 
focussed on cognitions, in the other treatment studies non-cognitive treatment variables 
may also have contributed to the reduction in health anxiety. 
1.2.2.4. Maintaining factors 
 From a cognitive behavioural perspective, various factors are thought to be 
responsible for the maintenance of health anxiety (Salkovskis & Warwick, 2001). I now 
review potential maintaining factors for the maintenance of health anxiety. 
Cognitive rumination: A study of 198 undergraduate students found a relationship 
between increased health anxiety and increased cognitive rumination, the authors argue 
the cognitive model of health anxiety should be extended to include this variable 
(Marcus, Hughes, & Arnau, 2008). A later study with a medically-healthy community 
sample of 410 also found increased rumination was associated with increased health 
anxiety and remained a unique predictor even when negative affect was included in the 
analysis (Fergus, 2013b). 
Mental imagery; In the study reviewed above by Wells and Hackman (1993), those 
being treated for health anxiety report specific mental images associated with health. 
For all 10 participants, these involved images of being dead or of others being happy 
that they are dead. A qualitative study concerning mental imagery in 55 individuals with 
a DSM-IV diagnosis of hypochondriasis reported 72% of participants experienced 
distressing imagery about being ill, dying or of how their death may affect their family 
or friends (Muse, McManus, Hackmann, & Williams, 2010). 
Memory bias: an experimental word recognition and recall task was carried out with 28 
participants with hypochondriasis or somatoform disorder and 14 healthy controls. 
Words categorised as either positive, negative, neutral or pain related, were displayed to 
participants. Compared to controls those with hypochondriasis were more likely to rate 
a word as being negative or related to pain and also demonstrated better recall of these 
words than controls. (Pauli & Alpers, 2002). 
In a delayed recall task, those with hypochondriasis could recall more health 
related words than controls, although because the delay in this study was only seven 
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minutes, it is unclear whether this bias is longer lasting (Brown, Kosslyn, Delamater, 
Fama, & Barsky, 1999). Specificity of recognition memory of health-related threat 
words was not replicated in an experimental study using the emotional Stroop. 
Individuals with hypochondriasis had equally good recognition memory of words 
relating to health-threat, panic and bodily symptoms, this effect reduced following 
cognitive-behavioural therapy (Gropalis, Bleichhardt, Hiller, & Witthoft, 2013). 
In an undergraduate sample, those with increased levels of health anxiety 
showed better recognition memory for health-related words, but did not recall more 
health-related words (Ferguson, Moghaddam, & Bibby, 2007). The delay before 
completing the recall task was shorter than in the study reported by Brown, Kosslyn, 
Delamater, Fama and Barsky (1999). Ferguson and colleagues argue that in their study 
there may have been insufficient time for participants to encode the health-related words 
in their study.  
Attentional bias; has been assessed using three methods, the dot-probe, the emotional 
Stroop task and visual search tasks.  
 As assessed by the Stroop task, higher levels of health anxiety related to greater 
interference in threat related words (Lecci & Cohen, 2002; Lecci & Cohen, 2007). 
Similarly, those scoring higher on the Illness Attitude Scales are more likely to attend to 
health related words (Owens, Asmundson, Hadjistavropoulos, & Owens, 2004). 
Another study also reported that compared to controls, those higher in health anxiety 
react more quickly to health related words than non-health words (Ferguson et al., 
2007). Two additional studies conducted with undergraduates reported that, those 
higher in health anxiety showed a greater tendency to attend towards health-threat 
words and then to generic-threat related words (Karademas, Christopoulou, Dimostheni, 
& Pavlu, 2008; Owens et al., 2004). A final study found those high in health anxiety 
attended more to words about bodily symptoms, but not to illness related or neutral 
words (Witthöft et al., 2013). This was an fMRI study with a sample of only 24, so may 
not have had sufficient statistical power to detect smaller effects on attention bias. 
All the previously reviewed studies using the Stroop task were carried out with 
undergraduate students and excluded those with hypochondriasis. This is potentially 
problematic as it may be that attentional biases differ in those with higher levels of 
health anxiety. Overcoming this shortcoming, again using the emotional Stroop task, 
Gropalis et al., (2013) found those with a DSM-IV diagnosis of hypochondriasis show 
an attentional bias towards threating words related to health and also to words relating 
to panic.  
The dot-probe task has also been employed as a measure of attention bias. In a 
sample of 95 undergraduates, Increased health anxiety was not related to attentional bias 
towards health-related information in a dot-probe task (Jacoby, Wheaton, & 
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Abramowitz, 2016). This lack of effect was despite a large enough sample size to detect 
a medium effect size, the authors suggest this may be because the health-related threat 
words may not have personal relevance to participants or because the dot-probe task has 
poor reliability. In contrast, an earlier study of 83 undergraduates did find a bias 
towards health-related information in a dot-probe task (Jasper & Witthoft, 2011). 
Similarly, following a mood induction that aimed to increase illness worry, a third study 
using the dot-probe found no relationship between increased health anxiety and 
attention toward health-threat (Kaur et al., 2013). One study (Lee, Watson, & Frey-Law, 
2013) personalised the dot-probe task to include health-threat words of personal 
relevance to individual participants. They found that rather than attending more rapidly 
to these words, participants were slower to remove their attention. 
Two studies assessed for attentional bias via use of a visual search task. 
Participants meeting diagnostic criteria for hypochondriasis and controls were shown 
‘perceptually degraded’ health-related and neutral words on a computer screen and read 
the word out loud. Those with hypochondriasis perceived less health-related words than 
controls (Brown et al., 1999). A study in undergraduate populations, found all 
participants (both low and high in health anxiety) selectively attended more towards 
health-related words (Shields & Murphy, 2011). 
Indirect evidence for the cognitive model of health anxiety is found in studies 
that report a reduction in somatically focused attention following an attention training 
intervention (Weck, Neng, & Stangier, 2013). A later study provided an attention 
training intervention to students high in health anxiety (Schwind, Gropalis, Witthoft, & 
Weck, 2016). There were three groups in this study, the first received an attentional 
training intervention designed to help participants divert their attention away from 
bodily states that concern them. The second group were taught to train their attention 
onto their body (predicted to increase somatically focussed attention) and another group 
that received no intervention. Contrary to their predictions, only those who were taught 
the body-focussed attention training showed a reduction in health anxiety. Similarly, 
attentional biases assessed by the Stroop task have been shown to reduce after 
completing cognitive-behavioural therapy Gropalis et al., (2013).  
Overall, the evidence for attentional biases in those experiencing health anxiety 
is mixed. Studies employing the emotional Stroop have reported a specific attentional 
bias and interference when health related words are presented, this effect has been found 
in both student and health-anxious populations. The only study that did not find an 
effect may have had too small a sample for differences between those with health 
anxiety and controls to be detected (Witthöft et al., 2013). Studies using the dot-probe 
task have been less likely to detect an attentional bias, although when stimulus words 
are personalised to the participants an effect is found. Visual search tasks have also 
reported contradictory findings, with those with hypochondriasis seeing less health-
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threat words than controls, whereas a study conducted with students found all 
participants attended towards health-related words. Finally, there is evidence for a 
reduction in attentional biases after successfully completing psychological therapy.  
1.3.2. Somatosensory amplification 
 Distinct, but complementary to the cognitive theory of health anxiety is the 
suggested process of somatosensory amplification (Barsky, 2001). A defining feature of 
health anxiety is the misattribution of benign bodily sensations as an indication of a 
health problem. Somatosensory amplification seeks to explain this as either being due to 
an increased sensitivity to one’s sensory information or due to a reporting style that 
overemphasises the severity of this information (Barsky, 2001).  
 Barsky (2001) points out that an individual’s reports of their sensory 
information cannot be separated from their interpretation of their senses: these reports 
are almost certainly influenced by a person’s belief structures, attentional biases or 
cognitive misattributions. 
 I suggest that although somatosensory amplification is a different theory to the 
cognitive behavioural model, it is in fact another perspective on the same information. 
The emphasis is placed on the senses and misinterpretations of sensory information: our 
thoughts, feelings and behaviours modulate this information. In the cognitive model, 
thoughts are primary and distort the information from the senses via attentional biases. 
 In his narrative review Barsky (2001) concluded that individuals with heath 
anxiety tend to report an increased sensitivity to sensory stimulation (e.g. painful 
stimuli). However, on more objective measures (e.g. awareness of own heartbeat) they 
perform identically to controls without health anxiety.  A meta-analysis conducted by 
Marcus et al. (2007) reported on an additional four studies that replicated these findings. 
Both papers point out that there have been inconsistent findings in the literature.  
Additionally, some of the included studies do not report co-morbidity with other mental 
health problems, which is problematic as somatosensory amplification has been 
reported in anxiety, depression and somatising disorder. Overall, I argue this evidence 
suggests that people with health anxiety experience sensory information related to their 
bodies as being heightened compared to those without health anxiety. This is most 
likely due to their appraisal of this information rather than actual sensory differences.  
1.4. Classical test theory, validity and reliability 
 I now provide a brief overview of validity and reliability as applied to 
psychological research. This is relevant because in chapter 3 I will provide a meta-
analytic review of the published reliability coefficients for the HAQ and SHAI, I will 
also conduct a reliability generalisability analysis (see chapter 2 for method). In chapter 
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4, I will provide a narrative review of information abstracted from these methods 
relating to the construct validity of health anxiety.  
1.4.1. Validity 
 Validity may be simply defined as ‘measuring what you intend to measure’. 
However, it is often wrongly thought of as a stable characteristic of a measure that one 
may continually assess and refine until a test’s validity is determined. This view is 
incomplete, as validity may be more accurately seen as a property of both tests and 
theories. Validity is also not a static property, rather it is an ongoing process: 
Information about the reliability and validity of a test can be used to aid development of 
theory, likewise theory generation should inform the construction of measures (Strauss 
& Smith, 2009). 
 In order to conduct research on a particular psychological concept (e.g. 
depression) or process (e.g. attention bias), it is necessary to have a valid means of 
measuring it (e.g. Beck depression inventory, emotional Stroop task). Early in the 
history of psychological research neither robust, valid theories nor robust valid 
measures existed. This lack of knowledge base meant that researchers would typically 
rely on observation and description of poorly understood concepts and attempt to 
measure them with the tools available to them. An initial advance came in the form of 
criterion validity, or the ability of a test to predict an individual’s membership of a 
certain class or category. For example, a person can be said to be depressed, 
establishing this could be achieved by direct observation (e.g. sleeping less, slower 
movements, more tearful) over the course of a number of weeks. The person could then 
be interviewed to understand their experiences (they may report feeling unhappy, 
lethargic and lacking in motivation). A scale could then be designed that predicted 
whether a person would fall into a ‘depressed’ category. As criterion validity continued 
to be employed, the problems inherent with it became apparent. The first is that the test 
is only as good as the criterion selected, which may itself not be valid. A second 
difficulty is that criterion validity does not facilitate theory building. Both difficulties 
are problematic, but understandable given the lack of robust psychological theory from 
which criteria may be developed (Strauss and Smith, 2009). 
 Construct validity is a term used to describe an overarching concept of validity, 
that subsumes the other types of validity. This approach argues for the legitimacy of 
hypothetical constructs that are not directly measurable, but are inferred by direct 
observation, self-report or scores on psychometric tests (Cronbach and Meehl, 1955). A 
test can be said to have good construct validity if it accurately and reliably assesses a 
hypothetical latent construct and any changes in that construct. For example, the 
existence of a latent construct of depression could be inferred using the criteria 
described in the previous paragraph and a scale developed to assess it. An example of 
this is the Beck Depression Inventory (Beck, Steer, & Brown, 1996) which has 
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undergone validation efforts and has been shown to reliably and accurately reflect a 
latent construct of depression. 
These sources of information can then be placed under further analysis to 
determine whether they are coherently and meaningfully related. For example, it would 
be expected that in depression, increased low mood would be related to more negative 
thinking. If these variables were highly correlated they could be considered to have 
convergent validity, or likely to be two distinct, but related indicators of the same 
construct. Similarly, depression should not be strongly associated with anxiety as it is 
considered to be a distinct construct. A measure or test that can distinguish between two 
separate constructs is said to have discriminant validity so can distinguish between two 
related but distinct constructs.  
 One means of investigating construct validity is by use of the multi-trait 
multimethod matrix (MTMM; Campbell and Fiske, 1959). This approach involves 
assessing the convergent and discriminant validity of various measurements of the 
construct of interest. This information is then summed in a correlational matrix and can 
be reviewed qualitatively to determine whether the pattern of results is as predicted and 
consistent with the current proposed theoretical construct (Campbell and Fisk, 1959). It 
is no longer necessary to evaluate MTMM data qualitatively as advances in statistical 
procedures and computation modelling such as Confirmatory Factor Analysis and 
Structural Equation Modelling allow for quantitative testing of latent variables and 
constructs (Strauss and Smith, 2009). 
As previously described, in line with falsificationist theories of science (Popper, 
1972) a measure can never be said to possess construct validity, rather it is property that 
should be continually evaluated. Additionally, every test of the construct validity of a 
measure also provides an opportunity to better understand the construct that the measure 
purports to assess (Strauss and Smith, 2009).   
1.4.2. Reliability 
 Reliability refers to the consistency of a test or instrument. A measure is said to 
have good reliability if test scores remain constant under the same conditions. It is 
important to note that reliability is not a fixed property of a test, rather it refers to a 
test’s performance on a particular occasion with a particular sample (Wilkinson, 1999). 
There are several methods of evaluating reliability, but only test-retest reliability and 
internal consistency are relevant to this thesis. This is because these are the forms of 
reliability that are used when assessing the quality of self-report measures. Parallel 
forms reliability is also sometimes employed when initially generating a scale, but did 
not feature in the development of either of the scales investigated in this thesis. Test-
retest reliability assesses the stability of test scores over time, by being administered to 
the same participants with a delay between administration. The internal consistency of a 
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test, assesses whether the items contained in an instrument are related to one another. 
This may be assessed in two ways: Split-half reliability is assessed by dividing an 
instrument into two halves. To avoid order effects, this is usually achieved by 
alternating items, with even numbers going into one half, odd numbers to the other. 
Each half of the scale is treated as a separate measure and then they are correlated with 
one-another. A test is considered to have good split-half reliability if the correlation 
coefficient is sufficiently high. Coefficient alpha  (Cronbach, 1951) is an internal 
consistency coefficient that is generated by correlating all items in a test with one-
another. A systematic evaluation of 696 (out of a total 2078) scale-development papers 
reported test-retest reliability (19.0% of papers) and the alpha coefficient (66.5% of 
papers) were the most frequently employed reliability coefficients used when evaluating 
questionnaires (Hogan, Benjamin, & Brezinski, 2000).  
 Reliability coefficients may provide additional sources of information about a 
construct under investigation. Classical test theory (Lord & Novick, 1968) regards an 
individual’s test score to be the sum of their ‘true score’ and their ‘error score’ and may 
be expressed as the following formula: 
 Observed score = true score + error score 
An individual’s ‘true score’ represents their actual score on a particular test. However, 
an individual’s observed score will also contain additional sources of variation, for 
example testing conditions or individual characteristics such as tiredness. These are 
summed and termed the ‘error score’. The various sources of variance summed in an 
individual’s ‘error score’ may be used to investigate whether there is systematic 
variance in test scores across participants (e.g. if reliability is reduced when a scale is 
used with particular samples). This may indicate specific variables that consistently 
impact on reliability estimates.  
Reliability generalizability analysis is a form of meta-analysis that investigates 
the variation in reliability scores across studies (Vacha-Haase, 1998). This analysis 
allows one to calculate an average reliability for a test or an average for the application 
of a test within particular populations. It also allows one to statistically investigate 
potential sources of variation in reliability coefficients. For example, if a particular test 
of depression were administered in a range of studies and its reliability estimate was 
consistently poorer in older people then this indicates that the test may not adequately 
capture the experience of depression in older adults. On the other hand, it may have 
implications for the theory of depression as the issue may lie in the theory rather the 
test.  
More recently it has been argued that a study’s mean scores and variances can be 
incorporated into a reliability generalisability analysis. This may then be used to 
determine moderators of variability in test scores (Botella, Suero and Gambara, 2010). 
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Reliability generalisability is relevant to this project as it will provide insight into the 
performance of the HAQ and SHAI with various populations. In addition, information 
about consistent sources of variance in reliability coefficients may add additional 
information to the theory of health anxiety. I return to the topic of reliability 
generalisability in the method section. 
 To comment on the reliability of a measure, it is important to briefly review 
what is considered ‘acceptable’ reliability. This varies according to which source text is 
consulted. Cicchetti (1994) suggests the following qualitative descriptions for reliability 
coefficients (including split-half reliability); α<0.70 ‘unacceptable’, α=0.70-.79 ‘fair’, 
α=0.80-0.89 ‘good’, α>0.90 ‘excellent’.  
Similar ratings specific to coefficient alpha have been advocated by George and 
Mallery (2003), who suggest a lower alpha coefficient is acceptable; α<0.5 
‘unacceptable’, α=0.5-0.6 ‘poor’, α=0.6-0.7 ‘questionable’, α =0.7-0.8 ‘acceptable’, α 
=0.8-0.9 ‘good’, α >0.9 ‘excellent’. An alpha coefficient over 0.95 is considered 
undesirable as it indicates there may be items in the scale that are measuring the same 
concept, so should be deleted (Streiner, 2003).  
Interestingly, the general ‘rule of thumb’ often published in text books is that 
reliability coefficients should be at least 0.7 or higher. This has been attributed to a text 
by Nunnally (1978) and has been described as a methodological ‘urban legend’ (Lance, 
Butts, & Michels, 2006). In the original text, Nunnally actually states that acceptable 
reliability for a test depends on its purpose and on the context in which it is to be used. 
He suggests that for basic correlational research an alpha of .70 is acceptable, whereas if 
a test is to be used in experimental studies an alpha of 0.80 is more appropriate. If a 
policy or other decision is being made on the basis of scores derived from a measure, 
then a minimum alpha coefficient of 0.90-0.95 should be selected (Nunnally, 1978).   
It is also important to note that the alpha coefficient may be inflated by larger 
samples and a larger number of test items. This has led several authors to suggest that 
psychometricians move to an alternative such as the Omega coefficient (Dunn, Baguley, 
& Brunsden, 2014; Peters, 2014). Cronbach has argued that the alpha coefficient is 
likely to be a flawed measure of reliability and should be used as part of a selection of 
tools and observations that may be used in concert to evaluate reliability (Cronbach & 
Shavelson, 2004). 
1.5 Measures of health anxiety 
 I now introduce the HAQ and SHAI, a description of the aims for their 
development and then provide a rationale for this thesis. 
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1.5.1. The Health Anxiety Questionnaire (HAQ) 
  Is grounded in a cognitive-behavioural model of health anxiety, has 21 items 
and is based on the Illness Attitude Scale (IAS; Kellner, Abbott, Winslow, & Pathak, 
1987). In the original scale development study, the HAQ demonstrated good test-retest 
reliability (r = 0.94) and internal consistency (alpha = 0.92). The HAQ also displayed 
good discriminant validity and could differentiate between those with health anxiety and 
those with other forms of anxiety. Norms have been published for the general 
population, nursing students, outpatients and users of a psychology service (Lucock & 
Morley, 1996).  
 The HAQ conceptualises health anxiety from a cognitive behavioural 
perspective and was developed using items from the Illness Attitude Scales (Kellner, 
1987) and in consultation with individuals experiencing health anxiety. The HAQ uses 
words such as ‘worry’ to describe cognitions (e.g. item 1. “Do you ever worry about 
your health?”) and includes affective states such as ‘afraid’ (e.g. item 15. “Do you ever 
feel afraid you may have cancer”). Reassurance seeking is also assessed (e.g. item 5. 
“Do you ever examine your body to find whether there is something wrong?”) as is the 
extent that bodily symptoms interfere with daily functioning (e.g. item 21. Do your 
bodily symptoms stop you from enjoying yourself?). Because of a focus on the 
cognitive behavioural perspective and because the measure was developed under DSM-
IV/ICD-10, an individual with DSM-IV hypochondriasis (or severe health anxiety 
according to the cognitive model) will likely score very highly on this scale. However, 
someone with a DSM-V diagnosis of illness anxiety disorder may have a lower score as 
the items concerning somatic symptoms may not apply to them. Likewise, an individual 
with DSM-V somatic symptom disorder may also score less highly as they may not 
experience any anxiety about their health, so the items about health worries and fear 
may not apply to their experience. Related to this is that fact that all items in the HAQ 
refer to generic worries, fears, body vigilance and somatic symptoms rather than 
concerning a specific symptom. This means that if an individual with somatic symptom 
disorder had a concern about a particular bodily state then this would be detected by 
generic items rather than an item tailored to their experience. See appendix A for the 
HAQ. 
1.5.2. The Short Health Anxiety Inventory (SHAI) 
Overview 
The SHAI has a long-form 64 item inventory (Salkovskis et al., 2002), which has 
been shortened to an 18-item version. The 18-item version has four questions 
concerning an individual’s perceptions of the negative consequences of becoming 
unwell. These items were not designed to measure health anxiety, but are often included 
in total scores of health anxiety (see Alberts, Hadjistavropoulos, Jones, & Sharpe, 2013 
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for review). Therefore, some studies provide a total score using either a 14- or 18-item 
version. Salkovskis et al., (2002) describe aiming to produce a scale that could 
differentiate between people who have health anxiety from those who have a genuine 
illness, but are not overly anxious about it. Previous measures can be criticised for 
having items that are applicable to people with a physical illness, which led to elevated 
health anxiety scores in groups evaluated with such scales (see below). According to the 
original validation paper, the SHAI has good discriminative validity and could 
differentiate between those with health anxiety, social anxiety, panic disorder and non-
anxious controls. The short version of the SHAI has good internal consistency (alpha = 
0.89). 
Similarly to the HAQ, the SHAI was deliberately designed to reflect the cognitive 
behavioural model of health anxiety, it also uses items that reflect a generic concern 
about health, including fear of illness (item 5d. “I am always afraid that I have a mental 
illness”) and mental imagery (item 6d. “I constantly have images of myself being ill”). 
It also assesses somatosensory amplification/preoccupation with bodily states (item 3d. 
I am constantly aware of bodily sensations or changes; item 10d. If I have a bodily 
sensation or change I must know what it means). The SHAI also assesses whether a 
respondent typically is reassured by a visit to a physician (e.g. item 8a. “I am lastingly 
relieved if my doctor tells me there is nothing wrong”). Similarly to the HAQ, all the 
question items refer to generic concerns so will not assess the presence (or change) in a 
specific somatic symptom. Again, those with a DSM-IV diagnosis of hypochondriasis 
are likely to score more highly than those with a DSM-V diagnosis of illness anxiety 
disorder (if they do not experience somatic symptoms) or somatic symptom disorder (if 
they do not experience anxiety). As with the HAQ, this means that if working clinically 
with individuals with the latter diagnoses care should be taken to capture their 
experiences that are highly relevant to their diagnosis (e.g. a specific somatic concern). 
This could be achieved by use of an idiographic measure such as a Personal 
Questionnaire (Shapiro, 1961) which may be helpful complements to standardised 
measures such as the HAQ and SHAI (Barkham et al., 2010).  
Interestingly, in contrast to the HAQ the SHAI does not contain items about fear 
of death, which is surprising as fear of death is often thought to be a feature of 
hypochondriasis (Kellner, 1987) and the two have shown to be related (Noyes et al., 
2002; Sirri & Fava, 2014). Although this may be because a specific fear of death does 
not feature in the cognitive model of health anxiety (Salkovskis & Warwick, 2001). 
An existing review and meta-analysis of the SHAI has been published (Alberts et 
al., 2013). However, it is limited to providing only a narrative review of sample means, 
standard deviations, reliability coefficients and scale factor structure. I intend to 
investigate all these variables using meta-analysis, so will significantly extend their 
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analysis. Alberts et al., (2013) used meta-analysis only to aggregate information 
concerning the correlations between the SHAI and other psychometric measures. 
Other SHAI versions 
Factor analysis of the SHAI-14 and -18 has indicated item number 13 does not 
load onto either of the two factors thought to underlie the scale (Abramowitz, Deacon, 
& Valentiner, 2007). This has led to some researchers deleting this item and creating a 
SHAI-13 and -17. The studies using these versions of the scale are detailed in the results 
section.   
1.5.3. Other measures of health anxiety 
 In this section I will briefly review information regarding the factor structure, 
reliability and validity of three other measures of health anxiety; the Whitely Index (WI; 
Pilowsky, 1967), Illness Attitude Scales (IAS; Kellner, 1987) and the more recent 
Multidimensional Inventory of Hypochondriacal Traits (MIHT; Longley, Watson, & 
Noyes, 2005). 
1.5.3.1. The Whitely Index (WI) 
 The WI is an older measure of health anxiety developed by Pilowsky (1967), the 
orignial version of the scale included 14-items, respondents select whether the each 
statement applies to them in a yes/no format. More recently, the WI was altered to a 5-
point likert scale format (Welch, Carleton, & Asmundson, 2009) scored from 0 (no) – 4 
(often).  
There have been 14 factor analytic studies of the Whitley Index. With six studies 
supporting a single factor solution (Pilowsky, 1967; Veddegjaerde, Sivertsen, 
Wilhelmsen, & Skogen, 2014), four finding a 2-factor and finally four studies finding a 
3-factor solution (Conradt, Cavanagh, Franklin, & Rief, 2006; Hiller, Rief, & Fichter, 
2002; Hinz, Rief, & Brahler, 2003). These have been reviewed by Veddegjaerde, 
Sivertsen, Wilhelmsen, & Skogen, (2014). The WI has shown good reliability, with 
alpha coefficients over 0.80 (Speckens, Van Hemert, Spinhoven, & Bolk, 1996). 
1.5.3.2. The Illness Attitude Scales (IAS) 
 Is a 29-item measure, originally designed to include nine subscales (Kellner, 
1987). It has been criticised for lacking a stable factor structure, as re-validation 
attempts have reported three, four or five factors, each corresponding to a different sub-
scale (Longley, Meyers, Maxwell, & Letizia, 2014). In a factor analytic study Ferguson 
and Daniel (1996) report sub-scale alpha coefficients as low as 0.29, with the best 
performing at 0.75. This level of reliability is insufficient for applied research 
(Nunnally, 1978). 
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1.5.3.3. The Multidimensional Inventory of Hypochondriacal Traits (MIHT). 
 Is a 31-item scale with four subscales, each assessing a distinct dimension of 
hypochondriasis, these are; affective, behaviour, cognitive and perceptual (referring to 
attention to bodily states). The scale validation paper reported four factors, each loading 
on to the four sub-scales (Longley et al., 2005). This factor structure has since been 
independently replicated (Stewart, Sherry, Watt, Grant, & Hadjistavropoulos, 2008). 
The sub-scales have reliability coefficients ranging from 0.80 to 0.88. 
 It would be equally plausible to carry out this study using either the WI or the 
IAS. However, I elected to assess the properties of the HAQ and SHAI because they are 
both founded on the cognitive-behavioural conceptualisation of health anxiety. This 
means they have been designed to assess the same latent construct, so the properties of 
both may be compared with one another to determine if one or the other is 
psychometrically superior. The MIHT also emerged from the cognitive-behavioural 
literature (although is thought to assess dimensions of hypochondriasis), however there 
was insufficient data available to include the MIHT in this analysis (seven studies 
meeting inclusion criteria). I now outline the study undertaken for this thesis. 
1.6 The current study 
 Valid and reliable measures are required for research and clinical purposes 
(Barkham et al., 2010). Scales will typically undergo a validation process where the 
reliability and construct validity are assessed  (Rust & Golombok, 2009). I argue that it 
is important to re-investigate the reliability and validity of a scale again after it has been 
published. Validation samples may not have been entirely representative of the 
populations with which the measure is later used. For example, because of their 
convenience, university students often participate in scale validation studies, but may be 
dissimilar in composition to clinical samples. This is especially problematic in health 
anxiety research as younger people generally have fewer health concerns than older 
people (Beard et al., 2015) and having a physical health problem is related to increased 
health anxiety (Noyes, 2001a). Another potential difficulty with only a one-off 
validation study is that the results reported may have been discovered by chance, 
although this problem is less likely as scales are usually validated over more than one 
study.  
 There are other advantages to reinvestigating psychometric measures. Meta-
analysis of the mean and standard deviation of health anxiety scores in various 
populations will allow the generation of normative data for use in future research or 
clinical practice. This would be particularly helpful if norms could be generated for 
populations that were not included in the initial scale validation procedure. It is likely 
that the mean scores in various populations will be heterogeneous in nature. This may 
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be due to differences in ‘true’ scores in the respective populations, may be influenced 
by differences in sampling or due to errors in measurement. I will also attempt to 
explore variations in mean score by use of meta-regression to determine if these 
variables systematically impact in HAQ/SHAI scores. 
Meta-analysis of reliability coefficients may offer two helpful sources of data. 
The first is to provide information about the variation in reliability estimates in different 
populations. This may be helpful when selecting the most appropriate scale for use with 
different populations. A second source of useful information may be obtained by using 
meta-analysis to investigate study-level characteristics that may lead to systematic 
variations in reliability coefficients. This has been named a reliability generalisability 
analysis (Vacha-Haase, 1998). 
 I also argue that re-examining the properties of psychometric measures using 
meta-analysis has other possibilities for furthering research. As outlined in the ‘validity’ 
section above, validity is both a property of tests and of psychological theory. 
Information about the validity of tests can inform theory generation and vice versa 
(Strauss & Smith, 2009). Therefore, I suggest that meta-analysis of the published data 
derived from the HAQ and SHAI provides an opportunity to investigate both the 
construct validity of both scales and an opportunity to investigate the cognitive-
behavioural conceptualisation of health anxiety.  
 In a validation study, the construct validity of a scale is generally assessed by 
examining the direction and strength of correlations between it and other measures that 
have known psychometric properties (Hinkin, Tracey, & Enz, 1997). It is assumed that 
a scale will correlate most strongly with other measures of the same construct 
(convergent validity), less strongly with related constructs and not correlate with 
measures of unrelated constructs (discriminant validity). For the HAQ and SHAI to 
have good construct validity they should correlate most strongly with other measures of 
health anxiety, then measures of generalised anxiety, followed by measures of obsessive 
compulsive disorder (OCD) and should correlate least strongly with measures of 
depression. I predict that this relationship will be found in this meta-analysis. I selected 
these measures because there is a theoretical rationale for the described expected pattern 
of relationships and because my scoping exercise indicated these measures would be 
available for analysis. 
 Indirect evidence relating to the construct validity of both scales may also be 
found by examining their correlations with measures of precursors of anxiety, for 
example the Intolerance of Uncertainty Scale (IUS; Freeston, Rheaume, Letarte, & 
Ladoucer, 1994), the Body Vigilance Scale (BVS; Schmidt, 1997) and the Anxiety 
Sensitivity Index (ASI-3; Taylor & Cox, 1998a). Examining these correlations can also 
provide evidence regarding the construct of health anxiety (Marcus, Gurley, Marchi, & 
Bauer, 2007).  
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Anxiety sensitivity refers to a fear that signs of anxiety will have a negative real-
life impact (Taylor & Cox, 1998b). It is based on Reiss’s (1991) expectancy model and 
is thought to be precursor or risk factor for developing anxiety. The initial 16-item 
version of the ASI was designed to assess anxiety sensitivity (Peterson & Reiss, 1987) 
although has been criticised as having insufficient items that are phrased in too general 
terms to detect the factors thought to underlie anxiety sensitivity. This led to the 
development of the longer, 36-item ASI-3R (Taylor & Cox, 1998a). Factor analysis of 
this scale revealed an overall anxiety sensitivity factor and the following lower order 
factors; fear of respiratory symptoms, fear of losing cognitive control, fear of appearing 
anxious in public and fear of cardiac symptoms. A clinical example of this would be 
someone fearing that a rapid heartbeat will lead directly to having a panic attack, or that 
increased breathing will lead to being rejected or humiliated by peers.  
 Intolerance of uncertainty (IU) refers to the inability to tolerate the 
uncomfortable feeling that may arise when one is in an uncertain situation and is 
thought to be a precursor to generalised anxiety disorder (Dugas, Gagnon, Ladoucer, & 
Freeston, 1998).  More recent research has indicated IU may be involved across other 
emotional disorders including OCD, social anxiety, post-traumatic stress disorder and 
panic disorder (Boswell, Johanna Thompson-Hollands). The same study found that 
during CBT treatment, intolerance of uncertainty reduced alongside symptoms of 
emotional disorder, the authors argue IU may be a helpful component of trans-
diagnostic therapy. The 27-item Intolerance of Uncertainty Scale (Freeston et al., 1994) 
was designed to assess IU and provides a total IU score.  
Body vigilance refers to when an individual consciously focusses their attention 
on somatic sensations and is assessed by the Body Vigilance Scale (Schmidt, Lerew, & 
Trakowski, 1997). A recent factor analysis of the BVS in a non-clinical and anxiety 
disorder sample revealed a unitary factor (Olatunji, Deacon, Abramowitz, & Valentiner, 
2007).  
Correlations with the ASI-3, BVS and IUS were included in an exploratory 
analysis, so no prediction is made regarding the strength or the direction of correlations 
with these measures.  
1.7 Aims  
 With the previous rationale in mind, this study aims to achieve the following 
with both the HAQ and SHAI: 
1) Generate normative scores in various populations by extraction and meta-
analysis of published mean scores and SDs;  
2) Investigate variations in mean scores via use of meta-regression (supplementary 
analysis); 
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3) Calculate an average reliability for each scale and where possible for different 
populations; 
4) Investigate sources of systematic variation in reliability via reliability 
generalisability analysis; 
5) Examine the construct validity of both scales by review and meta-analysis of 
correlations with other measures; 
6) Review the cognitive-behavioural conceptualisation of health anxiety by 
examining correlations between both scales and other measures. 
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2. Method 
 My choice of method for this thesis is meta-analysis. I begin with a general 
discussion of the aims and range of the applications of meta-analysis, including a 
rationale for why meta-analysis is the appropriate method to meet the research aims 
outlined in the preceding section. Next, I will consider the various criticisms levelled at 
meta-analysis and where possible how I overcome or ameliorated their impact.  
 In the ‘meta-analysis procedure’ section, I summarise the steps I took in 
conducting this analysis including my search strategy, inclusion/exclusion criteria and a 
discussion of risk of bias. I will argue that in this study, assessing risk of bias is not an 
appropriate strategy. Instead I will directly investigate the impact of various study level 
characteristics on variations in mean scores and reliability coefficients. Some of these 
variables are the same as those contained in a risk of bias scale. However, my use of this 
data differs from the usual application of these variables. This discussion is placed in 
the ‘investigating heterogeneity in mean scores’ section. 
 Finally, in the ‘data analysis’ section, I outline each component of the analysis 
conducted on both the SHAI and the HAQ. In summary, these are: (a) developing 
normative scores for various populations by meta-analysis of published mean scores and 
standard deviations; (b) reviewing the variation in alpha coefficients in various 
populations and use of reliability generalisability analysis to reveal potential sources of 
this variation; (c) review the construct validity of both scales via systematic review and 
meta-analysis of their correlations with other measures. This final section includes a 
discussion of the impact of these findings on the cognitive-behavioural 
conceptualisation of health anxiety as a latent construct. 
 In summary, the first half of the method section discusses and critically 
evaluates meta-analysis as a research tool. I then discuss the assumptions that underlie 
all my analyses such as employing a random-effects model and assessing heterogeneity. 
The closing half of this method section outlines the detail of the steps undertaken for 
each type of analysis. 
2.1. What is meta-analysis? 
The term meta-analyses was coined by Glass (1976), in an early analysis of 
psychotherapy outcome studies. Since then, meta-analysis has evolved into a collection 
of statistical procedures used to aggregate and analyse data from published research 
(Borenstein, Hedges, Higgins, & Rothstein, 2009). The use of meta-analysis as a 
research tool is increasing. For instance, one study searched Pubmed for all studies 
‘tagged’ as a meta-analysis and reported 334 were published in 1991; this increased to 
9,135 published in 2014 (Ioannidis, 2016). Pubmed tags, a form of article keyword are 
unlikely to be a wholly reliable source of information about the content of a study. 
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Nevertheless, these figures provide some indication of the increasing popularity of 
meta-analyses. Two other more methodologically rigorous studies estimated the number 
of meta-analyses published in 2004 to be over 1,300 (Moher, Tetzlaff, Tricco, Sampson, 
& Altman, 2007) this increased to 5,000 published in 2014 (Page et al., 2016). Both 
studies conducted a literature search for one month using Medline (November 2004 and 
February 2014 respectively) and used these figures to estimate the total likely to be 
published that year. Again, these studies are estimates, but still point to a large increase 
in the use of meta-analysis. 
A meta-analysis will typically take the following steps (Borenstein, Hedges, 
Higgins, & Rothstein, 2009):  
1. Define research question  
2. Conduct literature search  
3. Define inclusion/exclusion criteria  
4. Extract data  
5. Calculate effect sizes for each study  
6. Conduct meta-analysis – by calculating a weighted effect size from those 
available in each study, then provide an overall effect size.  
 
My research questions have been outlined in the introduction and I will detail my 
methods for each of the above points in the ‘meta-analysis procedure’ section. Before 
doing this, I outline an important methodological issue regarding choice of a random- or 
fixed-effect model. This is followed by a discussion of some of the criticisms levelled at 
meta-analysis and my efforts to overcome or ameliorate their impact. 
2.2. Why employ meta-analysis?  
This project aims to develop normative data for the SHAI and the HAQ and 
investigate the construct validity of both scales. Meta-analysis was selected because it 
allows data to be collected from all published applications of the HAQ and SHAI. This 
will allow normative data to be collected from multiple populations (e.g. those with 
health anxiety, an anxiety disorder and those attending medical outpatients). This 
permits a far broader range of data to be gathered amongst a greater number of 
populations than would be possible if collecting raw data. Similarly, collecting 
reliability coefficients from multiple applications of a test allows a far more 
comprehensive assessment of its reliability than would be possible via a one-off 
application with a single population of participants. This approach has the advantage of 
being able to assess the impact of study-level variables (e.g. language of test, nationality 
of participants) that may explain variations in HAQ/SHAI mean scores and reliability 
coefficients that would be impossible without collecting a large amount of raw data 
amongst multiple populations and languages. 
- 40 - 
2.2.1. Fixed vs random effects models  
An important decision when conducting a meta-analysis is whether to adopt a 
fixed or random effects model, each is founded in different assumptions about the 
populations that are under analysis. A fixed-effect model assumes the effect sizes within 
the sampled population do not vary in magnitude, so will be homogenous (Hunter & 
Schmidt, 2014). In contrast, a random effects model assumes the effect sizes within the 
sampled population have a component of random variance, so will be heterogeneous 
(Hedges & Vevea, 1998).   
The choice of whether to adopt a random or fixed effect model depends on which 
assumption is most appropriate to the study population of interest (Borenstein et al., 
2009). This decision is also important as incorrectly applying a fixed-effect model to a 
population containing varying (heterogeneous) effect sizes can increase the type 1 error 
rate from the usual 5% up to 80% (see Field & Gillett, 2010). It has been argued that in 
real-world research concerning the populations of interest to psychology researchers 
that the average effect sizes are likely to be heterogeneous (Field, 2003). 
Rather than selecting between a fixed or random effects model prior to analysis, 
Hedges and Vevea (1998) argue the choice of model should be determined statistically, 
by assessing the homogeneity of effect sizes: If the effect sizes are homogenous then a 
fixed-effect model is most appropriate, if significantly heterogeneous then a random 
effects model should be employed. If a random effects model is adopted because of 
significant heterogeneity of effect sizes it may be described as a ‘conditional random 
effects model’. This term has been suggested to make it clear that this decision has been 
made statistically (Hedges & Vevea, 1998). 
A second consideration when choosing between a fixed or random effects model 
concerns the generalisability of results. If a researcher intends to generalise their 
findings beyond the strictly defined range of studies included in the analysis then a 
random effects model must be used. If this is not required then a fixed effects model is 
more appropriate (Borenstein et al., 2009). 
 I employed a random effects model because there was significant heterogeneity 
in effect sizes (see results section) and as the goal of this thesis is to generate population 
norms for the SHAI and HAQ it is necessary to generalise my findings beyond the 
included studies. I also conducted a meta-analytic technique known as reliability 
generalisability analysis (Vacha-Haase, 1998), again assuming random effects. I discuss 
this in detail in the ‘meta-analysis procedure’ section.  
2.3. Criticisms of meta-analysis 
 In this section, I discuss some of the general criticisms of meta-analysis and how 
they may be managed. These criticisms mostly apply to more ‘traditional’ applications 
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of meta-analysis such as evaluating pre/post treatment effect sizes or odds ratios in 
RCTs. In this study, I applied meta-analytic techniques to developing population norms, 
employed meta-regression to investigate the reliability and performed a meta-analysis of 
correlation coefficients to investigate the construct validity of the SHAI and the HAQ. I 
did not evaluate treatment effects, this means that although the usual criticism of meta-
analysis are applicable to this study, they required accounting for in a different way. My 
attempts to do so are detailed in the meta-analysis procedure section. Because of my 
bespoke application of meta-analysis, I needed to adapt my response to these criticisms 
to the demands of this study, therefore some of my responses to these criticisms are 
accounted for in more depth in the meta-analysis procedure section. 
2.3.1. The ‘file drawer problem’ 
Journal editors are more likely to publish statistically significant or novel findings 
(Rosenthal 1979), meaning that non-significant findings are less likely to appear in 
journals and remain ‘in the file drawer’. The usual level of acceptable probability in 
psychology research is 0.05, which means 5% of significant results are false-positives 
(type I error). In an extreme example, it may be that of 100 studies investigating a 
relationship between depression and shoe size, 5 found a significant result and were 
subsequently published. However, the remaining 95 did not find a significant result so 
were not published. This may easily lead to the conclusion that there is a relationship 
between depression and shoe size, even though all the published results are due to 
chance. Rosenthal (1979) offered a ‘fail safe n’ calculation that enables a researcher to 
calculate the number of studies reporting non-significant results required to reject a 
significant finding. Publication bias is important to consider when accepting the 
conclusions of published research and can also be an unwanted source of bias when 
conducting a meta-analysis. It should be noted that Rosenthal’s calculation has been 
criticised for overestimating the number of null-findings necessary to reject a significant 
result (see Scargle, 2000 for an alternative formula). 
The concept of publication bias has been extended to include effect sizes (Hedges, 
1992). There is evidence for the existence of publication bias in the medical literature; a 
meta-analysis of studies investigating publication bias reported that significant effect 
sizes are more than twice as likely to be published than non-significant (odds ratio (OR) 
2.40, 95% CI [1.18, 4.88]; Song et al., 2009). This replicated an earlier study reporting 
similar findings (OR 2.54, 95% CI [1.44, 4.47]; Dickersin, 1997). This realisation led to 
the development of a ‘fail safe n’ calculation for effect sizes in meta-analyses (Orwin, 
1983). Similarly, to Rosenthal’s (1979) formula discussed above, it allows a researcher 
to calculate the number of studies reporting zero effect that would be required to reject a 
positive finding. It is beyond the scope of this thesis to evaluate different means of 
calculating a failsafe n for effect sizes, but it should be noted that alternative methods 
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exists, for example employing a maximum likelihood model (Iyengar & Greenhouse, 
1988). 
 Each analysis I conducted required distinct approaches to evaluate the potential 
effect or extent of publication bias. Therefore, I have discussed these in more detail in 
the corresponding ‘meta-analysis procedure’ sections.  
2.3.3. Biased study inclusion and data analysis 
When reporting the results of a systematic review or meta-analysis it is essential to 
report the risk of bias in both the included studies and resulting data analysis 
(Borenstein et al., 2009). This enables the reader to critically evaluate whether the 
authors’ conclusions are warranted or if their analysis is flawed. For example, non-
disclosure of the funding organisation is a potential risk of bias as the authors may have 
a conflict of interest, so selectively report their findings. 
Despite this, an analysis of 300 systematic reviews and meta-analyses that were 
published in November 2004 reported widespread omissions of data essential in 
evaluating  risk of bias (Moher et al., 2007). For example, only 23% assessed 
publication bias and 33% did not provide a report of how risk of bias was assessed. 
Because of these shortcomings, the Preferred Reporting Items of Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines were developed to ensure systematic 
reviews and meta-analyses are reported correctly (Moher, Liberati, Tetzlaff, & Altman, 
2009). These emphasise the need for clear description of the method used when 
conducting a meta-analysis or systematic review, and includes a review of risk of bias 
(see PRISMA checklist items 12, 15, 19 and 22). I have followed the PRISMA 
guidelines throughout this thesis and have aimed to describe my study inclusion criteria, 
method and analysis in sufficient detail that they may be replicated.  
Bias in included studies is important to consider because meta-analysis is a 
statistical analysis based on previously published research so cannot overcome the input 
of poor quality data (Eysenck, 1978). Of course the same can be said about any research 
that has not been conducted in a scientifically rigorous way (Greenland, 1994). This 
difficulty is generally overcome by having robust inclusion and exclusion criteria and 
transparent reporting of the data-analytic strategy. 
The inclusion of biased or flawed studies is of relevance to meta-analyses 
examining treatment effects, where the input of effect-sizes from poorly conducted trials 
(e.g. researchers not blinded to condition, intervention characteristics not adequately 
described) may adversely affect the analysis. However, it has less relevance for the 
study in this thesis as I will not be investigating treatment outcome. Again, I argue that 
even a poorly conducted trial will be unlikely to affect an individual’s baseline health 
anxiety scores. However, there are some scenarios that may potentially affect my study 
more dramatically than a meta-analysis of treatment effects; for instance, if the sample 
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description is poorly described, or if study conditions artificially (and temporarily) alter 
an individual’s health anxiety score. I discuss these examples and others in detail along 
with a rationale for how I assessed study quality in the ‘risk of bias’ section. 
2.3.4. Comparing ‘apples and oranges’ 
 A final criticism is that it is inappropriate for meta-analysts to compare different 
kinds of studies that employ varying measures or include differing participants  or 
‘apples and oranges’ (Sharpe, 1997). In contrast, others argue the ability of meta-
analysis to aggregate effect sizes from disparate analyses is a strength  (Borenstein et 
al., 2009). Regardless, I argue this criticism has little impact on this analysis as I will 
only be comparing samples on the same measure. This is consistent with Sharpe's 
(1997) recommendation that when the scope and research question of a meta-analysis is 
sufficiently narrow then the ‘apples and oranges’ criticism is of less relevance. It is 
possible to determine whether a study is comparing studies that are too dissimilar be 
examining the homogeneity of effect sizes (Borenstein et al., 2009). The effect of 
moderator variables (such as quality of study or sampling strategy) on homogeneity can 
also shed light on the differences between studies that may influence variability in effect 
sizes.  
2.4. Alternative study designs 
 I considered alternative designs to the study I eventually carried, I now discuss 
these designs and my reasons for selecting meta-analysis of published data. 
2.4.1. Alternative design 1: collect new data 
 An alternative design would be to collect new raw data from various populations 
and develop norms based on this information. This approach would have the advantage 
of conducting a confirmatory factor analysis and the collection of detailed demographic 
information that (with a sufficient sample size) would allow precise norms based on 
age, gender and ethnicity to be produced. However, scale validation papers typically 
have samples in the hundreds (Anthoine, Moret, Regnault, Sébille, & Hardouin, 2014) 
and 300 participants are recommended as the minimum required for exploratory factor 
analysis (Tabachnick & Fidell, 2012).  
Collecting new data would involve gathering sufficient information to develop 
norms for several populations (e.g. students, community controls and hypochondriasis) 
each requiring a corresponding programme of data collection. It would be important to 
collect data amongst multiple populations rather than focussing on undergraduates. This 
is because undergraduate students are a limited sample as they are better educated, 
younger and at a much earlier life stage than those in the wider community. They also 
differ in terms of personality traits (as assessed by the Big-5) and their values as 
compared to older peers. The magnitude of these differences also vary according to 
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nationality (Hanel et al., 2016). Crucially for health anxiety research, young people are 
also likely to have stronger immune systems (Roberts-Thomson, Young, Whittingham, 
& Mackay, 1974), be healthier and have had fewer illness than older populations (Beard 
et al., 2015).  This means their experience of illness and ill health is different to the 
general public as health anxiety is more common after being physically ill and also is 
more likely to appear when in one’s 30s or 40s (Starcevic & Lipsitt 2001). I suggest this 
is highly problematic as much health anxiety research is based on studies conducted 
with undergraduates and there is evidence this group significantly differs from the wider 
population (Henrich, Heine, & Norenzayan, 2010). 
Another difficulty with this approach is that it is incompatible with my goal of 
investigating the construct validity of each scale. In the study design I eventually 
selected, this was achieved by examining the correlations between the SHAI/HAQ and 
psychometric measures of other constructs. Completing this with a new sample would 
require each participant to complete a large number of questionnaires. Although this 
would be advantageous as a more complete picture of the nomothetic span of the 
construct validity of each scale could be obtained, a disadvantage is the extra time 
required to gather information for multiple populations. As such it may not be 
achievable given the constraints of completing this thesis. In addition, there may be 
ethical difficulties in asking participants to complete questionnaires when this data is 
already available in the literature.  Overall, I argue collecting new raw data would be 
unachievable for a project of this nature and would only allow for a limited range of 
population norms to be developed. 
2.4.2. Alternative design 2: contact authors for existing raw data 
A second alternative design would be to contact authors of primary studies and 
requesting access to their data. This would enable me to calculate normative data with 
greater precision than meta-analysis of mean scores. Another advantage of this approach 
is that detailed demographic data may be available for analysis, which would allow for 
further differentiation of the variability of health anxiety scores across groups, for 
example dividing a sample by age and gender. This approach may have been an equally 
helpful means of developing normative data and investigating the construct validity of 
both scales. I contacted authors via email requesting access to their data, but these 
attempts were unsuccessful. Furthermore, this method is limited as it relies on authors 
sharing their data, which although a condition of publication in many journals, few 
authors do so in practice (Savage, Vickers, Kats, & Molenaar, 2009; Wicherts, 
Borsboom, Kats, & Molenaar, 2006). This means that the amount of data available is 
likely to be narrower than that in the published literature, so will limit the range of 
normative data that can be produced. Therefore, I elected to continue this project by 
meta-analysis of published data only.  
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2.5. Meta-analysis procedure 
 I now outline each step taken in conducting this meta-analysis, beginning with 
my search strategy. 
2.5.1. Search strategy 
Medline, PsycINFO and Web of Science were used to search for articles citing the 
original scale validation study of the SHAI (Salkovskis et al., 2002) and the HAQ 
(Lucock & Morley, 1996). These databases were selected as they are the major subject 
databases for clinical psychology and medical research. Other studies may exist in the 
literature, though this is unlikely given the scope of the databases searched. The output 
of each database search were collated and duplicate articles were removed. Reference 
lists of included papers were searched for other citations not discovered in initial 
literature search. The literature search was restricted by date: The start date for the HAQ 
literature search was 1996, for the SHAI it was 2002 (the dates when both scales were 
first published) The closing date for published literature to be used in the meta-analysis 
was 31 April 2016.  
2.5.2. Inclusion and exclusion criteria 
Studies were included if they were published in a peer reviewed journal and 
reported on any of the following; sample mean, sample standard deviation, reliability 
coefficients and correlations with other measures. Table 1 below states reason for 
selection of each variable. 
When the HAQ/SHAI were utilised in a RCT or at multiple time-points, only 
baseline data was extracted to provide pre-intervention scores and norms for untreated 
populations. Follow up data was not included in the meta-analysis as this thesis does not 
aim to evaluate treatment approaches for health anxiety.  
Table 1. Variables extracted for meta-analysis and rationale for inclusion 
Variable  Reason for inclusion 
Mean score • Generate normative data for different 
populations. 
• Predictor variable in reliability 
generalizability analysis. 
Standard deviation • Generate normative data for different 
populations. 
• Predictor variable in reliability 
generalizability analysis. 
Alpha coefficients • Generate normative reliability data for 
different populations. 
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• Dependent variable in reliability 
generalizability analysis. 
• Narrative review of internal consistency 
estimates in different populations. 
Test re-test reliability 
coefficients 
• Narrative review of test re-test reliability. 
Correlations with other 
measures 
• Review the construct validity of both scales. 
Demographics (age, gender, 
nationality) 
• Predictor variables in exploring 
heterogeneity in mean scores. 
• Predictor variables in reliability 
generalizability analysis. 
Other study level variables 
(sample composition, 
measurement context)  
• Predictor variables in exploring 
heterogeneity in mean scores. 
 
 
Studies were excluded if: (a) Papers cite either measure but do not report any 
numerical data (e.g. narrative reviews, editorials); (b) Where multiple studies report on 
the same sample, data was only extracted once, although if additional data were 
available in a second study this data was combined with data from the first so that each 
sample was only reported once. For example, Norr and colleagues published three 
separate papers, each reporting different information relating to the SHAI (used as a 
secondary measure) but collected all the data from the same student sample (Norr, 
Oglesby, et al., 2015; Norr, Albanese, Oglesby, Allan, & Schmidt, 2014; Norr, Allan, 
Boffa, Raines, & Schmidt, 2015). Data from these three studies were combined into one 
data-point to avoid the same sample being counted more than once; (c) When extracting 
data it emerged that 4 studies selected participants based on SHAI cut-off scores 
(Abraham et al., 2013; Brady & Lohr, 2014; Lee, Goetz, Turkel, & Siwiec, 2015; 
Roberts, Hart, & Eastwood, 2010; Wattar et al., 2005). In these studies participants were 
selected for being very high, or very low in health anxiety so will not represent the true 
range of scores found in that population. Therefore, these studies were excluded from 
the meta-analysis as their inclusion would bias the normative data produced. For 
comprehensiveness their mean scores, standard deviations and reliability coefficients 
are reported in appendix B along with data derived from studies that were included in 
the analysis. 
See the PRISMA diagram in figure 2 for a summary of the quantity of included 
and excluded studies.  
- 47 - 
 
Figure 2. PRISMA diagram of included studies. 
 
2.5.3. Assessing risk of bias (RoB) 
As stated previously, it is important to assess RoB as studies with flawed design 
may produce inaccurate results which in turn will affect the accuracy of the conclusions 
drawn from a meta-analysis (Gluud, 2006). There has been much consideration of this 
topic amongst medical researchers using RCTs to investigate the efficacy of treatments 
(Wood et al., 2008). The effects of poorly conducted trials on a meta-analysis can be 
striking; for example a review of 250 RCTs reported that including trials with high RoB 
can increase an odds ratio by 41% (Schulz, Chalmers, Hayes, & Altman, 1995). 
Government policy such as NICE guidelines are developed based on results from 
clinical trials, systematic reviews and meta-analysis. Therefore, it is important that these 
are not based on flawed results, especially as analysis of flawed trials could lead to a 
treatment being erroneously recommended as effective. The realisation of the need to 
systematically review RoB in RCTs led to the Cochrane Collaboration development of 
guidelines in achieving this (Higgins et al., 2011). This guidance focussed on evaluating 
allocation procedures, blinding of participants and researchers to treatment arm and 
participation attrition. Of course, not all of these criteria can be achieved in trials of 
psychotherapy as it impossible for participants and trial therapist to be blind to the 
intervention being used. The ROBINS-I toolkit is a similar set of guidelines used to 
evaluate non-randomised intervention studies (Sterne et al., 2016). Clearly, evaluating 
risk of bias in research is of great importance when carrying out a meta-analysis of 
treatment studies.  
Studies citing HAQ and 
SHAI scale development 
papers:
HAQ n = 105
SHAI n= 202
Studies reporting data 
meeting inclusion criteria:
HAQ n=25 (34 study arms)
SHAI n=62 (93 study arms)
Studies excluded (with rationale):
HAQ
Only HAQ subscale used, n=14
Foreign language paper, n=4
No data reported, n=10
Scale not used, n=52
SHAI
No data reported, n=37
Foreign language paper, n=8
Scale not used, n=22
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As previously mentioned, I am not researching treatment effects and have only 
analysed baseline data from RCTs, in fact the vast majority of the studies included in 
this analysis were from cross-sectional research. Additionally, I did not extract post-
treatment data, so all studies in this analysis could be considered cross-sectional. The 
National Institute of Health (NIH; 2014) have published guidelines for evaluating RoB 
in for cross-sectional and observational studies. These guidelines assess whether a study 
was designed and conducted in robust way, has a sufficient sample size with minimal 
attrition and whether the report has sufficient information to allow replication.  
The overarching aim of assessing RoB in a meta-analysis of treatment effects is to 
uncover the true effect of an intervention rather than any spurious effects that result 
from a poorly designed study or measurement error. Studies that are deemed to be at 
greater risk of bias are often excluded from an analysis. Initially I planned to develop a 
bespoke RoB scale, calculate a score for each study and input these scores as a 
moderator in a regression analysis to determine if studies with a greater RoB lead to 
systematic variation in mean scores or reliability coefficients. I generated this scale 
from the relevant items included in the Cochrane Collaboration guidelines, ROBINS-I 
toolkit and NIH guidelines. After constructing a bespoke scale, I realised the items 
included in this scale may be potential sources of heterogeneity in mean scores. 
Therefore, rather than creating a RoB scale, collating the data and generating an overall 
rating I have entered various RoB items that were initially planned to comprise the scale 
as predictors of mean scores. These predictors along with a rationale for inclusion are 
detailed in the next section along with a description of each step taken in the analysis.   
As with the Cochrane Collaboration and ROBINS-I toolkit, the NIH RoB 
guidelines were designed to evaluate medical studies, so also includes information 
about exposure to a particular intervention, for example diabetes medication. This 
means that none of the reviewed guidelines could be used in unadulterated form in this 
analysis, instead I assessed RoB using my own items. This has the disadvantage of not 
being standardised and has not been agreed with other researchers, unlike the above 
toolkits which were developed by several researchers in collaboration. However, I am 
applying meta-analysis to a research problem that does not concern treatment effects, so 
required an alternative means of assessing RoB. I am unaware of any other study that 
attempts to generate population norms using meta-analysis, so there are no established 
guidelines or precedent to follow when conducting this study.  
The rationale for assessing RoB in a meta-analysis is to describe and (via 
exclusion of problematic studies) remove heterogeneity in calculated effect sizes. 
During the analysis phase of this project, I realised I could investigate potential sources 
of heterogeneity in mean scores by utilising this RoB information. Therefore, I will 
describe this component of my analysis as investigating heterogeneity in mean scores.  
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As there is no precedent for this approach, I attempted to follow the scientific 
reasoning fundamental to the Cochrane Collaboration, ROBIN-I toolkit and the NIH 
RoB guidelines and applied it to this study. I now describe which variables I selected to 
investigate as potential sources of heterogeneity in means scores.  
2.5.4. Investigating heterogeneity in mean scores 
 In this section I discuss the study level variables that I selected to investigate 
their impact on mean health anxiety score. These variables fall into three domains; 
sample composition, recruitment strategy and testing conditions, I now describe the 
rationale for selecting each variable. 
2.5.4.1. Exploring heterogeneity domain 1: Sample composition 
For the normative data generated by this analysis to be helpful in research or 
clinical practice it will need to refer to specific populations, for example students or 
those with a chronic medical condition. Therefore, the composition of the sample may 
impact on mean scores. If a study sample is less homogenous, for example including 
both students and those with clinical levels of health anxiety, then any normative data 
developed may only be accurately applied to samples of the same population. I aimed to 
establish risk of sampling bias by inclusion of the following items, all coded yes/no: 
1. Homogeneous sample (defined as homogenous if containing only one diagnostic 
group); 
2. Representative of population of interest (rated as ‘yes’ if the sample 
demographics and description matches with the study design); 
3. Well described sample (met this criteria if demographics and diagnostic criteria 
were reported); 
4. Medically unwell included. 
The medically unwell participants item was included as being ill can increase an 
individual’s health anxiety (Katon, Lin, & Kroenke, 2007). Therefore, it may be 
inappropriate to aggregate studies that exclude the medically unwell with those that 
include them as health anxiety is likely to be higher in the latter. By collecting study-
level data about the inclusion of the physically unwell, I can determine whether this 
variable does have an impact on mean score. All of these items are designed to assess 
whether the sample in a study represents the target population of interest. 
2.5.4.2. Exploring heterogeneity domain 2: Recruitment strategy  
 A related domain concerns bias in recruitment, which may then influence the 
composition of the final sample. An example of a biased recruitment strategy would be 
use of ‘snowball’ sampling, where existing participants recommend friends to 
participate in the study; a less biased strategy would be asking consecutive referrals at 
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an anxiety disorder clinic. Recruitment strategy was grouped according to the following 
categories:  
1. Random sampling; 
2. Opportunity samples; 
3. Snowball sampling; 
4. Not reported. 
2.5.4.3. Exploring heterogeneity domain 3: Testing conditions 
 The conditions that a person is assessed under may affect their test scores, 
therefore for accurate comparison between groups it is important that these are 
standardised (Wechsler, 2008). This was assessed by the following items: 
1. Standardised testing conditions? 
2. Test administered correctly? 
Another consideration is the context within which the assessment of health anxiety 
occurred. If a health anxious person is assessed in a hospital setting then I argue that this 
may temporarily increase their anxiety and perhaps elevate their scores. Similarly, if 
measurement of health anxiety occurred at a time point in treatment or diagnosis likely 
to temporarily increase health anxiety, such as immediately prior to receiving 
information about a medical condition then this was recorded. I aimed to capture this 
information with the following items:  
3. Measurement context likely to elevate anxiety? 
4. Measurement point likely to elevate anxiety? 
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2.6. Data analytic strategy 
 There are four overarching aims, or domains of this thesis regarding the creating 
normative data and investigating the psychometric properties of the SHAI and the HAQ. 
Table 2 contains a summary of each aims and associated analysis. 
 
Table 2. Research questions and choice of analysis for each thesis domain. 
Research 
domain 




1. What are normative mean scores, 
SDs and reliability coefficients for 
various populations? 
 
1. Mean scores, SDs and 
reliability coefficients 
entered as effect sizes 
and meta-analysed. 
 2. Can the variability in mean scores 
be explained by demographic or study 
variables? 
2. Meta regression with 
mean scores as the 
dependent variable, 
demographic and study 




1. Is there systematic variation in 
reliability coefficients? 
2. Can this variation be accounted for 







1. Do the SHAI and HAQ have 
adequate construct validity? 
1. Meta-analysis of 
correlations with other 
measures. 
2. Qualitative review of 
correlation coefficients. 
 
In order to answer the research questions in table 2, I conducted three distinct 
meta-analyses, each with different aims, methodology and analysis. As previously 
stated, a random effects model (Hunter & Schmidt, 2000) was assumed in all analyses. I 
now describe each step taken to analyse the data for each study domain. This is reported 
in line with PRISMA guidelines so this analysis may be replicated and critically 
evaluated. 
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2.6.1. Meta-analysis 1: Calculating population norms 
 Population norms were developed by extracting the mean score, standard 
deviation and reliability coefficients for each population reported in the included 
studies. Mean scores and standard deviations were extracted in order to determine 
average health anxiety scores in different populations. Similarly, where possible 
reliability coefficients were extracted to provide an average reliability for each 
subpopulation.  
Because this study relied on previously published data, normative data could 
only be generated from that already available. Consequently, studies reporting data from 
distinct, but similar populations were grouped together for analysis. The descriptions of 
the sample types grouped to develop normative data are summarised in table 3 and 
apply to those derived from both the SHAI and HAQ.  








Generalised anxiety disorder, panic, 
obsessive compulsive disorder, social 
phobia, specific phobia.  
DSM-IV Diagnostic 
interview. 
Cardiac Cardiac syndrome X, coronary heart 





Those attending an amniotic fluid test, 
a breast cancer diagnostic test, general 
practice or attending a cardiac, 
gastroscopy or neurology clinic.  




Active Crohn’s Disease, inactive 
Crohn’s disease, active ulcerative 
colitis, inactive ulcerative colitis, non-









Heterogeneous, includes the physically 
well and physically unwell.  
No consistent 
definition of ‘healthy’. 
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Pain Chronic pain (lasting>6 months), acute 
pain (from tissue damage). Exclusion 
criteria; psychiatric disorders, 
fibromyalgia, arthritis. 
Physician diagnosis.  
Students Attenders at university N/A 
*Note Barsky and Ahern (2004b) defined health anxiety using WI and Somatic 
Symptom Inventory cut-off scores, only half of their sample met DSM-IV diagnostic 
criteria. Data from this study was not included in the meta-analysis.  
If multiple populations were reported in the same study, for example those 
experiencing hypochondriasis compared to healthy controls, then each sample in the 
study was reported separately. It is likely that health anxiety scores will vary across 
different populations (e.g. those attending medical outpatients vs. anxiety disorders).  
Therefore, this step was necessary so that a comparison of the typical level of health 
anxiety in each population could be made.  
 If the SHAI or HAQ were employed in a treatment trial or other longitudinal 
follow-up study then data was extracted from baseline scores only. This is because this 
study aims to determine the typical health anxiety in various populations that have not 
been treated. 
 In their earlier meta-analysis of the SHAI, Alberts et al., (2013) noted that some 
authors incorrectly scored the SHAI from 1-4, rather than 0-3 this lead to greatly 
inflated scores in some studies. Prior to analysis, I corrected these studies by subtracting 
14 points from the mean score if using the SHAI-14 and 18 points if using the SHAI-18.  
These corrected scores were employed in the meta-analysis, both corrected and raw 
mean scores for each study are presented in appendix c.  
 In 10 of the studies included in this thesis, participants from the same population 
were divided into two or more groups for analysis. In these studies, HAQ/SHAI 
information was reported for each sub-group but study-level data such as demographic 
and reliability information was reported for the entire sample. This lack of information 
pertaining to each sub-sample is problematic as it prevents further analysis of 
heterogeneity in mean score and reliability as the two sub-samples may differ in some 
way. To overcome this difficulty, I combined the sub-samples to create an overall 
sample. For example, in an RCT of mindfulness based cognitive therapy (McManus, 
Surawy, Muse, Vazquez-Montes, & Williams, 2012), a total of 72 participants were 
randomised to either mindfulness based cognitive therapy (n=36) or unrestricted 
services (n=36). In this analysis, the health anxiety mean scores and standard deviations 
were combined prior to meta-analysis to create a single sample of 72 with an overall 
mean and standard deviation.  
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 I combined the scores in each study by multiplying each variable of interest by 
the sub-sample size to create a weighted score. The weighted score for each sample was 
summed and then divided by the overall sample size. This is outlined in the equation 
below, where $	denotes the variable of interest (mean, standard deviation or reliability 
coefficient) in each study and & the size of the corresponding sub-sample: 
$ = 	




 To prepare the data for meta-analysis, I grouped each sub-sample with others 
derived from the same population. Using the SHAI-14 as an example, there were 16 
studies reporting on undergraduate psychology students and 7 studies reporting on 
populations with hypochondriasis.  
 Next, I calculated a weight for each variable of interest (mean, standard 
deviation and reliability coefficient). This step is required so that larger samples have 
more influence in the analysis and avoids studies reporting on smaller samples from 
overly influencing the meta-analysis. There are numerous methods for calculating the 
weight of a variable, the method I used involves weighting by the inverse of the 
variance of each variable. I selected this method because it has the advantage of 
accounting for both sample size and variability of scores, with a larger sample size and 
smaller variability being allocated a larger weight. It is the most frequently employed 
means of weighting variables in meta-analysis (Rodriguez & Maeda, 2006) and is also 
recommended for use in reliability generalisability analysis (Botella, Suero, & 
Gambara, 2010) which I outline in the next section.  
Table 4 outlines the equations I used to generate a weight for the mean, standard 
deviation and reliability coefficients. Note, se = standard error, sd = standard deviation,  
-, = variance of the ./0 group, &, = sample size of the ./0 group, 1, = the number of 
items in the scale under analysis and finally 2, = weight. The equations for weighting 
the standard deviation and alpha coefficients were taken from Rodriguez and Maeda 
(2006) and Botella et al. (2010) respectively. Data analysis was conducted in SPSS 
using the macro designed by Wilson (2010). 
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Table 4. Calculations of weights for means, standard deviations and alpha coefficients. 
(Table adapted from Morley, 2016). 
Meta-analysis 
variable 
Standard error/variance calculation Weight  
Mean 34 = 	
35
&




Standard deviation -, = 	
2 ∗ 	358
(& − 1)







18 ∗ 	 1, ∗ &, − 1 ∗ (1 − 	!)*/>
1, − 1 ∗ 	(9 ∗ &, − 11)*





2.6.2. Meta-analysis 2: Reliability generalisability analysis 
 Reliability generalisability (RG) analysis is a meta-analytic procedure developed 
to empirically assess the variability in reliability coefficients of a test across different 
populations and studies (Vacha-Haase, 1998). It allows the computation of the average 
reliability of a test across studies, the extent of this variability and an indication of 
potential sources of this variance. In the first paper utilising RG analysis, Vacha-Haase 
(1998) meta-analysed reliability coefficients of the Bem Sex Role Inventory (BSRI; 
Bem, 1974) using the ordinary least squares method and reported the average reliability 
across included studies with corresponding confidence intervals. The second component 
of the analysis involved the statistical evaluation of potential sources of variability in 
reliability coefficients, this was achieved by running a meta-regression with 
untransformed reliability coefficients as the dependent variable and various study-level 
variables (e.g. sample size, language of questionnaire) as predictors. These predictors 
were added to determine which explained a significant proportion of the variance in 
reliability coefficients.  
An example of a reliability generalisability analysis of the State-Trait Anxiety 
Inventory reported that STAI had poorer reliability when conducted in studies with 
younger people under the age of 16 (Barnes, Harp, & Woo, 2002). The authors also 
reported that the average re-test reliability for the state form of the scale was 0.7, this is 
a problematically low level of reliability. This example demonstrates the information 
about the reliability of a test that can be inferred from reliability generalisability 
analysis. 
Since Vacha-Haase’s initial paper, RG analysis has developed into a sub-field of 
meta-analysis in its own right with a diversity of analytical procedures being employed 
(Vacha-Haase & Thompson, 2011). RG studies differ according to the means of 
weighting reliability coefficients, whether transformed or untransformed coefficients are 
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analysed and the choice of meta-analytic model, e.g. ordinary least squares, fixed- or 
random- effects model (Sánchez-Meca, López-López, & López-Pina, 2013).  
Botella, Suero, and Gambara (2010) extended the work of Vacha-Haase (1998) 
and argued that the sources of variation in scale reliability coefficients can be better 
assessed when considered in relation to the means and standard deviation in the same 
study. They argue that this allows one to determine whether variability in reliability is 
due to biases in sampling, measurement error or variation in correlations between scale 
items. The distribution of alpha coefficients is highly skewed, violating an assumption 
of meta-regression, and therefore must be transformed prior to analysis. Several 
methods of adjusting alpha coefficients have been suggested (see Sánchez-Meca et al., 
2013), I used the following formula recommended by Botella et al., (2010) where @, 
refers to the transformed version of the alpha coefficient, !,: 
@, = 	 (1 −	!,)(/> 
After meta-analysis, the computed alpha coefficient was back-transformed using this 
formula: 
!, = |1 − @,
>| 
When conducting the RG analysis I followed the procedure outlined by Botella et 
al., (2010). They advocate weighting means, standard SDs and alpha coefficients by the 
inverse of the variance of each. This was achieved using the same equations as those 
used in the meta-analysis to develop normative data and are outlined in table 4. 
 After calculating weights for the mean score, SD and reliability I then computed 
a meta-regression analysis with alpha coefficients as the dependent variable and study-
level variables (e.g. language of scale) entered as predictors. The study variables 
inputted as predictors are outlines in the results section. 
2.6.2.1. Limitations of RG analysis  
A difficulty with RG analysis is that authors often do not report reliability 
information: a review of 12,994 papers reported that 54.6% did not mention reliability 
and a further 15.7% reported previously published reliability coefficients from other 
studies or manuals (Vacha-Haase & Thompson, 2011). Both of these situations are 
problematic for different reasons. I will now outline these reasons and how I attempted 
to overcome these difficulties. It has been suggested a lack of reporting of reliability 
coefficients is because authors erroneously believe reliability is a fixed property of tests 
rather than property of a specific test in a specific population at a specific time 
(Wilkinson, 1999).   
2.6.2.1.1. Limitation 1: Lack of reported reliability coefficients 
 A lack of reported reliability coefficients is problematic for the same reasons as 
the file drawer problem discussed in the ‘criticisms of meta-analysis’ section. If a study 
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is less likely to be published for having non-significant results, it also follows that 
studies reporting lower reliability coefficients may also face the same difficulty. It is 
possible to envision a hypothetical scenario where only studies reporting acceptable 
reliability are published and that there are many other unpublished studies all reporting 
coefficients of 0. If this is the case then a measure that is unreliable, or has poor 
reliability in certain populations may have been incorrectly used in research or clinical 
practice. Although such an extreme is unlikely, it is plausible that a measure may be less 
reliable when used outside of the rarefied clinical or student samples often recruited to 
validate measures. 
To overcome this difficulty, Howell & Shields, (2008) offer two calculations: the 
first allows one to estimate the average reliability in an overall population comprised of 
studies that do and do not report a reliability coefficient. The second equation is 
analogous to the failsafe-n calculation used in treatment studies. This calculation 
generates an estimation of the number of studies that would need to be published with 
reliability below a certain threshold (selected by the researcher) for the overall average 
reliability to drop below an unacceptable level.  
The first calculation provides an estimate of the average reliability in a population 
of studies. This population will include papers that have published a reliability 
coefficient and those that do not. Because the average reliability in the non-reporting 
sample is not known, Howell and Shields (2008) recommend assuming the average 
reliability in this sample is 0.8 standard deviations below the average reliability 
generated from the reporting studies. This figure is suggested as a difference of 0.8 
standard deviations corresponds to a large effect size (Cohen, 1988). 
This information is inputted into the below equation, where BCD  is the number 
of studies reporting an alpha coefficient and  !CD	EFGHIJ is the average reliability of this 
sample. The number of studies not reporting an alpha coefficient is BKC	EFGHIJ and the 






The second equation provides the failsafe-N of the number of unpublished 
studies with poor reliability that would be required for the average reliability of a test to 
become too low. In this equation, a threshold for the lowest acceptable reliability of a 
scale is selected by the researcher according to the intended use of a scale. If a greater 
degree of precision is required or if the consequences of a false-positive (type one error) 
finding are important then the chosen alpha threshold should be higher. An estimated 
alpha value for unpublished studies must also be selected, again Howell and  Shields, 
(2008) recommend this is set at 0.8 standard deviations below the value selected for the 
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alpha threshold. This difference is suggested as it corresponds to a large effect size. In 








I present the results of the alpha lower-bound estimate and the failsafe-n calculation for 
the SHAI in the results section. 
2.6.2.1.2. Limitation 2: Reliability induction 
Another difficulty associated with RG analysis occurs if researchers report 
reliability figures abstracted from test manuals as if they refer to their own sample; this 
has been termed reliability induction (Vacha-Haase & Thompson, 2011). As stated 
previously, reliability is not a static property of tests, rather it refers only to a specific 
application of a test. The induction of published reliability coefficients is problematic as 
they refer to previous applications so will not refer to the sample in question. This is 
problematic as it is possible that the test was insufficiently reliable, thus flawing any 
analysis based on the test.  
Reliability induction cannot be assessed numerically as it is an issue with incorrect 
reporting rather than incorrect analysis. I overcame this potential difficulty by paying 
close attention to the wording of results sections, for example if an author wrote ‘the 
reliability in the current sample was...” then it was assumed that coefficient alpha had 
been calculated for the study sample rather than inducted. More ambiguous wording 
included no mention of where the alpha coefficient was derived from. In such cases I 
cross-referenced the reported value with other studies published by the same research 
group to determine if the same value was reported on multiple occasions. There was no 
evidence of the second issue in the studies included in this analysis.  
2.6.3. Meta-analysis 3: Assessing scale construct validity 
 As outlined in the introduction, when a scale has good construct validity it can 
measure a latent construct. To assess the construct validity of the HAQ/SHAI I searched 
published articles for correlation coefficients between both questionnaires and other 
measures. I then used meta-analysis to combine the correlations derived from measures 
assessing the same construct to provide a grand weighted correlation coefficient 
expressing the direction and strength of the relationship between the HAQ/SHAI and 
the construct of interested. For example, there were 6 correlation coefficients expressing 
the relationship between the SHAI-14 and three other measure of health anxiety (3 
correlations with the WI, two with the IAS and one with the MIHT). These were 
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combined via meta-analysis to provide an overall correlation between the SHAI and 
other measures of health anxiety. 
 If there were more than three correlation coefficients available for a single 
measure (e.g. between the SHAI and Body Vigilance Scale) then these were combined 
using meta-analysis to provide an overall coefficient for this measure alone. I took this 
step to determine if there were differences in the strength of the relationship between the 
SHAI and other measures that assess the same construct in different ways. For example, 
the relationship between the SHAI and Beck Anxiety Inventory compared to the 
relationship between the SHAI and Trait version of the STAI.  
 I then reviewed the relationship between the HAQ/SHAI and other measures to 
determine whether these were consistent with my predictions. This provided an 
indication of the convergent and discriminant validity of the HAQ and SHAI (see 
results section). I now outline the steps taken to perform the meta-analysis of correlation 
coefficients.  
 The steps taken when performing a meta-analysis of correlation coefficients is 
the same as any other form of meta-analysis: Compose the research question; define 
inclusion/exclusion criteria; evaluate risk of bias; weight the coefficients; and finally 
perform the analysis. The first three steps have already been described in the previous 
section, so I will now discuss my method of weighting the coefficients and then my 
approach to analysis.   
As discussed in the ‘why a employ a meta-analysis’ section, a random effects model 
is most appropriate to this analysis as the findings are intended to be generalizable 
beyond the scope of the included studies. Field (2005) conducted a Monte Carlo 
simulation of two meta-analytic methods of analysing correlation coefficients; the 
Hunter and Schmidt (2004) and the Hedges and Vevea (1998) approaches. Both 
methods assume a random effects model, but differ regarding their use of transformed 
or untransformed correlation coefficients and method of weighting studies. Whilst a 
lengthy comparison of the differences between these two approaches is beyond the 
scope of this thesis, of relevance is Field’s (2005) conclusion that the Hunter and 
Schmidt approach produced less biased correlation estimates than that of Hedges and 
Vevea. Therefore, the approach advocated by Hunter and Schmidt was employed in this 
analysis.  
It is important to note that Hunter and Schmidt (2004) offer a range of techniques to 
adjust effect sizes according to various sources of error. To be consistent with Field’s 
(2005) simulation, this analysis employs the fundamental version of Hunter and 
Schmidt’s (2004) analysis. 
The first step in the Hunter and Schmidt (2004) random effects model meta-analysis 
is to weight the raw correlation coefficients by multiplying each coefficient Z, by the 
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size of the sample &, it is derived from. The sum of these coefficients is divided by the 
sum of the sample, yielding an average coefficient Z that has been weighted by sample 
size. This is outlined in the following equation: 
Z = 	
&( ∗ Z( +	 &* ∗ Z* +. . . (&, ∗ Z,)
(&( + &*+. . . &,)
 
Information extracted from the sample size and the variance of correlation coefficients 
may then be employed to calculate credibility intervals (analogous to confidence 
intervals) around the grand correlation coefficient. Description and evaluation of the 
steps taken to calculate these credibility intervals is beyond the scope of this thesis, but 
can be found in Borenstein et al. (2009).  
 As reviewed in the ‘Criticisms of meta-analysis’ section, publication bias can 
lead to an inflated estimation of effect size (Rosenthal, 1979). The presence of 
publication bias in correlational studies has been investigated empirically: the authors 
concluded there is little evidence for this in the literature (Dalton, Aguinis, Dalton, 
Bosco, & Pierce, 2012). Therefore, I have not assessed for publication bias in this 
section of my analysis. 
This meta-analysis of correlation coefficients was calculated in Microsoft Excel 
using the Hunter and Schmidt (2004) method described in Borenstein et al., (2009).  
2.7 Method summary 
 In summary, three domains of analysis were completed, these are as follows: 
1.  Develop normative data for the HAQ/SHAI by meta-analysis of mean scores, 
standard deviations and reliability coefficients. Investigate heterogeneity in 
mean scores by use of meta-regression with study-level variables inputted as 
predictor variables; 
2. Conduct a reliability generalisability analysis to report on average reliability for 
the HAQ and SHAI and an investigation of study characteristics that moderate 
reliability;  
3. Investigate the construct validity of the HAQ and SHAI by qualitative review 
and meta-analysis of correlation coefficients expressing the relationship between 
each measure and other standardised measures. 
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3. Analysis 
3.1 Structure of analysis 
This analysis is divided into four sections, in the first I describe the results of the 
meta-analysis of mean scores and standard deviations (SDs) for each scale according to 
sample population (e.g. students, health anxiety). There was significant heterogeneity in 
mean score for each population, I then report on my attempts to assess the sources of 
this variation using meta-regression. 
 The second section comprises the results of the reliability generalizability (RG) 
analysis, including an overview of the range and average reliability across various 
populations for each scale. There was significant heterogeneity of alpha coefficients, so 
this variation was investigated via use of meta-regression. 
 Part three contains a review and meta-analysis of the size and direction of 
correlations between the health anxiety measures and other psychometrics and includes 
a commentary of the construct validity of both scales. Finally, I conclude with a 
summary section and report on the normative data for various population as derived 
from the previously described analyses. 
As detailed in the method section, a random effects model was selected so that 
my results can be generalised beyond the current studies. This decision was also 
appropriate from a statistical perspective as the majority of computed effect sizes were 
heterogeneous (Hedges & Vevea, 1998).  
3.2 Population means and normative data 
In total 137 studies (or study arms reporting on two or more populations) reporting 
on the HAQ or a version of the SHAI were included in analysis. This yields an overall 
sample of 31,347 participants. 
The following sections are divided according to scale type (HAQ, SHAI-14, 
SHAI-18). Within each subsection, results are reported by sample type. Where there are 
three or more studies reporting on the same sample, I computed a meta-analysis to 
generate normative data. As the focus of this thesis is to generate mean score forest 
plots are provided for all the mean scores included in the analysis. I begin with the 
SHAI as there was more data available than the HAQ. 
 
3.2.1. SHAI-14 
A total of 37 studies provided a mean health anxiety score or standard deviation 
for the SHAI-14. These have been grouped into the following categories: healthy 
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community controls, undergraduate students, health anxiety, pain, and vomiting phobia. 
Finally, a mixed group contains all the studies that could not be readily combined with 
others as they report on distinct populations, this data is included in the forests plot in 
figure 4 and raw data for all studies is listed in appendix c. I performed a meta-analysis 
on all groups except the mixed sample, the results of which are displayed in table 5.   
The magnitude of the average mean SHAI-14 score for each group included in the 
meta-analysis is presented in figure 3. The healthy control grand mean was lowest at 
12.56 and the highest mean score was in health anxious populations. Of note is the 
mean score of 17.16 calculated in student populations. This is higher than the mean 
score generated in both healthy controls and populations experiencing pain (14.17). This 
result is unexpected as students are generally in better health and have experienced less 
illness, so it follows they should have less reason to be anxious about their health.  This 
mean score is higher than the mean score in both control samples (9.4) and anxiety 






score k N  
    
 










Note: k=number studies, N=number of 
participants *Three studies excluded from 
meta-analysis as SD not reported 
 
 Figure 3 Grand mean SHAI-14 scores and sample size for healthy control, student, 
hypochondriasis and pain populations. Error bars represent 95% confidence 
intervals. 
It is notable that, as assessed by the Q statistic (see table 5) there was significant 
heterogeneity in mean scores in all populations except the pain group. This means that a 
significant proportion of the heterogeneity in means score is explained by non-random 
factors. The significance of the Q statistic also affirms that the application of a random 
effects model was appropriate in this analysis. Examination of the [* values reveals that 
in all samples except the pain group, over 95% of the variance in mean scores is 
explained by non-random factors.  
5 15 25 35
Mean	SHAI-14	score
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The meta-analysed SDs for all population were similar with range 4.88-7.07 with 
the lowest dispersion in health anxiety populations and the largest distribution in pain 
populations. The [* values reveal over 94% of the heterogeneity in SDs was explained 
by non-random factors in healthy, student and pain populations. Only 18% of the 
variance in health anxiety SDs was explained by non-random factors, although this may 
be due to the smaller range of studies (k=3) included in the analysis. 
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Table 5. SHAI-14 meta-analytic results of mean score, standard deviation, Q statistic, 






Q df P \] 
Healthy  Mean 9.21        
[8.26, 10.16] 
285.73 13 <0.0001 95.45 
 SD 5.36        
[4.71, 6.01] 
321.76 13 <0.0001 95.96 
Student Mean 17.16    
[12.94, 21.37] 
662.44 5 p<0.0001 99.25 
 SD 5.78        
[5.03, 6.53] 
86.45 5 p<0.0001 94.22 
Health 
anxiety 
Mean 27.90    
[25.23-30.56] 
108.96 3 p<0.0001 97.25 
 SD 4.88        
[4.56, 5.20] 
3.69 3 0.297 18.70 
Pain Mean 14.52    
[12.66-16.38] 
5.36 2 0.069 62.69 
 SD 7.07        
[4.43, 9.71] 
1708.19 4 p<0.0001 99.77 
 
 The heterogeneity detected in mean scores detected by the Q statistic is apparent 
when viewed in the forest plot in figure 4. For ease of visual analysis, these have been 
divided into different populations to reflect those reported in the literature. The ‘mixed 
medically unwell’ section contains a diverse range of samples that could not be readily 
grouped to provide mean scores as they were too heterogeneous in nature. The variation 
in mean scores in student populations is striking, with two studies both reporting mean 
scores within the range usually consistent with hypochondriasis (study 1 and 2; 
Karademas, Christopoulou, Dimostheni, & Pavlu, 2008). I explore this heterogeneity 
via use of meta-regression in the supplementary analysis section as it was not a part of 
my original aims. 
Please note that three studies by Barsky and colleagues reported a mean item score 
for the SHAI (Barsky & Ahern, 2004; Barsky, Ahern, Bauer, Nolido, & Orav, 2013; 
Lovas & Barsky, 2010), yielding a possible score range of 0-3 or 1-4 according to 
scoring method. The first study (Barsky & Ahern, 2004a) reported a mean item-score of 
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2.69 and employed the SHAI-14, scoring responses from 1-4. To include this data in the 
meta-analysis, I multiplied the reported score by 14 to give a mean SHAI-14 score of 
37.71. The second study (Lovas & Barsky, 2010) reported a mean item score of 2.07, 
employed the SHAI-14, scoring from 0-3. Again, I multiplied this score by 14 to give a 
mean SHAI-14 score of 28.98. There was insufficient data available to calculate the 
standard deviation so this data was not included in the meta-analysis. The third study 
(Barsky et al., 2013) did not report the SHAI version or scoring used so it was not 
possible to calculate an overall mean score. I contacted the corresponding author on the 
paper to request this data but did not receive a response. Because of the lack of this data, 
this study was eliminated from the analysis. The mean scores from these papers are 









- 66 - 
 
Figure 4. Forest plot of mean SHAI-14 scores by sub-population. Square markers indicate individual studies, 
diamond markers the meta-analysed grand means score, error bars indicate 95% confidence intervals. Note, 
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3.2.2. SHAI-18 
A total of 56 studies provided a mean health anxiety score or standard 
deviation for the SHAI-18. Similarly to the previous section, these have been 
grouped into sub-populations, with the following categories available for 
analysis; healthy community controls, undergraduate students, health anxiety, 
pain, and anxiety disorders. A meta-analysis was performed on all these groups, 
the results of the meta-analysis of mean scores are displayed in the forest plot in 
figure 5. All SHAI-18 mean scores, SDs and reliability coefficients are reported 
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Figure 5. Grand mean SHAI-18 scores, number of studies and sample size for 
healthy control, student, hypochondriasis, anxiety disorder and pain 
populations. Error bars represent 95% confidence intervals 
Data from one study (Kate Muse, McManus, Leung, Meghreblian, & 
Williams, 2012) reports an overall mean score and SD from a sample consisting 
of both students and a group of treatment-seeking individuals with a diagnosis of 
hypochondriasis. Raw data from this study is reported in appendix c, but was not 
included in the meta-analysis that generated population norms because the 
overall sample is likely to be highly heterogeneous. The hypochondriasis sub-
sample was reported separately in another study (McManus et al., 2012) and 
does features in this meta-analysis. 
There were 2 studies investigating emetophobia (fear of vomiting), but the 
total number were insufficient to perform a meta-analysis. A further 8 studies 
10.00 15.00 20.00 25.00 30.00 35.00
Mean	SHAI-18 score
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reporting mean scores for various samples that could not be combined into a 
coherent population group, so again were not subjected to meta-analysis. All 
mean scores, along with meta-analysed grand mean scores for each population 
group are presented in the forest plot in figure 6. 
The lowest SHAI-18 scores were in the student and healthy control 
populations, which is as one would expect, those with an anxiety disorder scored 
more highly and the highest scores were in populations with hypochondriasis. 
All meta-analysed scores were similar to that reported in the SHAI validation 
paper (Salkovskis et al., 2002), I compare my findings with those from the 
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Table 6. SHAI-18 meta-analytic results of mean score, SD, Q statistic, degrees 
of freedom (df) and !" value for healthy, student, health anxiety, anxiety 
disorder and pain populations.  
Population Variable Value 
[95%CI] 
Q df P #$ 
Healthy  Mean 12.56 
[10.26,14.86] 
189.37 6 <0.0001 96.83 
 SD 6.03         
[5.37, 6.68] 
125.57 6 <0.0001 95.22 
Student Mean 12.35          
[11.78, 12.93] 
151.23 14 <0.0001 90.74 
 SD 6.51         
[6.11, 6.91] 
119.78 14 <0.0001 88.31 
Health 
anxiety 
Mean 32.13           
[30.77, 33.49] 
2.918 2 0.2324 31.46 
 SD 8.56         
[7.47, 9.66] 
267.70 2 <0.0001 99.25 
Anxiety 
disorders 
Mean 16.28          
[13.07, 19.48] 
23.13 6 0.0008 74.06 




6 <0.0001 99.99 
Pain Mean 14.17            
[9.97, 18.36] 
145.86 4 <0.0001 97.25 




4 <0.0001  
 
As assessed by the Q statistic (see table 5), there was significant 
heterogeneity in mean scores in all populations except the health anxiety group. 
Therefore, a significant proportion of heterogeneity in means score is explained 
by non-random factors. In addition, the significance of the Q statistic also 
affirms that the application of a random effects model was appropriate in this 
analysis. Examining the !" values reveals that, excepting the health anxiety 
group, over 90% of the variance in mean scores is explained by non-random 
factors. The meta-analysis of studies reporting on health anxiety populations 
only included three studies so any heterogeneity in mean scores may not be 
detected, particularly as the Q statistic is not sensitive to heterogeneity in smaller 
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samples (Bowden, Tierney, Copas, & Burdett, 2011). This heterogeneity is 
apparent when viewing the forest plot in figure 6, which presents all extracted 
mean scores by population. I explore sources of this heterogeneity in the 
supplementary analysis section. 
 
Figure 6. Forest plot of mean SHAI-18 scores by sub-population. Square 
markers indicate individual studies, diamond markers the meta-analysed 
grand means score, error bars indicate 95% confidence intervals. Note, 
confidence intervals could not be calculated in 5 studies as SD unreported. 
 
The meta-analysed SDs were all broader than those calculated from the 
SHAI-18, this may be due to the addition of 4-item ‘negative consequences of 
illness’ sub-scale which does not measure health anxiety. As the two parts of the 
scale measure different constructs, this may explain the greater dispersion in 
scores. The smallest SDs were derived from healthy, student and pain 
populations, indicating that for these groups the dispersion of scores in published 
studies was smaller. The largest SD was found in anxiety disorder populations. 
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Examination of the !" value reveals that for all samples over 88% of the variance 
in SDs is due to non-random factors. 
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3.2.3. Other SHAI versions  
 As outlined in the introduction, researchers have advocated the deletion 
of item 13 because it did not load onto either of two factors uncovered in a factor 
analysis (Wheaton, Berman, Franklin, & Abramowitz, 2010). Because of this, 
two studies (Fergus & Russell, 2016; Norr, Albanese, Oglesby, Allan, & 
Schmidt, 2015) reported scores for a 13-item and a 17-item version. Neither 
study recorded how the SHAI was scored (either 0-3 or 1-4), so could not be 
included in the meta-analysis. I attempted to contact the authors of both these 
studies and did not receive any response. The mean scores, SD and reliability 
coefficients reported for these studies are reported in appendix c.  
3.2.4. HAQ 
 A total of 34 studies reported an HAQ mean score or standard deviation. 
The lowest grand mean score was reported in healthy controls (12.29) and the 
highest was in gastroenterology patients (15.59). There was less dispersion in 
grand mean scores compared to the SHAI-14 and SHAI-18. This may be 
because the SHAI has been more frequently employed in mental health samples 
that include individuals with anxiety disorders or hypochondriasis (which are 
more likely to score more highly on health anxiety measures). The 95% 
confidence intervals around each meta-analysed mean are also all approximately 
broader by two points for the HAQ compared to the SHAI, meaning the 
dispersion of mean scores within each group is greater. This is likely to be 
because the studies I have combined in the HAQ analysis contain more 
heterogeneous populations than in the SHAI analysis. For example the cardiac 
group in the HAQ analysis includes populations with angina, cardiac syndrome 
x, coronary heart disease, myocardial infarction and stress cardiomyopathy. See 
table x for the results of the meta-analysis of HAQ mean scores. The SDs were 
similar in magnitude across all populations, ranging from 7.78-9.80, this 
indicates the dispersion in scores in each population is similar in size. 
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Table 7. Results of Meta-analysis of HAQ mean score, SD, Q statistic, degrees 
of freedom (df) and !" value for healthy, cardiac patients, gastro patients 





Q df P #$ 
Healthy  Mean 12.29      
[8.78, 15.80] 
113.36 3 <0.0001 97.35 
 SD 8.39 [7.04, 
9.74] 
285.13 3 <0.0001 98.95 
Cardiac Mean 13.51      
[9.57, 17.47] 
14.01 2 0.0009 78.59 
 SD 8.06 
[2.78, 13.35] 
6693.53 2 <0.0001 99.97 
Clinic 
attenders 
Mean 15.36    
[13.86, 
16.86] 
19.36 4 0.0007 79.34 
 SD 9.80        
[8.36, 11.24] 
4341.80 6 <0.0001 99.86 
Gastro 
patients 
Mean 15.59    
[10.79, 
20.38] 
275.32 4 <0.0001 98.18 
 SD 7.78        
[6.07, 9.50] 
1158.98 4 <0.0001 99.65 
 
 The grand mean scores for each population are presented in the forest 
plot in figure 7 and demonstrates that the grand mean health anxiety score in 
each population was remarkably similar, with only a 5 point difference between 
the lowest (healthy controls) and highest (cardiac patients). According to 
classical test theory (Lord & Novick, 1968) this lack of variation may originate 
in three sources either alone or in combination: 1) the true scores are similar in 
each population; 2) there are systematic non-random variables causing scores to 
appear similar; 3) the similarity is due to measurement error. I will attempt to 
investigate potential sources of variation in the next section.   
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Note: k=number of studies, N=total number 
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Figure 7. Grand mean HAQ scores, number of studies and sample size for 
healthy control, cardiac patients, medical clinic attenders and gastro 
patients. Error bars represent 95% confidence intervals. 
Examination of the 95% confidence intervals in figure 7 indicates the 
variation in mean scores were narrowest for the clinic attenders group, this may 
be due to the larger number of studies (9) included in this analysis compared to 
the other groups or due to a narrow range of mean scores generated from studies 
in this population. The broadest 95% confidence intervals were in the gastro 
patients group (also see table 6).   
To better view the variation in mean scores within each population, I 
have plotted the mean score (and 95% confidence intervals) derived from every 
included study in the forest plot in figure 8. This reveals a similar range of 
scores across each population, for example the lowest reported score for healthy 
control participants was 8 in a British female-only sample (Asbury, Creed, & 
Collins, 2004). The highest was over double at 16.83 (Meana & Lykins, 2009) in 
a USA female only sample. It is remarkable that two very similar populations, 
albeit of different nationalities, using the same measure can have such a 
difference in mean score, that as assessed by the Q statistic, is statistically 
significant.  
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Figure 8. Forest plot of mean HAQ scores by sub-population. Square markers indicate individual studies, diamond 
markers the meta-analysed grand mean score. Error bars indicate 95% confidence intervals. Note, confidence 
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Examination of scores in the other sub-populations revealed a similar range 
of mean scores. Studies reporting on cardiac patients had a lowest mean score of 7 in 
individuals seeking a cardiac screen in New Zealand (Zarifeh, Mulder, Kerr, Chan, & 
Bridgman, 2012) and a highest score of 19.15 in a UK study of cardiac rehabilitation 
(Asbury et al., 2012). The lowest score in clinic attenders was 7 (Aggarwal et al., 
2014), the highest was 19 (Jackson, Kincey, Fiddler, Creed, & Tomenson, 2004), the 
variation in this population was more expected as it contained studies reporting on 
more dissimilar populations (e.g. attenders at neurology clinics and attenders in a 
general medicine clinic). Finally, in the gastro patients the lowest score was 9.29 
(Graff et al., 2006) and the highest 20.60 (Esfandyari & Harewood, 2007). A single 
study reported on hypochondriacal populations reported a mean score of 31.90  
(Noyes et al., 2002). This score is consistent with a scale designed to measure health 
anxiety. It is the variation in mean scores described in the preceding paragraphs that I 
aim to investigate in the following section using meta-regression. 
 
3.2.5. Supplementary analysis: Exploring heterogeneity in mean scores 
 As stated in the method section, I initially intended to assess risk of bias in 
this study via use of a bespoke scale and determine if the overall score on this scale 
relates to mean scores. This scale included items that assessed study-level variables 
that may be responsible for heterogeneity (or bias) in mean scores. After collecting 
this data, I realised that similar to a reliability generalisability analysis, I could input 
these study-level variables into a regression equation as predictors to investigate their 
potential impact on heterogeneity in mean scores. In this section I describe the results 
of this exploratory analysis.   
Prior to analysis, nine study arms were removed this was because the authors 
did not report which version of the SHAI they employed, so could not be entered as 
predictor variables. These were derived from nine papers (Farmer, Doll, Levy, & 
Salkovskis, 2003; Fergus & Russell, 2016; Hollo, Kothy, Garas, Geczy, & Vargha, 
2012; Hollo, Kothy, Geczy, & Vargha, 2010; Inamura et al., 2015; Kirby & Yardley, 
2009; Norr, Albanese, Oglesby, Allan, & Schmidt, 2015; Aaron M. Norr, Oglesby, et 
al., 2015; Norr, Allan, et al., 2015) although the three studies by Norr and colleagues 
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3.2.5.1. Heterogeneity domain 1: Sample composition 
 As detailed in the method section, the composition of a sample included in a 
study may be a potential source of variation in SHAI mean scores. I investigated this 
by generating a dichotomous variable (0=no, 1=yes) for each of the following 
variables: homogenous sample; sample representing the population of interest; 
whether the sample was well described; whether the physically unwell were 
included. These variable were inputted as predictors in a meta-regression with mean 
SHAI score as the dependent variable.  
 The results of this regression are displayed in table 8. None of the 
independent variables significantly predicted SHAI mean score, the overall model 
explained a non-significant (F(4,96)=1.03, p=0.532) 0.05% of the between studies 
variance. Inspection of the I2 value reveals 99.49% of the between studies variance is 
due to non-random sources of heterogeneity.  
Table 8. Results of meta regression of sample composition on SHAI mean score. 
Predictor Coefficient SE t p 
Homogenous  0.278 1.08 0.26 0.797 
Population of interest 6.45 4.74 1.36 0.177 
Well described -5.97 3.91 -1.52 0.131 
Unwell included 1.32 1.60 0.83 0.41q 
Constant 13.27 4.90 2.71 0.008 
 
3.2.5.2. Heterogeneity domain 2: Sampling strategy 
 A second domain of potential sources of heterogeneity is sampling strategy, 
studies were rated according to which sampling strategy was used to recruit 
participants; random, part-random, or snowball sampling. If sampling strategy was 
not reported then this was also noted. Sampling strategy was inputted as a categorical 
predictor variable with four levels into a meta-regression with mean SHAI score as 
the dependent variable. 
 The results presented in table 9 reveal that sampling strategy did not predict 
mean score. Examining the adjusted R2 value reveals this model explained a non-
significant (F(4,95)=1.93, p=0.111), 4.16% of the between studies variance. The I2 
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Table 9. Results of meta regression of sample composition on SHAI mean score. 
Predictor Coefficient SE t p 
Random sampling -0.203 4.90 -0.04 0.867 
Part non-random -2.34 4.93 -0.47 0.636 
Snowball sampling -4.41 6.12 -0.72 0.473 
Not reported 2.96 5.07 0.58 0.561 
Constant 16.36 4.78 3.42 0.001 
 
3.2.5.3. Heterogeneity domain 3: Administration conditions 
 The final domain of potential sources of variation I investigated was whether 
the context that the SHAI was administered impacted on mean score. Again, I 
created a dummy variable (0=no, 1=yes) and rated studies according to whether the 
administration conditions of a test (e.g. in a hospital vs classroom) would be likely to 
temporarily increase health anxiety. I also rated studies as to whether the time point 
that the SHAI was used may be a time of increased health anxiety (e.g. immediately 
prior to receiving a medical test result). 
 The results are presented in table 10, neither variable predicted variation in 
SHAI mean score. The regression model explained a non-significant (F(2,94)=1.41, 
p=0.249), 1.01% of between studies variance was explained by this model. A 
remaining 99.45% of the between studies variance is due to unexplained non-random 
factors. 
Table 10. Results of meta regression of sample composition on SHAI mean score. 
Predictor Coefficient SE t p 
Measurement context 1.90 5.30 0.35 0.720 
Measurement point -0.361 5.17 -0.07 0.944 
Constant 14.81 0.948 15.62 <0.001 
 
Finally, again using a dichotomous dummy variable with ‘no’ coded as 0 and ‘yes' as 
1, I entered whether the SHAI was administered correctly and in a standardised 
manner. The Adjusted R2 value demonstrated that 1.50% of the variance in SHAI 
mean score was explained by this regression model and was not statistically 
significant (F(2,97)=0.34, p=0.706. The results of this meta-regression are presented 
in table 11. 
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Table 11. Results of meta regression of sample composition on SHAI mean score. 
Predictor Coefficient SE t p 
Standardised 
administration 
-2.18 2.85 -0.77 0.446 
Correct administration 1.80 2.85 0.63 0.529 
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4. Construct validity of the HAQ and SHAI 
 In this section I review the range and strength of correlation coefficients 
between the SHAI/HAQ and other psychological measures. As detailed in the 
method section, I have focussed on other measures of health anxiety, anxiety, 
depression, OCD and scales assessing precursors to anxiety. There were 15 
correlation coefficients available reporting a relationship between the HAQ and other 
psychometric measures. These correlations were derived from four studies and 
represent a relationship with 15 other scales. This means there were insufficient 
correlation coefficients to run a meta-analysis. Because of a lack of data this section 
only comprises my findings relating to variables correlated with the SHAI. 
4.1 SHAI – construct validation 
 There were 98 studies reporting at least one correlation coefficient between 
the SHAI and another psychometric measure. As detailed in the method, I extracted 
correlation coefficients expressing the relationship between the SHAI and measures 
of health anxiety, anxiety, depression and OCD.  
 The results of the meta-analysis of correlation coefficients is depicted in the 
forest plot in figure 9. It was not possible to perform a meta-analysis on individual 
measures of health anxiety as each was reported in three or less studies, therefore I 
combined all the available coefficients to provide a single grand correlation 
coefficient.  
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Figure 9. Forest plot of meta-analysis of correlation coefficients between the SHAI 
and measures of health anxiety, anxiety, depression and OCD. 
The pattern of correlations was broadly as expected, with the SHAI 
correlating most strongly with other measures of health anxiety, followed by the 
anxiety measures. It is notable that the grand correlation between the OCD-R and 
SHAI was lower than the depression measures, which was opposite to the predicted 
pattern. This data is presented in table 12 along with the number of studies and total 
sample size. 
   
Table 12. Results of meta-analysis of correlations between the SHAI and measures of 
anxiety, depression and OCD.  
Scale Total 
n 
No. studies Meta-analyzed r  
[95%CI] 
Health anxiety (multiple) 1481 6 0.690 [0.535, 0.846] 
GAD-7 440 3 0.505 [0.422, 0.588] 
DASS-Anxiety 633 4 0.510 [0.496, 0.523] 
BAI 1732 6 0.402 [0.334, 0.469] 
HADS-Anxiety 554 2 0.605 [0.535, 0.675] 
STAI-Hungarian 234 2 0.577 [0.521, 0.633] 
STAI - Trait 1329 3 0.490 [0.388, 0.591] 
PHQ-9 440 3 0.397 [0.216, 0.579] 
DASS-Depression 633 4 0.395 [0.164, 0.626] 
PANASS-Negative 2517 6 0.485 [0.361, 0.609] 
BDI-II 593 2 0.412 [0.271, 0.552] 
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The 95% credibility intervals of the health anxiety measures, indicates with 
95% probability that the true correlation falls between 0.535 and 0.846. This is due to 
the variability in the raw correlation coefficients, as reported in table 13.  The highest 
correlations were with the WI (r=0.71-0.84), followed by the IAS (r=0.63-0.73) and 
the lowest correlations was with the MIHT (r=0.61). These differences may be due to 
the differences in conceptualisation of health anxiety inherent in each scale, for 
example the MIHT considers health anxiety to have an interpersonal element, 
whereas the SHAI focusses on a cognitive-behavioural model. Alternatively, it may 
be that either the SHAI or another scale (or both) does not adequately assess health 
anxiety. As there were only six correlation coefficients available for analysis it is 
impossible to determine whether these relationships are consistent. Consequently, 
further analysis with more studies is warranted. If a consistent pattern emerges, for 
example correlations with the MIHT being consistently lower, this indicates the two 
scales may be measuring different constructs.  
Table 13. Correlations between the SHAI, Whitely Index (WI), Multidimensional 
Inventory of Hypochondriacal Traits (MIHT) and Illness Attitude Scales (IAS). 
Population Author 
(date) 
n WI MIHT IAS 
Community Fergus (2013b), 
(Fergus, 2014a) 
410 .80 .61 - 
Pregnant women Kowalyk, 
Hadjistavropoulos, & 
Jones, 2009) 
45 - - .73 
Students Abramowitz et al. 
(2007) 
442 - - .63 
Hypochondriasis McManus et al. 
(2012) 
74 .84 - - 
Arm pain Vranceanu, Safren, 
Cowan, & Ring 
(2010) 
100 .71 - - 
   
 
4.2 SHAI – correlations with precursors to anxiety 
 As an exploratory analysis, correlations between the SHAI and measures of 
precursor or risk-factor variables for anxiety were collected and meta-analysed. 
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These measures were the Anxiety Sensitivity Index-3 (ASI-3) the Body Vigilance 
Scale (BVS) and the Intolerance of Uncertainty Scale (IUS). The results of this meta-
analysis are presented in the forest plot in figure 10. 
 
 
Figure 10. Forest plot of results of meta-analysis of correlations between the SHAI 
and ASI-3, BVS and IUS.  
 
 The SHAI correlated moderately with all measures of precursors to anxiety, 
with the lowest meta-analysed correlation coefficient being with the ASI-3_social 
subscale (r=0.281) and the largest with the BVS (r=0.569). Overall, this provides 
indirect evidence that the SHAI has good construct validity as one would expect the 
SHAI to have only moderate correlations with the above variables. If the correlations 
were larger it would imply they are measuring similar or the same constructs; if they 
were nearer zero then it implies the constructs are unrelated. The latter scenario 
would be a problematic finding as there is sound theoretical (and experimental) 
evidence that that health anxiety should be related to anxiety sensitivity, body 
vigilance and intolerance of uncertainty. It is possible to present this claim as all the 
above scales have undergone validation programmes so their psychometric properties 
are robust. If the measures had not undergone validation then they may be potentially 
psychometrically unstable and these correlations may be due to measurement error. 
 Examination of the correlations between the SHAI and ASI-3 total score and 
ASI-3 subscales indicates some variation in the strength of relationship across 
studies. This was greatest in the ASI-3 total, ASI-3_cognitive and ASI-3_Social 
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3_Phys and ASI-3_Respiritory displayed little variation. This variability also 
provides some support for the construct validity of the SHAI as one would expect 
fear of physical and respiratory symptoms of anxiety to be consistently correlated 
with health anxiety. This is because catastrophic misinterpretation of somatic states 
are inherent components of the cognitive-behavioural health anxiety construct.  
 The BVS was also moderately correlated with the SHAI and showed 
moderate variation in strength of correlation coefficient across studies. This variation 
was broader than might be expected as body vigilance is thought to be an important 
variable in the maintenance of health anxiety so I would imagine this relationship 
would be more consistent. 
 Finally, there was less variation in the correlations between the SHAI and 
two IUS subscales, although this data was generated from only two studies, 
conducted by the same research group and within the same population 
(undergraduates). Therefore large heterogeneity is unlikely in these circumstances. 
 The results of the meta-analysis of the correlations between the SHAI and 
ASI-3, BVS and IUS along with the total number of studies and total sample size are 
presented in numerical form in table 14. 
 
Table 14. Meta-analysis results of correlation between the SHAI and ASI-3 







ASI-3 Total 3314 10 0.504 [0.325, 0.683]  
ASI-3 Cognitive 3988 10 0.369 [0.106, 0.632] 
ASI-3 Physical 3988 10 0.549 [0.517, 0.580] 
ASI-3 Social 3988 10 0.281 [-0.014, 0.577] 
ASI-3 Respiratory 1021 4 0.436 [0.357, 0.514] 
Body Vigilance Scale 1958 6 0.569 [0.459, 0.680]  
IUS Total 1758 7 0.527 [0.394, 0.660]  
IUS Inhibitory 1086 2 0.471 [0.428, 0.514] 
IUS Prospective 1086 2 0.467 [0.381, 0.552] 
 
4.3 Reliability generalisability analysis  
 I now provide the results of my investigation into the alpha coefficients 
reported for both scales. I begin by reviewing the quantity and range of published 
alpha coefficients. This is followed by the results of the meta-analysis where I report 
on the average reliability reported for various populations. Finally, I describe the 
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results of the meta-regression of SHAI reliability coefficients which revealed several 
potential moderating variables that may influence reliability. There was insufficient 
data to perform a meta-regression on HAQ alpha coefficients.  
4.3.1. Overview of reliability coefficients 
 A summary of the availability and range of published alpha coefficients is 
reported in table 15. There were more alpha coefficients reported for the SHAI 
(n=54, range 0.74-0.97) than the HAQ (n=4, range 0.79-0.95). As only four alpha 
coefficients were published for the HAQ it was not possible to perform a meta-
analysis. Therefore, I could not produce normative reliability data or investigate 
moderators of reliability coefficients. See appendix c for a summary of all alpha 
coefficients extracted. 
Next I calculated the lower bound estimate for alpha coefficients and a 
failsafe-n for the SHAI. The (unweighted) average alpha derived from this sample 
was 0.875 (SD=0.052) and was reported in 54 studies. A lower bound estimate of the 
level of reliability in these studies is 0.8 SD (0.041) below the average of 0.875, 
yielding an estimate of the average alpha=0.834 in the non-reporting studies. There 
were 83 studies that did not publish an alpha coefficient. Using this information, a 




54	 + 	83 = 0.850 
This means that the overall average reliability in both reporting and non-reporting 
studies is an acceptable 0.850, although this is a lower average reliability than the 
0.91 coefficient reported in the SHAI validation paper (Salkovskis et al., 2002). 
 The threshold I selected as an acceptable level for the SHAI is 0.80, this is 
because the SHAI is used in treatment trials so requires a higher level of reliability 
than the 0.7 level that would be required for exploratory or correlational research 
(Nunnally, 1978). Subtracting a further 0.8 SD from the alpha lower-bound threshold 
gives an estimate of 0.758 this may be combined with the average unweighted 
reliability (0.875) and inputted into the equation described in the method to provide a 
failsafe-n of the number of unpublished studies required to reduce the average alpha 
coefficient to an unacceptable level. This is as follows: 
789:	;8<=	> = 	54	× 0.875 − 	0.800.80 − 	0.758 = 97.99	 
Therefore 100 studies would need to be published with an alpha coefficient less than 
0.758 for the mean population alpha to be lower than 0.8. This is a large number of 
studies, especially given that only one study reported an alpha coefficient lower than 
this value ("=0.74; Zhang, Liu, Li, Mao, & Yuan, 2015). Therefore, I argue that the 
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results of this meta-analysis of SHAI alpha coefficients is unlikely to be affected by 
publication bias.  
Table 15. Summary of availability of SHAI and HAQ alpha coefficients.  










SHAI-14 44 20 45.5 0.81 0.97 
SHAI-18 78 33 42.3 0.74 0.96 
SHAI-13 1 1 100 0.90 0.90 
SHAI-17 1 0 0 - - 
SHAI-
unknown 
8 0 0 - - 
HAQ 41 4 9.8 0.79 0.95 
 
Next, I computed the meta-analysis of reliability coefficients to generate an 
average reliability, including 95% confidence intervals for the SHAI-14, SHAI-18. I 
also calculated an overall average reliability generated from all the available alpha 
coefficients from all versions of the scale (SHAI-13, 14,17 and 18). The results are 
presented in table 16.  
The range of the three average alpha coefficients is small, with a difference of 
only 0.003 between the smallest and the largest, indicating that the SHAI has good 
average reliability in the studies included in this analysis. It is notable that these 
coefficients are lower that the α=0.91 reported in the original validation paper 
(Salkovskis et al., 2002). 




















0.001446 30149.15(49) <0.0001 99.84 
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Note, v = random effects component, Q=homogeneity statistic, 
df=degrees of freedom, CD=proportion of variance explained by true 
heterogeneity rather than measurement error.  
 
Examination of the meta-analysis Q statistics (see table 17) indicates 
significant heterogeneity in alpha coefficients. This means there is statistically 
significant variation in SHAI scores that cannot be explained by random error. The 
CD statistic indicates that for all scale types, over 99% of the heterogeneity in alpha 
coefficients can be explained by non-random factors. This is important to investigate 
further as it is possible the SHAI may have systematically poorer reliability under 
certain conditions or when employed with certain populations. 
 To investigate the heterogeneity of alpha coefficients I have plotted all 
available coefficients and the average reliability derived from the meta-analysis in 
the forest plot depicted in figure 11. Examining this graph reveals both scales have 
greater reliability in mixed samples comprised of both community controls and 
people with health anxiety (range 0.84-0.96). In student populations, there was 
greater dispersion in alpha coefficients (range 0.74-0.91) compared to healthy 
controls (0.76-0.92) and the medically unwell (0.82-0.90). 
Table 17. Meta-analysis of alpha coefficients, for healthy, student, medically unwell 
and mixed anxiety disorders populations. 
Population Alpha  
[95%CI] 
V Q(df) P AB 
Healthy 0.867 
[0.847, 0.885] 
0.001022 3235.90 (10) <0.0001 99.69 
Student 0.851 
[0.837, 0.865] 














- 88 - 
 
Figure 11. Forest plot of all SHAI alpha coefficients and meta-analysis providing 
overall mean reliability divided by sample composition. Note, square markers 
indicate SHAI-18 coefficients, crosses SHAI-14 coefficients, diamonds 
indicate the results of the meta-analysis of reliability coefficients, triangles 
indicate meta-analysis of reliability coefficients for each sub-population, error 
bars indicate 95% confidence intervals.  
 
It is notable that that SHAI-18 has a broader dispersion of alpha coefficients 
(as denoted by the square markers). To further illustrate this, I have plotted the 
frequency of magnitude of SHAI alpha coefficients in figure 12. Examining figure 
12a, the histogram summarising all published alpha coefficients, reveals a positive 
skew. As detailed in the method section this was corrected prior to meta-analysis. 
The distribution of SHAI-18 alpha coefficients (0.74-0.96) is broader than SHAI-14 
coefficients (0.81-0.97). This suggests that either the version of the scale may impact 
on reliability, or potentially that each scale has been systematically employed in 
different populations, which themselves impact on reliability. Also of note is the 
criticism of the 4 additional ‘negative consequences of illness items in the SHAI-18 
as not being a measure of health anxiety (Alberts et al., 2013). Inclusion of these 
additional items in the SHAI-18 may reduce the scale’s reliability as they are 
measuring a different construct. 
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Figure 12. a, b & c. Histograms displaying frequency of SHAI-all, SHAI-14 and 
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The data presented in figures12a-c indicate there may be differences in SHAI 
reliability according to scale type and population composition. Therefore, these 
variables were entered as predictors in a meta-regression of reliability coefficients. 
The results of this first meta-regression model are displayed in table 18 below. 
Table 18. Model 1: Meta-regression of scale type and diagnostic group on coefficient 
alpha. 
Predictor Coefficient SE t p 
Scale type .0006718 .0061682 0.11 0.914 
Diagnosis -.0008571 .0003246 -2.64 0.011 
Constant .5135555 .0153503 33.46 <0.001 
 
 The results of model 1 indicated that diagnostic group significantly predicted 
alpha, this first result appeared to statistically confirm the observation gleaned from 
the forest plot in figure 11 that alpha coefficients are generally higher in mixed 
samples. Scale type (SHAI-14 vs SHAI-18) did not predict variation in the strength 
of alpha coefficient. Therefore, the variation observed in the histograms reported in 
figure 12 was not responsible for statistically significant variations in alpha 
coefficients. It may be that the studies using the SHAI-18 that report lower reliability 
may have other factors (e.g. language of scale) that account for the lower alpha 
value. The ED value indicates this model accounts for a non-significant 
(F(3,43)=2.62, p=0.062), 9.84% of the between studies variation in alpha 
coefficients. 
Botella and colleagues (Botella et al., 2010) recommend interpreting the 
variation in alpha coefficients in relationship to the mean score and variance of the 
included studies. They argue that if alpha varies as a function of mean score, then 
variability in reliability is related to the true score, whereas if alpha varies as a 
function of the sample variance then the variability in alpha is due to sampling error. 
Therefore, I added these as predictors in a second regression model presented in table 
19. 
Table 19. Model 2: Meta-regression of mean SHAI score and variance on coefficient 
alpha. 
Predictor Coefficient SE t p 
Mean .0019543 .0014143 1.38 0.176 
Variance -.0016114 .000304 -5.30 <0.001 
Constant .5485561 .0240314 22.83 <0.001 
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This second model explained a total of 44.31% of the between-studies 
variance in alpha coefficient size and was statistically significant (F(2,33)=17.53, 
p<0.0001. Only the variance significantly predicted variations in coefficient alpha, as 
the variance increased, the alpha coefficient reduced in size, indicating the variation 
in alpha coefficients may be due to error in measurement rather than variations in 
alpha true scores.   
Finally, as a third, exploratory analysis I also inputted the average age of 
sample, the language of scale and the nationality of participants in a third regression 
model. This was because the SHAI may perform differently in different nationalities 
due to the cross-cultural differences in the conceptualisation of health anxiety. 
Language of scale was included as a translated scale may affect reliability, again 
because the health anxiety construct may not be accurately related to non-English 
speaking languages or cultures. Finally, I inputed average age and gender mix to 
determine their impact on reliability. The results of this analysis are presented in 
table 19.  
Table 20. Model 3: Meta-regression of sample average age, nationality and scale 
language on coefficient alpha. 
Predictor Coefficient SE t p 
Age -.0011043 .0007498 -1.47 0.148 
Nationality .000448 .0022986 0.19 0.846 
Language .0065963 .0034817 1.89 0.065 
Constant .5132198 .0240359 21.35 <0.001 
  
 The third regression model explained a combined 10.00% of the between-
studies variance in alpha coefficients and was not statistically significant 
(F(3,43)=2.62, p=0.0626). Only scale language emerged as a significant predictor of 
coefficient alpha, nationality and average age of participants did not predict 
variations in alpha coefficients.   
 The final regression model is presented in table 21 where diagnostic group, 
sample variance and scale language were entered as predictors, this model explained 
69.00% of the variance in alpha coefficients and was statistically significant 
(F(3,32)=24.86, p<0.0001). In this model, diagnostic group was no longer a 
significant predictor of coefficient alpha, whereas language and variance in mean 
scores did predict variations in alpha. It may be that the variance explained by 
diagnostic group is shared with scale language and errors in measurement in these 
samples rather than due to an inherent property of the sample in these studies. 
Because diagnostic group no-longer predicted variations in alpha I did not investigate 
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this further, if diagnostic group had been a significant predictor then I would have 
investigated which groups did predict variation in coefficient alpha. 
Table 21. Model 4: Meta-regression of diagnostic group, variance and scale language 
on coefficient alpha. 
Predictor Coefficient SE t p 
Diagnosis -.0000827 .0002313 -0.36 0.723 
Variance -.001296 .0002379 -5.45 <0.001 
Language .0117084 .0022283 5.25 <0.001 
Constant .5399614 .0134814 50.05 <0.001 
 
 A summary of all 4 regression models, with ED values representing the 
proportion of variation in alpha coefficients along with F probability statistics are 
presented in table 22. 
Table 22. Summary of results of all regression models. 
Model Predictors FB GB F(df) p 
M1 Scale type, diagnosis .003725 9.84% 3.50(2,48) 0.0382 
M2 Mean, variance .001877 44.31% 17.53(2,33) <0.0001 
M3 Age, nationality, language .00373 10.00% 2.62(3,43) 0.0626 
M4 Diagnosis, variance, 
language 
0.001044 69.00% 24.86(3,32) <0.0001 
4.4. Summary of results 
In summary, I have generated means scores for the SHAI-14, -18 and the HAQ 
for various populations, these may be employed as normative values. I have 
investigated the construct validity of the SHAI via use of the correlations between 
the SHAI and other psychometric measures. This is complemented by a reliability 
generalisability analysis of SHAI alpha coefficients. Unfortunately there was 
insufficient data for an investigation of the construct validity and reliability of the 
HAQ. I will now discuss these findings.
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5. Discussion 
 There were four aims of this project, the first was to generate normative 
data for the HAQ and SHAI for all populations with three or more published 
mean scores or alpha coefficients. The second aim was to generate an average 
reliability coefficient for each scale and then to explore variation in alpha 
coefficients using meta-regression. The third aim involved evaluating the 
construct validity of both scales by examining their correlations with other 
psychometric measure.  
 I will now summarise and discuss my findings regarding each of the 
above aims. This is followed by a discussion of the strengths and weaknesses of 
the project, clinical and research implications and finally suggestions for future 
research. I begin by discussing the population norms I calculated through meta-
analysis. 
5.1. Population norms 
 As there was a larger quantity of data available for the SHAI, I begin by 
discussing the norms generated for this scale, how I explored heterogeneity in 
mean scores and then move on to discuss norms generated for the HAQ.  
5.1.1. SHAI population norms 
Using published data, I was able produce norms for the SHAI-14 and 
SHAI-18 in the following populations; healthy community controls, 
undergraduate students, health anxiety and pain populations. A norm for anxiety 
disorder populations was generated for the SHAI-18 only. This study adds to the 
literature by producing norms for student and pain populations, which did not 
feature in the original scale validation study. Additionally, there were sufficient 
alpha coefficients available to generate an average alpha for healthy control and 
student populations for both the SHAI-14 and -18. This data is presented in table 
23.  
The meta-analysed grand mean scores and SDs may be used as a 
normative value for each population. The score for the health anxiety 
populations for the SHAI-14 and -18 may be used to develop a clinical cut-off 
score. This score can be used to indicate whether an individual has made 
clinically significant change. Jacobson et al., (1984) recommend three different 
means to calculating a cut off for clinical significance. Criterion ‘a’ is a score 
that is two standard deviations below the average in a clinical population. The 
data produced in this analysis can be used to calculate a clinical cut-off score. 
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Using Jacobson’s criterion ‘a’, the clinical cut-off score for the SHAI-14 is 
18.34 and for the SHAI-18 it is 15.35. Reliable change (Jacobson & Truax, 
1991) refers to a change in an individual’s psychometric scores that are greater 
than can be attributed to measurement error alone. This is calculated by use of a 
measure’s reliability coefficient and represents a magnitude of change that only 
5% of a population would achieve by chance. This yields a reliable change index 
of 4.82 for the SHAI-14 and 8.46 for the SHAI-18. Clinically significant and 
reliable change calculations were performed using the Leeds Reliable Change 
Indicator (Morley & Dowzer, 2014). This information may be used in clinical 
practice or for research purposes to determine if an individual has made 
clinically significant or reliable change during treatment. Use of clinically 
significant and reliable change is of particular use when conducting single case 
research (Kazdin, 2011).  
It is notable that the grand mean scores I calculated for healthy control 
populations are very similar to those in the original SHAI validation paper (see 
table 23; Salkovskis et al., 2002). In contrast the grand mean scores in health 
anxiety populations are lower in my analysis than in the SHAI validation paper. 
Although they are within one SD of the scores provided by Salkovskis and 
colleagues. It is difficult to determine why this is the case, it may be that health 
anxiety was simply higher in the original sample compared to the populations 
from which I generated norms. I next attempted to discover whether sample 
composition or other study-level variables were responsible for variations in 
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Table 23. Normative data for the SHAI-14 and SHA-18 and equivalent values reported in Salkovskis et al., (2002). 
 
Population Variable Meta-analysis score [95%CI] Validation paper score 
SHAI-14 SHAI-18 SHAI-14 SHAI-18 
Healthy  Mean 9.21 [8.26, 10.16] 12.56 [10.26,14.86] 9.4  12.2 
 SD 5.36 [4.71, 6.01] 6.03 [5.37, 6.68] 5.1 6.2 
 Alpha 0.885 [0.863, 0.907] 0.840 [0.767, 0.913]   
Student Mean 17.16 [12.94, 21.37] 12.35 [11.78, 12.93] - - 
 SD 5.78 [5.03, 6.53] 6.51 [6.11, 6.91] - - 
 Alpha 0.844 [0.813, 0.876] 0.853 [0.835, 0.870] - - 
Health 
anxiety 
Mean 27.90 [25.23-30.56] 32.13 [30.77, 33.49] 30.1 37.9 
SD 4.88 [4.56, 5.20] 8.56 [7.47, 9.66] 5.5 6.8 
Anxiety 
disorders 
Mean - 16.28 [13.07, 19.48] 14.9 18.5 
SD - 12.04 [10.16, 13.92] 6.2 7.3 
Pain Mean 14.52 [12.66-16.38] 14.17 [9.97, 18.36] - - 





5.1.1.1. Exploring heterogeneity in SHAI mean scores 
The majority of the effect sizes I computed using mean health anxiety 
scores were heterogeneous in nature. The presence of heterogeneity is often seen 
as a problem with a meta-analysis as it can indicate the included studies are too 
different to be compared (see the 'comparing apples and oranges' section; 
Sharpe, 1997). Indeed, this is potentially a fair criticism of my attempts to 
develop population norms for different populations; the existence of significant 
heterogeneity in mean health anxiety score means it is difficult to state that my 
calculated grand mean adequately reflects the population of interest. It may be 
that statistical outliers or extreme variables may bias these findings. There is a 
risk that a mean score reported in any study could be an outlier, so could equally 
be an issue in a scale development study. The advantages of using multiple 
studies is that the effect of extreme scores should be lessened by the presence of 
other mean scores. A second advantage of using meta-analysis to develop 
normative data is that it allows statistical investigation of heterogeneity in mean 
scores. This would not be possible in studies with only one sample. 
In terms of classical test theory (Lord & Novick, 1968), there are three 
potential reasons for this heterogeneity: 1) the studies I analysed employed an 
inadequate sampling strategy therefore producing mean scores that do not 
adequately represent the population of interest; 2) the performance of the SHAI 
varies when used with different samples; 3) studies reporting on the same kind 
of participants (e.g. students) were sampled from true populations that were 
different in composition and had different health anxiety scores.  
I attempted to explore various sources of heterogeneity by use of meta-
regression, I explored option 1) by entering study-level variables regarding 
sampling strategy as predictors in a meta-regression but did not find any 
association between sampling strategy and SHAI mean score. It may be that 
there was no effect of sampling strategy on mean score or that this effect was too 
small to be detected. As assessed by the I2 statistic, the levels of heterogeneity in 
SHAI mean score were above 80% across all populations (except health anxious 
populations assessed by the SHAI-18). This is a high level of heterogeneity left 
unexplained and none of the study level variables I selected could account of a 
significant proportion of this variation. It is possible that other study level 
variables exist that may explain this variation. Although meta-analysis will 





The second potential source of heterogeneity according to classical test 
theory (option number 2 above) is that the SHAI varies in accuracy (a 
component of method variance and error variance; Campbell & Fiske, 1959) 
when used with different populations. Some indirect evidence for this comes 
from the finding that the SHAI has lower reliability when used in mixed-medical 
and student samples. However, the meta-analysed reliability coefficient was 
above 0.85 in all populations, so is sufficiently high to have sufficient reliability 
for research purposes, so does not support the notion that this variability is due 
to error in measurement. I will comment on this again in the construct validity 
discussion section. 
The final option is simply that the levels of health anxiety true scores 
differed between the various samples across the same populations, this 
hypothesis has the most support from the data that I collected.  
It is unfortunate that the heterogeneity in mean scores could not be 
explained, this is potentially problematic as it is difficult to determine the 
accuracy of the normative data that I have produced. On the other hand, 
identifying that there is significant heterogeneity in SHAI mean score even 
within groups with health anxiety that were selected by diagnostic interview may 
be helpful to future researchers: this study demonstrates that SHAI scores can 
significantly vary even between highly similar samples and this effect may be a 
limitation of the measure itself. I argue the impact of heterogeneity in mean 
score may be reduced by use of the 95% confidence intervals giving the range of 
health anxiety score in each population rather that than the mean score that was 
calculated by meta-analysis. 
5.1.1.2. HAQ population norms 
 There were less studies reporting data for the HAQ (n=34) compared to 
the SHAI (n=86). I have produced grand mean scores for healthy control 
populations, cardiac patients, clinic attenders and gastroenterology patients, 
these are presented in table 24. There was only one published use of the HAQ 
with a health anxiety population (Noyes et al., 2002). Therefore, a norm could 
not be created for this population, nor could I calculate a cut-off for clinically 
significant change or a reliable change index.  
Similarly, to the SHAI, the data in table 24 may be utilised as HAQ 
normative data for each population. Compared to the scores reported in the HAQ 
validation paper (Lucock & Morley, 1996), the meta-analysed grand mean score 





mean score was lower (15.36 vs. 17.35). Although, the differences in scores in 
both populations was within one SD (of both the original paper and my meta-






Table 24. Normative data for the HAQ and equivalent values reported in Lucock 
and Morley (1996). 
 






Mean 12.29 [8.78, 15.80] 8.62 
SD 8.39 [7.04, 9.74] 7.96 
Cardiac Mean 13.51 [9.57, 17.47] - 
 SD 8.06 [2.78, 13.35] - 
Clinic 
attenders 
Mean 15.36 [13.86, 16.86] 17.35 
SD 9.80 [8.36, 11.24] 11.16 
Gastro 
patients 
Mean 15.59 [10.79, 20.38] - 
SD 7.78 [6.07, 9.50] - 
 
One potential criticism of my analysis of HAQ scores is that the clinic 
attenders sample was comprised of several populations (e.g. medical outpatients, 
attenders at neurology) so may be too heterogeneous in nature to be 
appropriately combined into a single population norm.  
Exploring heterogeneity in mean SHAI scores was a supplementary and 
exploratory analysis. Because not a single study level variable predicted 
variation in SHAI mean score, I did not repeat this analysis with the HAQ. This 
is also because the HAQ and SHAI are both questionnaire measures, so will 
presumably account for a similar proportion of method-variance. As detailed in 
the method, there were insufficient HAQ alpha coefficients available for meta-
analysis (Lopez-Lopez, Marin-Martinez, Sanchez-Meca, Noortgate, & 
Viechtbauer, 2014), so an average reliability could not be generated for any 
population. 
5.2 Construct validity 
 I now consider information relating to the construct validity of the SHAI 
generated from the meta-analysis of correlation coefficients between the SHAI 
and other measures.  
Overall, the pattern of relationships between the SHAI and measures of 





SHAI correlated most strongly with other measures of health anxiety, followed 
by generalised anxiety measures. A finding that was contrary to predictions was 
that the average correlation with measures of depression were higher than with 
measures of OCD. 
There was significant heterogeneity in all correlation coefficients, 
unfortunately there was insufficient data to perform a moderator analysis. It is 
possible that sample type may impact on the strength of these relationships, or 
that there are multiple populations within each study sample. It is also possible 
that other study level variables that may explain the heterogeneity in correlation 
coefficients between the SHAI and other measures. 
The correlation coefficients between the SHAI and OCD-R were highly 
heterogeneous, in fact the credibility interval was broader than the strength of 
the correlation itself. This is problematic, as such a large interval implies there 
may be no relationship between these variables. This finding is hard to interpret, 
but is surprising nevertheless as I predicted there would be some relationship 
between the two measures. 
Another possibility is that the construct of health anxiety is categorical 
rather than dimensional. Consequently, even in a homogenous sample (e.g. 
undergraduate students) there would be two populations that differ in their 
experience of health anxiety. The latent structure of health anxiety is still 
debated (Asmundson et al., 2012; Ferguson, 2009; Longley et al., 2010), 
however the most methodologically rigorous taxometric analysis found a 
categorical latent structure comprising two distinct groups or ‘taxons’. One ‘non-
anxious’ group scored universally low on all IAS items, a second ‘anxious’ had 
a dimensional latent structure (Asmundson et al., 2012). This non-anxious group 
comprised approximately 15% of the undergraduate study sample. It may be that 
a portion of the heterogeneity in correlation coefficients is due to two distinct 
groups, each with a differring experience of health anxiety being included in 
study samples. This is of particular relevance as the taxometric analysis 
conducted by Asmundson and colleagues was conducted with North American 
undergraduate students, which are the same population that the majority of 
SHAI studies that reported correlations were carried out with. 
 Correlations between the SHAI, IUS, ASI and BVS were entered as an 
exploratory analysis. These variables are all considered to be precursors or risk 
factors for anxiety (Alberts et al., 2013) and correlated moderately with the 
SHAI. This provides evidence that these risk factors may also be involved in 





magnitude of correlations between these precursor variables. The narrowest 
ASI-3R credibility intervals (indicating less heterogeneity) occured in 
correlations between the SHAI and the ‘respiratory’ and ‘physical’ subscales. 
These subscales assess an individual’s fear that a bodily symptom will lead to 
negative consequences. I argue the finding that most studies reported a similar 
strength of relationship (so have narrower credibility intervals) with the SHAI 
lends support to the cognitive model, as in this model a catastropic 
misinterpretation of bodily states is central to the development of health anxiety. 
The correlation coefficients between the SHAI and the measures 
assessing precursors to anxiety (ASI-3, BVS and IUS) were heterogeneous, with 
some having large credibility intervals. This variation warrants further 
investigation. It may be that the relationships between these scales and the SHAI 
vary as a function of some other variable, for instance the sample composition or 
mean SHAI score or by some other demographic variable. This could be 
investigated via a moderation analysis, unfortunately there were insufficient 
correlation coefficients available for this kind of analysis. Simulation studies 
have revealed that a minimum of 20 studies are required to have sufficient power 
to detect variation in heterogeneity (Lopez-Lopez et al., 2014). In the included 
studies, the ASI-3 was used ten times, the BVS six and the IUS on 7 occasions, 
so were insufficient in number to perform a moderator analysis of the impact of 
other variables on heterogeneity. Studies typically utilised more than one of 
these measures in one analysis (e.g. IUS and BVS), which is problematic for 
further analysis as their variance will be shared (Borenstein et al., 2009).  
 The correlations between the ASI-3 cognitive and social subscale and the 
SHAI were more heterogenous. These variables assess fear of the consequences 
of the thoughts associated with anxiety and fear of the social consequences of 
anxiety respectively. Again, I argue this provides suport for the cognive model, 
as these variables are thought to be more peripheral in the maintenance of health 
anxiety. 
 The data extracted regarding correlation coefficients provides some 
support for the cognitive-behavioural conceptualisation of health anxiety and for 
the ability of the SHAI to measure this construct. This is because the pattern of 
correlation coefficients were broadly in the pattern that was expected, 
demonstrating that SHAI has ‘discriminant validity’. That is, for example the 
SHAI can distinguish between those scoring highly on health anxiety from those 
scoring more highly on generalised anxiety. Additionally, the pattern of 





way with the correlations between the SHAI and measures of generalised 
anxiety being strongest. On the basis of these results, health anxiety can be 
considered to be a construct that is distinct, but related to generalised anxiety, (if 
the two were the same construct, then correlations between SHAI and anxiety 
measures would be higher). The fact that there is a moderate relationship 
between anxiety and health anxiety may provide some support for the notion that 
health anxiety is an anxiety disorder (Salkovskis & Warwick, 1986), as if there 
were no relationship between the two then the meta-analysed correlation 
coefficient would be smaller. There was heterogeneity in the magnitude of the 
correlation coefficents between the SHAI and anxiety measures. Assessing the 
relationship between anxiety and health anxiety solely in ‘pure’ samples (e.g 
only studies with samples of indiviuals experiencing hypochondraisis) may be 
another helpful means of assessing whether health anxiety is an anxiety disorder. 
If the relationship between the two is consistent across studies then may provide 
support for this hypothesis, if there is variability then this may indicate that 
anxiety is a less important component of hypochondriasis. Conducting a 
moderator analysis with diagnosic label inputted as a moderating variable may 
be an alternative means of achieving this using meta-analysis. This was not 
possible in the current study due to a lack of available data. 
An unexpected finding was that the correlation between the SHAI and 
measures of depression were greater than those with measures of OCD. This 
relationship is the opposite to my predictions as some similarities between OCD 
and health anxiety have been noted, for example compulsive checking or 
monitoring one’s body for signs of illness (Ania Greeven et al., 2009). 
 Another means of assessing the cognitive behavioural construct of health 
anxiety may be to examine its relationship to quality of life (QoL). It follows 
that worry about one’s health should lead to increased stress and this will 
consequently reduce one’s QoL. Similarly to the previously described analysis, 
this could be assessed by examining the correlation coefficients between 
measures of health anxiety and measures of QoL and clinical stress and if 
consistent with this prediction, clinical stress should be positively related to 
health anxiety and QoL negatively related. One study (Porritt, Sufi, Barlow, & 
Baker, 2014) reported a correlation of r=0.49, p<0.001 between the SHAI and 
the Index of Clinical Stress (Walmyr Publishing Company, 1992), another study 
(Olatunji et al., 2009) reported a correlation of r=-0.19,p=n.s. between the SHAI 
and the EuroQol (The EuroQol Research Group, 1990) a measure of Quality of 





cognive behavioural conceptualisation of health anxiety, but the non-significant 
relationship between the SHAI and QoL is not. The lack of research 
investigating between health anxiety, stress and QoL is a limitation of the 
literature and could not be adequately assessed using meta-analysis in this study.  
A note of caution is warranted about these conclusions, the first is that 
correlation coefficients only indicate a potential relationship. It may be this is a 
spurious finding and this relationship is an artifact due to them both co-relating 
to another unknown variable. A second issue is the potential existence of two 
taxons within an undergradute sample. This is problematic for my attempts to 
assess the health anxiety construct using correlations between the SHAI, IUS, 
ASI and BVS, this is because all of the studies making use of these scales were 
in student samples. It may be that the precursers to anxiety relate differently to 
the each of the two taxons. I suggest this is highly likely, as Asmundson et al. 
(2012) report that a non-anxious sub-sample scored very low on all IAS items. 
Future research should attempt to separate these groups prior to analysis. 
The factor structure of both scales has relevance to a discussion of the 
cognitive behavioural construct of health anxiety as factor analysis has revealed 
that each scale may be comprised of multiple underlying factors. In the original 
scale validation paper, the HAQ was found to have four factors; ‘interference 
with life’, ‘fear of illness and death’, health worry and preoccupation’ and 
‘reassurance seeking-behaviour’ (Lucock & Morley, 1996). The presence of 
multiple latent factors indicate that the cognitive behavioural construct of health 
anxiety (as assessed by the HAQ) may comprise related, but distinct constructs. 
Beyond the original validation paper, there have been no attempts to 
reinvestigate the factor structure of the HAQ and doing so may be a helpful 
avenue for future research. 
The factor structure of the SHAI has been re-evaluated and both a two- and 
three- factor solution have been reported in the literature (Alberts et al., 2013). 
The initial validation paper of the SHAI-18 reported a two-factor solution, with 
one factor comprising the the SHAI-14 items, the second was formed of the 4-
item ‘negative consequences of illness’ subscale (Salkovskis et al., 2002), this 
structure has been replicated in a study using a student sample (Wheaton et al., 
2010). However, two additional studies also employing student samples reported 
a three-factor solution. In both studies this included the 4-item ‘negative 
consequences of illness’ subscale, the remaining 14-items comprising the SHAI-
14 were divided into two subscales named ‘illness likelihood’ and ‘body 





study conducted in a community and a multiple sclerosis sample found the 
SHAI-14 was better explained by a two-factor solution, the authors named these 
‘fear of illness’ and ‘thought intrusion’ (Alberts, Sharpe, Kehler, & 
Hadjistavropoulos, 2011). The study conducted by Abramowitz, Deacon, et al., 
(2007) also found that the ‘body vigilance’ scale alone predicted use of medical 
services (as assessed by the medical utilisation questionnaire) and that ‘body 
vigilance’ and the ‘illness likelihood’ scales predicted safety behaviours related 
to health (e.g. telephoning for medical advice). These findings indicate that the 
cognitive behvioural conceptualisation of health anxiety as measured by the 
SHAI may be considered to have multiple components rather than a unified and 
generic health anxiety construct. The fact that each factor may differentially 
predicit medical use and safety behaviours provides some prelminary evidence 
that separating body vigilance and perceived likelihood of illness may be helpful 
for future research and may also indicate separate constructs within the health 
anxiety domain.  
Related to the findings regarding the factor analysis is that the average  
alpha coefficient reported for all the SHAI versions were above 0.87. This high 
alpha value indicates that even if the SHAI (and cognitive behavioural construct 
of health anxiety) may be divided, it is likely that the scale items comprising 
each component are consistently related to all the other items and therefore each 
construct is also likely to be related. This could be investigated in the future by 
reporting correlation coefficients between factors and also by publication of 
alpha coefficients specific to each factor. 
5.2.1 Reliability 
In this section I discuss the reliability information gathered about each 
scale. There was a large difference between the SHAI and HAQ in terms of the 
number of available reliability coefficients (n=53 and n=4 respectively). I also 
observed the same pattern in terms of correlations between the SHAI/HAQ and 
other scales, with fewer coefficients reported by researchers employing the 
HAQ. I suggest this may be explained by differences in the disciplines of the 
scholars employing the scales: the HAQ was far more likely to be employed in 
medical research being conducted by medical personnel, whereas the SHAI was 
used more frequently by psychologists. I suggest that due to the differences in 
research training and applications of psychometrics, psychologists are more 
likely to report additional psychometric information. Because of lack of HAQ 





The mean SHAI-14 and -18 alpha coefficients were all at 0.870 or above. 
This indicates that on average, for the samples included in this analysis the 
SHAI has good reliability. The meta-regression of SHAI reliability coefficients 
explained 69% of the variance in alpha coefficients, this was explained by a 
combination of scale language and study variance. This indicates that majority 
of this variance is due to poor translations of the SHAI, or that the health anxiety 
construct is not applicable in other cultures. Unfortunately, it is not possible with 
the data available to determine which of these is that case. It was only possible 
to say there was an overall effect of scale language on reliability. This is because 
the majority of foreign language translations of the SHAI were used in only one 
or two studies, making it difficult to determine if a there is a systematic 
relationship between one particular translation of the SHAI and reliability. 
However, further investigation of this effect may be potentially fruitful direction 
for future research. 
5.3. Strengths and limitations 
 A strength of this study is the breadth of analysis. Population norms were 
generated for a range of samples, this exceeded the range of populations that 
were assessed in the original validation papers of both papers. Use of data 
gleaned from multiple sources regarding the same populations also has the 
advantage of reducing the impact of erroneous findings or outliers. It is possible 
that in the original scale validation papers the SHAI and HAQ included samples 
that were not entirely representative of the wider population. There was some 
evidence for this in my analysis, as the mean health anxiety scores I generated 
were lower than in the SHAI validation paper (Salkovskis et al., 2002). There is 
a risk that samples included in this analysis were not from the same population 
as those in the Salkovskis paper, for example it may be that some samples were 
simply not as health anxious. However, this is unlikely as in the included 
studies, health anxiety was generally assessed using DSM interview, the same 
criteria used by Salkovskis et al. In addition, I assessed for the impact of sample 
composition on mean score and found no relationship. The latter analysis would 
not be possible without collecting a large amount of data from multiple 
populations. 
Another strength of this study is the large total sample size, for example 
there were nearly 4,000 participants included in the correlations between the 
ASI-3 subscales and the SHAI, far exceeding the usual size in a scale validation 





methodologically rigorous way, this offers a more precise estimate of scale mean 
scores as the impact of outliers within study samples has less impact in larger 
samples (Cousineau & Chartier, 2010). 
 A limitation is the use of data derived from mean scores which were then 
aggregated via meta-analysis. If this data were available in raw format, with 
participant demographics then more precise norms could be generated and 
related to age and gender. However, as discussed in the method section, this was 
not possible as authors did not respond to requests to share their data.  
Another limitation of this approach is that there is some heterogeneity in 
the composition of samples included in each normative value generated by meta-
analysis. This means the normative values may have been influenced by a 
sample containing unusually high numbers of individuals with (or without) 
health anxiety, so may affect the accuracy of these normative values. I attempted 
to correct for this in the meta-regression of sample characteristics (whether the 
sample was well described or homogenous in composition) on SHAI score and 
found no statistical relationship. Heterogeneity of samples should still be 
considered a limitation as there may be insufficient data for an effect of sample 
composition to be observed statistically, but this may still be a potential 
explanatory factor for the significant levels of heterogeneity found in mean 
health anxiety score found in each group of studies. This difficulty may be 
overcome by solely including studies that identify participants using diagnostic 
interview, this will only be possible when additional data regarding each 
measure has been published.  
 It is unfortunate that there was insufficient data to perform an analysis on 
the construct validity and reliability of the HAQ. The available alpha 
coefficients did not indicate that the HAQ lacks reliability, but there was no 
additional information that could confirm the scale has good reliability.  
 In summary, this meta-analysis allowed for the production of norms from 
a large number of studies, which can help shed light on the range of health 
anxiety scores across a broader range of populations than the original validation 
paper. Employing mean scores from a greater number of applications of the 
scale in the same population, which has the advantage of reducing the impact of 
outliers or erroneous findings. A robust scale re-validation attempt such as this 
adds to the evidence that the SHAI and to a lesser extent the HAQ generally 





5.4. Research implications 
 With the data reviewed in this study, the SHAI can be confirmed as a 
valid and reliable research instrument. Translated versions should be used with 
caution as this negatively impacts reliability. A future study may investigate 
which translations are particularly problematic, this could be achieved by 
analysis of reliability coefficients published in future research. Another option 
might be to review translated scales and back-translate them and conduct face 
validity checks. A more robust procedure would be to assess the construct 
validity of scales numerically via comparison with other measures that have 
been validated in the corresponding language.  
 It was not possible to examine the construct validity of health anxiety 
within certain groups (e.g. comparing students with clinic attenders), as there 
were insufficient correlation coefficients available. It may be that health anxiety 
has a different form or quality at different intensities, there is some evidence for 
this as reported by Asmundson et al. (2012). This is not a limitation of the design 
of the present study, as it is due to insufficient data. Nevertheless, this may be a 
fruitful area for research in the future when more data is available.  
 Another area for research that may shed light on the cognitive 
behavioural construct of health anxiety may be investigating its relationship with 
stress and QoL. Due to a lack of research it was not possible to achieve this in 
the current study, future research could investigate whether increased health 
anxiety leads to increased stress and reduced quality of life. It may also be 
helpful to assess whether this relationship varies according to population, for 
example it may be that those with medically unexplained symptoms do not 
experience a high level of anxiety, but nevertheless are preoccupied with a 
somatic symptom and have a correspondingly lower QoL.  
 It was not possible to calculate information beyond normative data for 
the HAQ. It was not possible to provide additional information about the 
psychometric properties of the HAQ.  
5.5. Clinical implications 
 In terms of the implications for clinical practice, the SHAI can be 
supported as a measure with good construct validity and reliability. This makes 
it a suitable measure for use within clinical practice. The normative data that was 
generated in this analysis may be used as a point of comparison in clinical 





reliable change index can be employed in clinical practice to determine if a 
client has made clinically significant and reliable change (Jacobson & Truax, 
1991). Similarly, to the research implications, translated versions of the SHAI 
should be used with caution until their reliability and validity has been better 
assessed. 
5.6. Future research 
When more studies have been published, across a range of populations it 
may be possible to generate more precise normative data and investigate whether 
there are more fine-grained differences in health anxiety between populations.  
 The relationship between OCD and health anxiety could be investigated 
further, there was a large heterogeneity in the calculated grand correlation 
coefficients. In the current study, it was not possible to determine whether this 
heterogeneity was due to some conceptual overlap in some people (perhaps with 
lower levels of health anxiety) and not in others (anxiety/hypochondriasis 
samples). As previously stated, if more correlations were available a moderator 
analysis could be conducted to determine if severity of health anxiety (or another 
variable) moderates this relationship. 
 Another potential area for research would be evaluating the 
heterogeneity in HAQ and SHA standard deviations. I did not investigate this in 
the current study, nevertheless moderators of the standard deviation may provide 
further information about sources of error of measurement captured by the 
scales. 
Studies conducted by the same research group, using the same methods 
but in different populations may lead to a better understanding of sources of 
heterogeneity in means scores. An example of this is in the studies by (Graff et 
al., 2006) who in the same study, reported different HAQ scores according to 
whether a patient had active or inactive Crohne’s Disease or Ulcerative Colitis. 
If more studies are published using the same method, then we can be more 
confident that this difference is due to changes in true scores rather than due to 
measurement error. 
5.7. General discussion of method  
There are a number of advantages and disadvantages of applying meta-
analysis to better understand psychometric questionnaires. Beginning with an 





normative data for a wider range of populations than would be possible in a 
single scale development study. Similarly, this approach allows one to generate a 
grand mean and standard deviation for a non-clinical control population, this 
data may then be used to generate criteria for reliable (Jacobson et al., 1984) and 
clinically significant change (Jacobson & Truax, 1991).  
A potential difficulty inherent in this approach is use of published data. It 
is unknown what the effect of publication bias may be on baseline mean health 
anxiety scores. I am unaware of a means to asses this statistically as existing 
techniques such as funnel plots (Egger, Smith, Schneider, & Minder, 1997) are 
designed for use with pre/post treatment effect sizes or correlational data. Also, 
as previously discussed there is a risk that the samples’ composition in included 
studies may be poorly described or be biased in some way, this may then lead to 
a biased mean score being included in the meta-analysis. However, these same 
criticisms may also be levelled at the norms generated from any scale 
development study and it is equally plausible that any such paper is at risk of 
publication bias or of inadvertently employing a non-representative sample. An 
advantage of using meta-analysis to develop normative data is that a greater 
number of studies may be included. This may help reduce the impact of using 
norms generated from a single study that may have a non-representative sample 
or other confounding variable. On the other hand, there is the potential for 
normative data to be appear more precise than is warranted given the potential 
for confounding variables or non-representative sampling. It may be possible to 
minimise the impact of this by only including studies with well described 
samples. Another possibility is relying on the 95% confidence intervals, so 
reporting a range of values as a norm rather than using the grand mean generated 
from the meta-analysis. This way a lower and upper bound for the range of 
health anxiety could be calculated for various samples. 
Calculation of an average reliability and exploration of the variation in 
reliability coefficients is another strength of this approach as it has the potential 
to reveal samples or circumstances that a test should not be employed. Assessing 
reliability across many studies can provide much additional information about a 
test than can be gleaned from a single application (Vacha-Haase & Thompson, 
2011). 
Finally, meta-analysis of correlation coefficients as a means to investigate 
the convergent and discriminant validity of the SHAI has been previously 
investigated (Alberts et al., 2013). I followed the same steps of Alberts and 





construct validity of a scale in this way. The advantages and disadvantages of 
this approach are similar to those relevant to generating normative data using 
meta-analysis. The advantages include collecting data from a wider range of 
sources than a scale development paper and the potential to investigate 
moderating variables such as sample or study characteristics to determine 
whether these may impact on the relationship between constructs. A 
disadvantage of this approach is that it may lead to what Egger and colleagues 
(Egger, Schneider, & Smith, 1998) refer to as ‘spurious precision’. That is, the 
potential for data from observational studies to appear as if they provide an 
accurate reflection of the relationship between two or more variables even 
though confounding variables or sample characteristics may distort this 
relationship. Egger and colleagues recommend paying attention to moderating 
variables that explain the heterogeneity in correlation coefficients in different 
studies. This was not possible in this study due to insufficient data, however 
when more research is published using the SHAI or HAQ this may be a possible 
extension to this analysis. 
This method could easily be applied to other psychometric measures, for 
example the PHQ-9 (Kroenke & Spitzer, 2002) a widely used measure of 
depression. A meta-analysis conducted using the same method employed in this 
thesis would complement an existing meta-analysis of studies that assesses the 
diagnostic accuracy of the PHQ-9 (Manea, Gilbody, & McMillan, 2015). This is 
because the study conducted by Manea and colleagues focussed only on the 
effectiveness of the PHQ-9 as a tool for diagnosing depression and recommends 
a clinical cut off score (they report a score of between 8 and 11 will have 
sufficient sensitivity and specificity for accurate diagnosis). The approach I have 
used also allows the potential for normative data for different groups to be 
collected and for a great deal more information about the reliability and validity 
of a measure to be collected.  
5.8. Conclusion 
 In conclusion, the analysis in this thesis has provided normative data for 
the HAQ and SHAI. Meta-analysis of correlation coefficients indicated that the 
SHAI has good construct validity. The average reliability of the SHAI was 
sufficiently high that the scale can be recommended for use within clinical 
practice and applied research (Nunnally, 1978). The reliability generalisability 
analysis also indicated that translated versions of the SHAI may have poorer 





responsible for reducing reliability. There was no evidence for the HAQ to be 
lacking in reliability. Due to insufficient data, it was not possible to provide any 
additional information about the construct validity or reliability of the HAQ. 
When more data regarding both scales is published, future research could repeat 
and extend the analyses reported in this thesis and provide additional 
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Appendix A HAQ and SHAI 
 The Health Anxiety Inventory 
HAI                                                                                    
 
            name: ______________________________                              date: 
_______    
 
Each question is this section consists of a group of four statements. Please read 
each group of statements carefully and then select the one which best describes 
your feelings, over the past six months (or other agreed time period).  Identify 
the statement by ringing the letter next to it, i.e. if you think that statement a.) is 
correct, ring statement a.).  It may be that more than one statement applies, in 
which case, please ring any that are applicable. 
 
1. a.) I do not worry about my health. 
 b.) I occasionally worry about my health. 
 c.)  I spend much of my time worrying about my health. 
 d.)  I spend most of my time worrying about my health. 
 
2.  a.)  I notice aches/pains less than most other people (of my age). 
 b.)  I notice aches/pains as much as most other people (of my 
age). 
 c.)  I notice aches/pains more than most other people (of my 
age). 
 d.)  I am aware of aches/pains in my body all the time. 
 
3.  a.)  as a rule, I am not aware of bodily sensations or changes. 
 b.)  sometimes I am aware of bodily sensations or changes. 
 c.)  I am often aware of bodily sensations or changes. 






4.  a.)  resisting thoughts of illness is never a problem. 
 b.)  most of the time I can resist thoughts of illness. 
 c.)  I try to resist thoughts of illness but am often unable to do 
so. 
 d.)  thoughts of illness are so strong that I no longer even try to 
resist them. 
 
5.  a.)  as a rule, I am not afraid that I have a serious illness. 
 b.)  I am sometimes afraid that I have a serious illness. 
 c.)  I am often afraid that I have a serious illness. 
 d.)  I am always afraid that I have a serious illness. 
 
6.  a.)  I do not have images (mental pictures) of myself being ill. 
 b.)  I occasionally have images of myself being ill. 
 c.)  I frequently have images of myself being ill. 
 d.)  I constantly have images of myself being ill. 
 
7.  a.)  I do not have any difficulty taking my mind off thoughts 
about my health.  
 b.)  I sometimes have difficulty taking my mind off thoughts 
about my health. 
 c.)  I often have difficulty in taking my mind off thoughts about 
my health. 
 d.)  Nothing can take my mind off thoughts about my health. 
 
8.  a.)  I am lastingly relieved if my doctor tells me there is nothing 
wrong. 






 c.)  I am initially relieved but the worries always return later. 
 d.)  I am not relieved if my doctor tells me there is nothing 
wrong. 
 
9.  a.)  if I hear about an illness I never think I have it myself. 
 b.)  if I hear about an illness I sometimes think I have it myself. 
 c.)  if I hear about an illness I often think I have it myself. 
 d.)  if I hear about an illness I always think I have it myself. 
 
10. a.)  if I have a bodily sensation or change I rarely wonder what 
it means. 
 b.)  if I have a bodily sensation or change I often wonder what it 
means. 
 c.)  if I have a bodily sensation or change I always wonder what 
it means. 
 d.)  if I have a bodily sensation or change I must know what it 
means. 
 
       
 [cont.] 
11. a.)  I usually feel at very low risk for developing a serious illness. 
 b.)  I usually feel at fairly low risk for developing a serious illness. 
 c.)  I usually feel at moderate risk for developing a serious illness. 
 d.)  I usually feel at high risk for developing a serious illness. 
 
12.  a.)  I never think I have a serious illness. 
 b.)  I sometimes think I have a serious illness. 
 c.)  I often think I have a serious illness. 






13.  a.) if I notice an unexplained bodily sensation I don't find it difficult to 
think about other things. 
 b.)  if I notice an unexplained bodily sensation I sometimes find it 
difficult to think about other   things. 
 c.)  if I notice an unexplained bodily sensation I often find it difficult to 
think about other things. 
 d.)  if I notice an unexplained bodily sensation I always find it difficult 
to think about other things. 
 
14. a.)  my family/friends would say I do not worry enough about my 
health. 
 b.)  my family/friends would say I have a normal attitude to my health. 
 c.)  my family/friends would say I worry too much about my health. 
 d.)  my family/friends would say I am a hypochondriac. 
 
For the following questions, please think about what it might be like if you 
had a serious illness of a type which particularly concerns you (e.g. heart 
disease, cancer, multiple sclerosis & so on).  Obviously, you cannot know for 
definite what it would be like; please give your best estimate of what you 
think might happen, basing your estimate on what you know about yourself 
and serious illness in general. 
 
15. a.)  if I had a serious illness I would still be able to enjoy things in my 
life quite a lot. 
 b.)  if I had a serious illness I would still be able to enjoy things in my 
life a little. 
 c.)  if I had a serious illness I would be almost completely unable to 
enjoy things in my life. 







16. a.)  if I developed a serious illness there is a good chance that modern 
medicine would be able to cure me. 
 b.) if I developed a serious illness there is a moderate chance that 
modern medicine would be able to cure me. 
 c.)  if I developed a serious illness there is a very small chance that 
modern medicine would be able to cure me. 
 d.)  if I developed a serious illness there is no chance that modern 
medicine would be able to cure me. 
 
17. a.)  a serious illness would ruin some aspects of my life. 
 b.)  a serious illness would ruin many aspects of my life. 
 c.)  a serious illness would ruin almost every aspect of my life. 
 d.)  a serious illness would ruin every aspect of my life. 
 
18.  a.)  if I had a serious illness I would not feel that I had lost my dignity. 
 b.)  if I had a serious illness I would feel that I had lost a little of my 
dignity. 
 c.)  if I had a serious illness I would feel that I had lost quite a lot of my 
dignity. 




all groups are scored 0, 1, 2 or 3 depending on the statement selected; 
if more than statement is selected, use the highest-scoring statement of those 
chosen. 
                   main section score (questions 1 to 14) = 
  negative consequences score (questions 15 to 18) = 









scoring the 18 item HAI 
In the 2002 paper describing the development of both the full Health Anxiety 
Inventory and this current shortened 18 item version, the following scores were 
reported for the shortened form in a series of different populations.  The table 







































At an initial assessment, it is probably appropriate to ask these questions about 
the last six months.  When monitoring treatment, applying the scale questions to 
the last week is more usual. 
Salkovskis P.M., Rimes K.A., Warwick H.M.C. & Clark D.M.  The health 
anxiety inventory: development and validation of scales for the measurement of 








Appendix 2. The Health Anxiety Questionnaire 
HAQ                                                                                    
 
            name: ______________________________                                     date: 
_______    
 
Below is a list of questions about health anxiety.  Please carefully read each item 
on the list.  Indicate how often you have been bothered in this way during the 
past week, including today (or other agreed time period), by placing an x in the 













most of  
the time 
1 
do you ever worry               
about your health? 
   
2 
are you ever 
worried that        
you may get a 
serious illness     in 
the future? 
    
3 
does the thought of 
a serious illness 
ever scare you? 
    
4 
when you notice an 
unpleasant feeling 
in your body, do 
you   tend to find it 
difficult to think    
of anything else? 
    
5 
do you ever 
examine your     
body to find 
whether there is 
something wrong? 
    
6 
if you have an ache 
or pain       do you 
worry that it may 
be caused by a 
serious illness? 
    
7 
do you ever find it 
difficult         to 
keep worries about 
your  health out of 
your mind? 
    
8 when you notice an 
unpleasant feeling 





in your body, do 
you ever worry 
about it? 
9 
when you wake up 
in the morning do 
you find you        
very soon begin to 
worry     about your 
health? 
    
10 
when you hear of a 
serious  illness or 
death of someone     
you know, does it 
ever make   you 
more concerned 
about     your own 
health? 
    
11 
when you read or 
hear about    an 
illness on tv or 
radio does it ever 
make you think 
you may be 
suffering from that 
illness? 
    
      
 
  





most of  
the time 
12 
when you experience   
unpleasant feelings in your    
body do you tend to ask     
friends or family about them? 
    
13 do you tend to read up about 
illness and diseases to see if 





you may be suffering from 
one? 
14 
do you ever feel afraid of news 
that reminds you of death (such 
as funerals, obituary notices)? 
    
15 
do you ever feel afraid           
that you may die soon? 
    
16 
do you ever feel afraid           
that you may have cancer? 
    
17 
do you ever feel afraid that      
you might have heart disease? 
    
18 
do you ever feel afraid that     
you may have any other serious 
illness?  which illness? 
………………………………
………… 
    
19 
have your bodily symptoms 
stopped you from working 
during the past six months or 
so? 
    
20 
do your bodily symptoms       
stop you from concentrating     
on what you are doing? 
    
21 
do your bodily symptoms stop 
you from enjoying yourself?   
    
      
 
for each question score 0 for "not at all or rarely", 1 for "sometimes", 2 for 
"often", and  
3 for "most of the time" 
 







  add scores for 2, 3, 10 & 14 – 17 to give fear of illness and death score = 
 
  add scores for  5, 12 & 13 to give reassurance-seeking behaviour score = 
 
  add scores for 19, 20 & 21 to give interference with life score = 
 
           
           ____________________ 
  total score = 
Lucock MP & Morley S  The health anxiety questionnaire 













Appendix B: Data capture form 
Author name: Study ID:  
 HAQ   
SHAI: 
14  /  18 
 Scoring: 0-3  /  1-4 
Title: Introduction: Y  /  N 
   















 Yes No Other (CD, 
NA, NR)* 
Sample composition:    
-Homogenous and     
-Sample from the same population?    
-Represent population of interest?     
-Well described?     
-Medically unwell included?     
    
Recruitment bias:    
-Non-biased sampling strategy?    
-Participation rate at least 50%?    
-Uniform inclusion/exclusion criteria?    
    
Testing conditions    
Standardised?     
Test administered correctly?    
-Measurement context likely to elevate 
anxiety?  





-Measurement point likely to elevate 
anxiety? 
   
-Researcher ‘blinded’ to participant 
grouping? 
   
    
Data analysis    
-Missing data reported?     
-Adequately dealt with?    
-How:     
 
*CD = could not determine, NR = not reported, NA = not applicable 
 























     
       































Appendix C: SHAI and HAQ mean, standard deviations and reliability coefficients  
 
HAQ mean score, SD and reliability coefficients by population for all studies. 
 





Asbury, Creed and Collins (2004) Healthy control 8.00 - 9 - 
Meana and Lykins (2009) Healthy control 16.83 - 10.20 - 
Melli, Carraresi, Poli and Bailey, (2016) Healthy control 32.47 11.47 8.70 .92 
Asbury, Chandrruangphen and Collins (2006) Post menopausal 
women 
10.15 10.15 5.35 - 
Lucock and Morley (1996) Healthy control 8.26 - 7.96 - 
Lucock and Morley (1996) Students 12.10 - 6.71 - 
      
Asbury, Webb and Collins (2011) Cardiac syndrome X 13.25 - 8.10 - 
Asbury, Creed and Collins (2004) Cardiac syndrome X 13.50 - 10 - 





Asbury, Creed and Collins (2004) Coronary heart 
disease 
14.00 - 11 - 
Asbury et al. (2012) Angina 19.15 - 12.59 - 




14.00 -  - 
Zarifeh et al. (2012) Stress 
cardiomyopathy 
7.00 -  - 
      
Zarifeh et al. (2012) Attenders cardiac 
clinic 
13.00 -  - 
Lucock, Morley, White and Peake (1997) Gastroscopy 
attender 
12.73 - 4.22 - 




13.15 - 9.56 .79 
Fiddler, Jackson, Kapur, Wells and Creed 
(2004) 
Frequent attenders at 
Cardiology and 
neurology 
16.37 - 1.12 - 
Hewison et al. (2006) Amniotic test 31.73 10.73 7.48 - 





Noyes, Stuart, Longley, Langbehn and Happel 
(2002) 
General medicine 14.60 - 9.30 - 
Jackson, Kincey, Fiddler, Creed and Tomenson 
(2004) 
Attenders cardiology 19.00 - 12.80 - 
Jackson, Kincey, Fiddler, Creed and Tomenson 
(2004) 
Attenders neurology 15.00 - 9.10 - 
     - 
Graff et al. (2006) Active Crohn's 
disease 
17.98 - 10.60 - 
Graff et al. (2006) Active Ulcerative 
colitis 
15.07 - 9.16 - 
Esfandyari and Harewood (2007) Gastro-internal 
symptoms 
20.60 - 1.40 - 
Graff et al. (2006) Inactive Crohn's 
disease 
11.85 - 7.70 - 
Graff et al. (2006) Inactive ulcerative 
colitis 
9.29 - 5.59 - 
Meana and Lykins (2009) Intercourse pain 21.46 21.46 9.60 - 
Dolin et al. (2003) Osteoarthritis 11.20 11.20 8.71 - 





Lucock and Morley (1996) Mixed medical and 
mental health 
- - - 0.91 
      
White et al. (2002) Chronic fatigue 36.50 15.50 9.50 - 
Priebe, Fakhoury and Henningsen (2008) Chronic fatigue 37.80 16.80 9.50 - 
      
Aggarwal et al. (2014) Medically 
unexplained 
symptoms 
12.00 - - - 
Aggarwal et al. (2014) Medically 
unexplained 
sympoms 
14.00 - - - 
      
Noyes, Stuart, Longley, Langbehn and Happel 
(2002) 
Hypochondriasis 31.90 31.90 10.60 - 






SHAI-14 mean score, SD and reliability coefficients by population for all studies. 
 





Alberts, Sharpe, Kehler and Hadjistavropoulos, 
(2011) 
Healthy control 9.19 - 4.86 - 
Bailer et al., (2014) Healthy control 5.80 - 2.80 - 
Boston and Merrick (2010) Healthy control 7.04 - 4.30 - 
Fergus (2013b) Healthy control 10.97 - 6.62 .91 
Fergus (2014a) Healthy control 11.42 - 6.71 .90 
Fergus (2013a) Healthy control 10.95 - 6.83 .92 
Goodwin, Fairclough and Poole (2013) Healthy control 10.01 - 5.82 - 
Kehler and Hadjistavropoulos (2009) Healthy control 9.37 - 5.12 - 
Kowalyk, Hadjistavropoulos, and Jones (2009) Healthy control 9.02 - 4.66 - 
Payne et al., (2007) Healthy control 11.70 - 6.95 - 
Tang, Wright and Salkovskis (2007) 
 
Healthy control 6.90 - 4.50 - 





Veale et al., (2013) Healthy control 7.70 - 5.10 - 
Kowalyk and Hadjis-Tavropoulos (2007) Pregnant women 8.22 - 4.33 .83 
Fergus (2014b) Healthy control - - - .91 
Boschen, Veale, Ellison and Reddell (2013) Healthy control - - - - 
Dzhambov and Dimitrova (2014) Healthy control 15.02 - 4.51 - 
      
Alberts and Hadjistavropoulos (2014) Student  13.03 - 5.60 .86 
Goodwin et al., (2013) Students    .87 
Jeffers et al., (2015) Students 32.91 18.91 7.25 .86 
Karademas, Christopoulou, Dimostheni, and 
Pavlu (2008). Study 1. 
Students 24.86 - 5.06 .81 
Karademas, Christopoulou, Dimostheni, and 
Pavlu (2008). Study 2. 
Students 25.20 - 5.33 .82 
Macatee and Cougle (2013) Students 10.44 - 4.65 .82 
Norr, Capron, and Schmidt (2014) Students 10.12 - 6.60 .91 
Singh and Brown (2014) Students 14.13 - 5.80 - 
      
Bailer et al., (2014) Hypochondriasis 30.10 - 4.60 - 





Lovas and Barsky, (2010) Hypochondriasis 28.90 - - - 
Sorensen et al., (2011) Hypochondriasis 27.60 - 5.20 - 
Tyrer et al., (2014) Hypochondriasis 25.00 - 4.35 - 
Wattar et al., (2005) Hypochondriasis 30.50 - - - 
      
Bailer et al., (2014) Depression 9.60 - 3.60 .97 
      
Bailer et al., (2014) Mixed anxiety 
disorder 
9.60 - 3.60 - 
     - 
Tang et al., (2007) Chronic pain 12.50 - 6.90 - 
Tang, Goodchild, Sanborn, Howard and 
Salkovskis (2012) 
Chronic pain & 
insomnia 
14.60 - 7.40 - 
Tang et al., (2007) Chronic pain & 
insomnia 
16.40 - 7.20 - 
      
      
Boschen et al., (2013) Vomiting phobia  - - 0.91 





Veale et al., (2013) Vomiting phobia 19.80  8.60 .95 
      
Jones, Hadjistavropoulos and Gullickson, 
(2014) 
Breast cancer 15.51  6.93 .90 
Porritt, Sufi, Barlow and Baker, (2014) Dentine sensitivity 26.30  8.60  
Claude, Hadjistavropoulos,= and Friesen, 
(2014) 
Diabetes 14.78  7.05 .88 
DeMarinis, Barsky, Antin, and Chang (2009) Stem cell transplant 40.84 26.84 9.02  
Payne et al., (2007) Vulvar vestibular 
syndrome 
19.45  8.24  







SHAI-18 mean score, SD and reliability coefficients by population for all studies. 
Study author Population Mean SD 
Alpha 
coefficient 
Annagur, Avci, Demir and Uygur 
(2015) 
Myocardial infarction (early 
age) 
18.62 9.34 - 
Annagur, Avci, Demir and Uygur 
(2015) 
Myocardial infarction (late 
age) 
14.25 8.90 - 
     
Robertson, Javed, Samani and Khunti 
(2008) 
Attenders cardiac clinic 13.01 7.49 - 
Seivewright et al., (2004) Attenders GUM clinic 11.02 6.09 - 
Brown et al., (2012) Endoscopy MUS 14.50 10.50 - 
Brown et al., (2012) Endoscopy organic illness 17.60 14.00 - 
     
Hedman et al., (2013) Health anxiety 33.70  - 
Hedman et al., (2013) Health anxiety 34.00  - 
Abramowitz, Deacon and Valentiner 
(2007) 
Hypochondriasis 31.40 9.26 - 






McManus, Surawy, Muse, Vazquez-
Montes and Williams (2012) 
Hypochondriasis 33.23 7.22 .89 
     
Abramowitz, Deacon and Valentiner 
(2007) 
Anxiety disorder mixed 
including hypochondriasis 
18.60 13.22 .96 
Olatunji, Deacon, Abramowitz and 
Valentiner (2007) 
Anxiety disorder mixed 
including hypochondriasis 
37.45 11.27 - 
     
Aydemir, Kirpinar, Sati, Uykur, and 
Cengisiz (2013) 
Depression 14.30 7.90 - 
Abramowitz, Deacon and Valentiner 
(2007) 
GAD 13.09 11.91 - 
Abramowitz, Deacon and Valentiner 
(2007) 
OCD 17.44 16.07 - 
Deacon and Abramowitz  (2006) OCD 15.43 12.87 - 
Abramowitz, Deacon and Valentiner 
(2007) 
Panic 21.67 12.28 - 
Aydemir, Kirpinar, Sati, Uykur, and 
Cengisiz (2013) 





Deacon and Abramowitz  (2006) Panic 19.08 10.32 - 
Abramowitz, Deacon and Valentiner 
(2007) 
Social phobia 11.62 9.13 - 
Abramowitz, Deacon and Valentiner 
(2007) 
Somatoform disorder 24.80 1.30 - 
Abramowitz, Deacon and Valentiner 
(2007) 
Specific phobia 14.93 11.68 - 
     
Morales, Espada, Carballo, Piqueras 
and Orgiles (2015) 
Adolescents 10.48 5.70 .93 
Koteles, Freyler, Kokonyei and 
Bardos (2015) 
Adolescents 13.70 5.78 .78 
     
Aydemir, Kirpinar, Sati, Uykur, and 
Cengisiz (2013) 
Healthy controls 16.60 6.70 - 
Gerolimatos and Edelstein (2012b) Healthy controls 11.23 6.97 .90 
Gerolimatos and Edelstein (2012a) Healthy controls 14.68 6.97 .86 
Kobori, Okita, Shiraishi, Hasegawa 
and Iyo (2014) 





Koteles, Freyler, Kokonyei and 
Bardos (2015) 
Healthy controls 14.40 5.43 .76 
Rode, Salkovskis, Dowd and Hanna 
(2006) 
Healthy controls 8.50 4.40 - 
Ucar et al., (2015) Healthy controls 9.38 4.24 - 
     
Abramowitz and Moore (2007) Students 10.79 6.38 .86 
Brady, Cisler and Lohr (2014) Students 11.54 6.19 - 
Fan and Olatunji (2013) Students 14.70 6.13 .86 
Fergus and Valentiner (2011) Students 13.83 8.37 .91 
Fetzner et al., 2014) Students 12.13 6.96 .88 
Goetz, Lee and Cougle (2013) Students 9.69 5.77 .86 
Abramowitz, Olatunji and Deacon 
(2007) 
Students 14.70 6.02 .84 
Olatunji et al., (2007) Students 10.79 6.37 - 
Olatunji et al., (2009) Students 12.85 6.01 .86 
Olatunji, Ebesutani, Haidt and 
Sawchuk (2014) 
Students 13.57 7.08 - 





Shahidi, Molaie and Dehghani (2012) Students   0.78 
Sulkowski et al., (2011) Students 12.20 6.46 .87 
Wheaton, Berman, Franklin and 
Abramowitz (2010) 
Students 12.48 6.79 .88 
Wheaton, Abramowitz, Berman, 
Fabricant and Olatunji (2012) 
Students 12.03 6.75 .89 
Zhang, Liu, Li, Mao and Yuan (2015) Students 11.98 5.78 .74 
Zhang, Zhao, Mao, Li and Yuan 
(2014) 
Students 11.14 - - 
     
Bot, Anderson, Neuhaus and Ring 
(2013) 
Arm pain 11.00 6.80 .88 
Vranceanu, Safren, Cowan and Ring 
(2010) 
Arm pain non-traumatic 9.38 5.45 - 
Rode, Salkovskis, Dowd and Hanna 
(2006) 
Chronic pain 16.30 7.80 - 
Ucar et al., (2015) Fibromyalgia 23.50 10.78 - 
Rode, Salkovskis, Dowd and Hanna 
(2006) 
Pain 10.50 4.50 - 





Kobori, Okita, Shiraishi, Hasegawa 
and Iyo (2014) 
Chronic health problems 18.93 10.55 - 
Kobori, Okita, Shiraishi, Hasegawa 
and Iyo (2014) 
Mixed 16.07 - .93 
Muse, McManus, Leung, Meghreblian 
and Williams (2012) 
Mixed students and clinic 14.35 7.91 .90 
 
 
